Ingersoll Rand (IR) 10-K 19 Feb 25 2024 FY Annual report Financial data

Cover Page

Cover Page - USD ($) $ in Billions	12 Months Ended
	Dec. 31, 2024	Feb. 14, 2025	Jun. 30, 2024
Cover [Abstract]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Dec. 31, 2024
Current Fiscal Year End Date	--12-31
Document Transition Report	false
Entity File Number	001-38095
Entity Registrant Name	Ingersoll Rand Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	46-2393770
Entity Address, Address Line One	525 Harbour Place Drive
Entity Address, Address Line Two	Suite 600
Entity Address, City or Town	Davidson
Entity Address, State or Province	NC
Entity Address, Postal Zip Code	28036
City Area Code	704
Local Phone Number	655-4000
Title of 12(b) Security	Common Stock, $0.01 Par Value per share
Trading Symbol	IR
Security Exchange Name	NYSE
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Document Financial Statement Error Correction [Flag]	false
Entity Shell Company	false
Entity Public Float			$ 36.6
Entity Common Stock, Shares Outstanding		403,083,248
Documents Incorporated by Reference	Portions of the Proxy Statement for the registrant’s 2025 Annual Meeting of Stockholders are incorporated by reference in Part III of this report.
Entity Central Index Key	0001699150
Amendment Flag	false
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	FY

Audit Information

Audit Information	12 Months Ended
	Dec. 31, 2024
Audit Information [Abstract]
Auditor Name	DELOITTE & TOUCHE LLP
Auditor Location	Charlotte, NC
Auditor Firm ID	34

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
Revenues	$ 7,235	$ 6,876.1	$ 5,916.3
Cost of sales	4,065	3,993.9	3,590.7
Gross Profit	3,170	2,882.2	2,325.6
Selling and administrative expenses	1,344.4	1,272.7	1,095.8
Amortization of intangible assets	373	367.5	347.6
Impairment of other intangible assets	13.9	0	0
Other operating expense, net	138.6	77.7	64.9
Operating Income	1,300.1	1,164.3	817.3
Interest expense	213.2	156.7	103.2
Loss on extinguishment of debt	3	13.5	1.1
Other income, net	(48.9)	(37)	(29.2)
Income Before Income Taxes	1,132.8	1,031.1	742.2
Provision for income taxes	262.5	240	149.6
Income (loss) on equity method investments	(24)	(6)	0.7
Income from Continuing Operations	846.3	785.1	593.3
Income from discontinued operations, net of tax	0	0	15.2
Net Income	846.3	785.1	608.5
Less: Net income attributable to noncontrolling interests	7.7	6.4	3.8
Net Income Attributable to Ingersoll Rand Inc.	838.6	778.7	604.7
Amounts attributable to Ingersoll Rand Inc. common stockholders:
Income from continuing operations, net of tax	838.6	778.7	589.5
Income from discontinued operations, net of tax	0	0	15.2
Net Income Attributable to Ingersoll Rand Inc.	$ 838.6	$ 778.7	$ 604.7
Basic earnings per share of common stock:
Earnings from continuing operations (in USD per share)	$ 2.08	$ 1.92	$ 1.45
Earnings from discontinued operations (in USD per share)	0	0	0.04
Net earnings (in USD per share)	2.08	1.92	1.49
Diluted earnings per share of common stock:
Earnings from continuing operations (in USD per share)	2.06	1.90	1.44
Earnings from discontinued operations (in USD per share)	0	0	0.04
Net earnings (in USD per share)	$ 2.06	$ 1.90	$ 1.47

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Comprehensive Income Attributable to Ingersoll Rand Inc.
Net income attributable to Ingersoll Rand Inc.	$ 838.6	$ 778.7	$ 604.7
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments, net	(231.6)	34.8	(252.9)
Unrecognized gain (loss) on cash flow hedges	(9.1)	(3.8)	16
Pension and other postretirement prior service cost and gain (loss), net	(0.2)	(6.9)	26.8
Other comprehensive income (loss), net of tax	(240.9)	24.1	(210.1)
Comprehensive income attributable to Ingersoll Rand Inc.	597.7	802.8	394.6
Comprehensive Income (Loss) Attributable to Noncontrolling Interests
Net income attributable to noncontrolling interests	7.7	6.4	3.8
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments, net	2.7	1.7	(7.2)
Total other comprehensive income (loss), net of tax	2.7	1.7	(7.2)
Comprehensive income (loss) attributable to noncontrolling interests	10.4	8.1	(3.4)
Total Comprehensive Income	$ 608.1	$ 810.9	$ 391.2

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents	$ 1,541.2	$ 1,595.5
Accounts receivable, net of allowance for credit losses of $57.3 and $53.8, respectively	1,335.4	1,234.2
Inventories	1,055	1,001.1
Other current assets	231.9	219.6
Total current assets	4,163.5	4,050.4
Property, plant and equipment, net of accumulated depreciation of $567.5 and $500.8, respectively	842.1	711.4
Goodwill	8,148.1	6,609.7
Other intangible assets, net	4,372.8	3,611.1
Deferred tax assets	26.1	31.5
Other assets	457.2	549.4
Total assets	18,009.8	15,563.5
Current liabilities
Short-term borrowings and current maturities of long-term debt	3.1	30.6
Accounts payable	843.6	801.2
Accrued liabilities	972.2	995.5
Total current liabilities	1,818.9	1,827.3
Long-term debt, less current maturities	4,754.4	2,693
Pensions and other postretirement benefits	139.3	150
Deferred income tax liabilities	757.6	612.6
Other liabilities	294.3	433.9
Total liabilities	7,764.5	5,716.8
Commitments and contingencies (Note 22)
Stockholders’ equity
Common stock, $0.01 par value; 1,000,000,000 shares authorized; 430,745,964 and 428,589,061 shares issued as of December 31, 2024 and 2023, respectively	4.3	4.3
Capital in excess of par value	9,633.6	9,550.8
Retained earnings	2,503.5	1,697.2
Accumulated other comprehensive loss	(468.5)	(227.6)
Treasury stock at cost; 27,865,885 and 25,241,667 shares as of December 31, 2024 and 2023, respectively	(1,493.9)	(1,240.9)
Total Ingersoll Rand Inc. stockholders’ equity	10,179	9,783.8
Noncontrolling interests	66.3	62.9
Total equity	10,245.3	9,846.7
Total liabilities and equity	$ 18,009.8	$ 15,563.5

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Allowance for credit losses	$ 57.3	$ 53.8
Accumulated depreciation on property, plant and equipment	$ 567.5	$ 500.8
Common stock, par value (in USD per share)	$ 0.01	$ 0.01
Common stock authorized (in shares)	1,000,000,000	1,000,000,000
Common stock issued (in shares)	430,745,964	428,589,061
Treasury stock (in shares)	27,865,885	25,241,667

CONSOLIDATED STATEMENTS OF STOC

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Millions	Total	Total Ingersoll Rand Inc. Stockholders’ Equity	Common Stock	Capital in Excess of Par Value	Retained Earnings	Accumulated Other Comprehensive Loss	Treasury Stock	Noncontrolling Interests
Balance at beginning of period (shares) at Dec. 31, 2021			423,800,000
Balance at beginning of period at Dec. 31, 2021	$ 9,071.2	$ 9,001.5	$ 4.3	$ 9,408.6	$ 378.6	$ (41.6)	$ (748.4)	$ 69.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	608.5	604.7			604.7			3.8
Dividends declared	(32.4)	(32.4)			(32.4)
Issuance of common stock for stock-based compensation plans (in shares)			2,500,000
Issuance of common stock for stock-based compensation plans	17.3	17.3	$ 0	17.3
Purchases of treasury stock	(261.1)	(261.1)					(261.1)
Issuance of treasury stock for stock-based compensation plans	2.2	2.2		(22.8)			25
Stock-based compensation	73.7	73.7		73.7
Other comprehensive income (loss), net of tax	(217.3)	(210.1)				(210.1)		(7.2)
Dividends attributable to noncontrolling interests	(4.9)							(4.9)
Balance at end of period (shares) at Dec. 31, 2022			426,300,000
Balance at end of period at Dec. 31, 2022	9,257.2	9,195.8	$ 4.3	9,476.8	950.9	(251.7)	(984.5)	61.4
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	785.1	778.7			778.7			6.4
Dividends declared	(32.4)	(32.4)			(32.4)
Issuance of common stock for stock-based compensation plans (in shares)			2,300,000
Issuance of common stock for stock-based compensation plans	27.8	27.8		27.8
Purchases of treasury stock	(264.1)	(264.1)					(264.1)
Issuance of treasury stock for stock-based compensation plans	2.8	2.8		(4.9)			7.7
Stock-based compensation	51.1	51.1		51.1
Other comprehensive income (loss), net of tax	25.8	24.1				24.1		1.7
Dividends attributable to noncontrolling interests	$ (6.6)							(6.6)
Balance at end of period (shares) at Dec. 31, 2023	403,347,394		428,600,000
Balance at end of period at Dec. 31, 2023	$ 9,846.7	9,783.8	$ 4.3	9,550.8	1,697.2	(227.6)	(1,240.9)	62.9
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	846.3	838.6			838.6			7.7
Dividends declared	(32.3)	(32.3)			(32.3)
Issuance of common stock for stock-based compensation plans (in shares)			2,100,000
Issuance of common stock for stock-based compensation plans	30.1	30.1		30.1
Purchases of treasury stock	(261.2)	(261.2)					(261.2)
Issuance of treasury stock for stock-based compensation plans	2.1	2.1		(6.1)			8.2
Stock-based compensation	58.8	58.8		58.8
Other comprehensive income (loss), net of tax	(238.2)	(240.9)				(240.9)		2.7
Dividends attributable to noncontrolling interests	$ (7)							(7)
Balance at end of period (shares) at Dec. 31, 2024	402,880,079		430,700,000
Balance at end of period at Dec. 31, 2024	$ 10,245.3	$ 10,179	$ 4.3	$ 9,633.6	$ 2,503.5	$ (468.5)	$ (1,493.9)	$ 66.3

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Cash Flows From Operating Activities
Net Income	$ 846.3	$ 785.1	$ 608.5
Income from discontinued operations, net of tax	0	0	15.2
Income from continuing operations	846.3	785.1	593.3
Adjustments to reconcile income from continuing operations to net cash provided by operating activities from continuing operations:
Amortization of intangible assets	373	367.5	347.6
Depreciation	109	91.6	85.2
Impairment of other intangible assets	13.9	0	0
Non-cash restructuring charges	1.6	2.7	6
Stock-based compensation expense	58.8	51.9	78.9
Loss (income) on equity method investments	24	6	(0.7)
Foreign currency transaction losses (gains), net	3.2	5.1	(5.9)
Non-cash adjustments to carrying value of LIFO inventories	6.7	12	36.1
Loss on extinguishment of debt	3	13.5	1.1
Loss on sale of asbestos-related assets and liabilities	33.7	0	0
Deferred income taxes	(33.1)	(76.9)	(85.8)
Other non-cash adjustments	7.7	8.3	7
Changes in assets and liabilities:
Receivables	(45.1)	(48.6)	(195.2)
Inventories	39.8	117.3	(225.6)
Accounts payable	13.3	(23.9)	120.4
Accrued liabilities	(34.5)	94.8	101.2
Other assets and liabilities, net	(24.6)	(29)	1.8
Net cash provided by operating activities from continuing operations	1,396.7	1,377.4	865.4
Cash Flows From Investing Activities
Capital expenditures	(149.1)	(105.4)	(94.6)
Net cash paid in acquisitions	(2,958.7)	(963)	(246.8)
Disposals of property, plant and equipment	6.1	7.6	0
Other investing	(6)	0.3	4.1
Net cash used in investing activities from continuing operations	(3,107.7)	(1,060.5)	(337.3)
Cash Flows From Financing Activities
Principal payments on long-term debt	(1,242.7)	(1,518)	(655.6)
Proceeds from long-term debt	3,296.9	1,490.4	0
Purchases of treasury stock	(260.7)	(263)	(261.1)
Cash dividends on common stock	(32.3)	(32.4)	(32.4)
Proceeds from stock option exercises	32.2	30.3	19.3
Payments to settle cross-currency swaps	(19.9)	0	0
Payments of interest rate cap premiums	0	0	(13.4)
Payments of deferred and contingent acquisition consideration	(23.4)	(17.5)	(4.6)
Payments of debt issuance costs	(32.3)	(18.5)	0
Other financing	(10.3)	(8.8)	(6.2)
Net cash (used in) provided by financing activities from continuing operations	1,707.5	(337.5)	(954)
Cash Flows Used In Discontinued Operations
Net cash used in operating activities	0	0	(5.1)
Net cash provided by investing activities	0	0	4.4
Net cash used in discontinued operations	0	0	(0.7)
Effect of exchange rate changes on cash and cash equivalents	(50.8)	3.1	(70)
Net decrease in cash and cash equivalents	(54.3)	(17.5)	(496.6)
Cash and cash equivalents, beginning of year	1,595.5	1,613	2,109.6
Cash and cash equivalents, end of year	1,541.2	1,595.5	1,613
Supplemental Cash Flow Information
Cash paid for income taxes, net of refunds	276.7	302	181.5
Cash paid for interest, net of interest rate derivative settlements	$ 209	$ 100.5	$ 95.2

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2024
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Overview and Basis of Presentation Ingersoll Rand Inc. is a global provider of mission-critical flow creation products and life science and industrial solutions. The accompanying consolidated financial statements include the accounts of Ingersoll Rand Inc. and its consolidated subsidiaries (collectively referred to herein as “Ingersoll Rand” or the “Company”). Principles of Consolidation The accompanying consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). All intercompany transactions and accounts have been eliminated in consolidation. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. The Company regularly evaluates the estimates and assumptions related to the allowance for credit losses, inventory valuation, warranty reserves, fair value of stock-based awards, goodwill, intangible asset, and long-lived asset valuations, employee benefit plan liabilities, over time revenue recognition, income tax liabilities and deferred tax assets and related valuation allowances, uncertain tax positions, restructuring reserves, and litigation and other loss contingencies. Actual results could differ materially and adversely from those estimates and assumptions, and such results could affect the Company’s consolidated net income, financial position, or cash flows. Foreign Currency Translation Assets and liabilities of the Company’s foreign subsidiaries, where the functional currency is not the U.S. Dollar (“USD”), are translated at the exchange rate in effect at the balance sheet date, while revenues and expenses are translated at average rates prevailing during the year. Adjustments resulting from the translation of the assets and liabilities of foreign operations into USD are excluded from the determination of net income, and are reported in accumulated other comprehensive loss, a separate component of stockholders’ equity, and included as a component of other comprehensive income (loss). Assets and liabilities of subsidiaries that are denominated in currencies other than the subsidiaries’ functional currency are remeasured into the functional currency using end of period exchange rates, or historical rates for certain balances, where applicable. Gains and losses related to these remeasurements are recorded within the Consolidated Statements of Operations as a component of “Other operating expense, net.” Revenue Recognition The Company recognizes revenue when the Company has satisfied its obligation and control is transferred to the customer. The majority of the Company’s revenues are derived from short duration contracts and revenue is recognized at a single point in time when control is transferred to the customer, generally at shipment or when delivery has occurred or services have been rendered. The Company also has certain contracts in which revenue is recognized over time based on the Company’s progress in satisfying the contractual performance obligations. See Note 16 “Revenue from Contracts with Customers” for additional information regarding revenue recognition. Cost of Sales Cost of sales includes the costs the Company incurs, including purchased materials, labor and overhead related to manufactured products and aftermarket parts sold during a period. Depreciation related to manufacturing equipment and facilities is included in cost of sales. Purchased materials represent the majority of costs of sales, with steel, aluminum, copper and partially finished castings representing the most significant materials inputs. Cost of sales for services includes the direct costs the Company incurs including direct labor, parts and other overhead costs including depreciation of equipment and facilities to deliver repair, maintenance, and other field services to the Company’s customers. Selling and Administrative Expenses Selling and administrative expenses consist of (i) employee related salary, stock-based compensation expense, benefits and other expenses for selling, administrative functions and other activities not associated with the manufacture of products or delivery of services to customers; (ii) the costs of marketing and direct costs of selling products and services to customers including internal and external sales commissions; (iii) facilities costs including office rent, maintenance, depreciation, and insurance for selling and administrative activities; (iv) research and development expenditures; (v) professional and consultant fees; and (vi) other miscellaneous expenses. Cash and Cash Equivalents Cash and cash equivalents are highly liquid investments primarily consisting of demand deposits and have original maturities of three months or less. Accordingly, the carrying amount of such instruments is considered a reasonable estimate of fair value. As of December 31, 2024 and 2023, cash of $10.5 million and $1.2 million, respectively, was pledged to financial institutions as collateral to support the issuance of standby letters of credit and similar instruments on behalf of the Company. Accounts Receivable Trade accounts receivable consist of amounts owed for products shipped to or services performed for customers. Reviews of customers’ creditworthiness are performed prior to order acceptance or order shipment. Trade accounts receivable are recorded net of an allowance for expected credit losses. The allowance for credit losses is based on the Company’s assessment of losses that will result from its customers’ inability or unwillingness to pay amounts owed to the Company. The allowance is determined using a combination of factors, including historical credit loss experience and the length of time that the trade receivables are past due, supplemented by the Company’s knowledge of customer-specific information, current market conditions and reasonable and supportable forecasts of future events and economic conditions. Inventories Inventories, which consist primarily of raw materials and finished goods, are carried at the lower of cost or net realizable value. Fixed manufacturing overhead is allocated to the cost of inventory based on the normal capacity of production facilities. Unallocated overhead during periods of abnormally low production levels is recognized as cost of sales in the period in which it is incurred. Property, Plant and Equipment Property, plant and equipment includes the historical cost of land, buildings, equipment, and significant improvements to existing plant and equipment or in the case of acquisitions, a fair market value of assets at the time of acquisition. Repair and maintenance costs that do not extend the useful life of an asset are recorded as an expense as incurred. Depreciation is provided using the straight-line method over the estimated useful lives of the assets, which are generally as follows: buildings — 10 to 30 years, machinery and equipment — 7 to 10 years, and office furniture and equipment — 3 to 10 years. Goodwill and Indefinite-Lived Intangible Assets Goodwill is recorded as the difference, if any, between the aggregate consideration paid for an acquisition and the fair value of the net tangible and intangible assets acquired, liabilities assumed, and non-controlling interests, if any. Intangible assets, including goodwill, are assigned to the Company’s reporting units based upon their fair value at the time of acquisition. Goodwill and indefinite-lived intangibles such as tradenames are not subject to amortization but are assessed for impairment annually, or more frequently if events or changes in circumstances indicate that the asset might be impaired or that there is a probable reduction in the fair value of a reporting unit below its aggregate carrying value. The Company tests goodwill for impairment annually in the fourth quarter of each year using data as of October 1 of that year and whenever events or changes in circumstances indicate the carrying value may not be recoverable. The impairment test consists of comparing the fair value of the reporting unit to the carrying value of the reporting unit. An impairment charge is recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value; provided, the loss recognized cannot exceed the total amount of goodwill allocated to the reporting unit. If applicable, the Company considers income tax effects from any tax deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss. The Company determined fair values for each of the reporting units using a combination of the income and market multiple approaches which are weighted 75% and 25%, respectively. Under the income approach, fair value is determined based on the present value of estimated future cash flows, discounted at an appropriate risk-adjusted rate. The Company uses its internal forecasts to estimate future cash flows and includes an estimate of long-term future growth rates based on its most recent views of the long-term outlook for each reporting unit. Actual results may differ from those assumed in the Company’s forecasts. The Company derives its discount rates using a capital asset pricing model and analyzing published rates for industries relevant to its reporting units to estimate the cost of equity financing. The Company uses discount rates that are commensurate with the risks and uncertainty inherent in the respective businesses and in its internally developed forecasts. Under the market approach, the Company applies performance multiples from comparable public companies, adjusted for relative risk, profitability, and growth considerations, to the reporting units to estimate fair value. The Company tests intangible assets with indefinite lives annually for impairment using a relief from royalty discounted cash flow fair value model. The quantitative impairment test for indefinite-lived intangible assets involves a comparison of the estimated fair value of the intangible asset with its carrying value. If the carrying value of the intangible asset exceeds its fair value, an impairment loss is recognized in an amount equal to that excess. The relief from royalty method requires the Company to estimate forecasted revenues and determine appropriate discount rates, royalty rates, and terminal growth rates. See Note 9 “Goodwill and Other Intangible Assets” for additional information related to impairment testing for goodwill and other intangible assets. Long-Lived Assets Including Intangible Assets With Finite Useful Lives Intangible assets with finite useful lives are amortized on a straight-line basis over their estimated useful lives, which vary depending on the type of intangible assets. In determining the estimated useful lives of definite-lived intangibles, we consider the nature, competitive position, life cycle position and historical and expected future operating cash flows of each acquired assets, as well as our commitment to support these assets through continued investment and legal infringement protection. The Company reviews long-lived assets, including identified intangible assets with finite useful lives and subject to amortization for impairment, whenever events or changes in circumstances indicate that the related carrying amounts may not be recoverable. Determining whether an impairment loss occurred requires comparing the carrying amount to the sum of undiscounted cash flows expected to be generated by the asset. Such events and circumstances include the occurrence of an adverse change in the market involving the business employing the related long-lived assets or a situation in which it is more likely than not that the Company will dispose of such assets. If the comparison indicates that there is impairment, the impairment loss to be recognized as a non-cash charge to earnings is measured by the amount by which the carrying amount of the assets exceeds their fair value and the impaired assets are written down to their fair value or, if fair value is not readily determinable, to an estimated fair value based on discounted expected future cash flows. Assets to be disposed are reported at the lower of the carrying amount or fair value, less costs to dispose. Warranty Reserves Most of the Company’s product sales are covered by warranty provisions that generally provide for the repair or replacement of qualifying defective items for a specified period after the time of sale, typically 12 months. The Company establishes reserves for estimated product warranty costs at the time revenue is recognized based upon historical warranty experience and additionally for any known product warranty issues. The Company’s warranty obligation has been and may in the future be affected by product failure rates, repair or field replacement costs, and additional costs incurred in correcting any product failure. Stock-Based Compensation Stock-based compensation is measured for all stock-based equity awards made to employees and non-employee directors based on the estimated fair value as of the grant date. The determination of the fair values of stock-based awards at the grant date requires judgment, including estimating the expected term of the relevant stock-based payment awards and the expected volatility of the Company’s stock. The fair value of each stock option grant under the stock-based compensation plans is estimated on the date of grant or modification using the Black-Scholes-Merton option-pricing model. The expected stock volatility assumption was based on an average of the historical volatility over the expected term of the stock options. Forfeitures of stock options are accounted for as they occur. Restricted stock units and performance share units with internal performance metrics (i.e. EPS) are valued at the share price on the date of grant. The grant date fair value of performance share units with external performance metrics (i.e. TSR) is determined using a Monte Carlo simulation pricing model. See Note 19 “Stock-Based Compensation Plans” for additional information regarding the Company’s equity compensation plans. Pension and Other Postretirement Benefits The Company sponsors a number of pension plans and other postretirement benefit plans worldwide. The calculation of the pension and other postretirement benefit obligations and net periodic benefit cost under these plans requires the use of actuarial valuation methods and assumptions. These assumptions include the discount rates used to value the projected benefit obligations, future rate of compensation increases, expected rates of return on plan assets and expected healthcare cost trend rates. The discount rates selected to measure the present value of the Company’s benefit obligations as of December 31, 2024 and 2023 were derived by examining the rates of high-quality, fixed income securities whose cash flows or duration match the timing and amount of expected benefit payments under the plans. In accordance with GAAP, actual results that differ from the Company’s assumptions are recorded in accumulated other comprehensive income (loss) and amortized through net periodic benefit cost over future periods. While management believes that the assumptions are appropriate, differences in actual experience or changes in assumptions may affect the Company’s pension and other postretirement benefit obligations and future net periodic benefit cost. See Note 13 “Benefit Plans” for disclosures related to the Company’s benefit plans, including quantitative disclosures reflecting the impact that changes in certain assumptions would have on service and interest costs and benefit obligations. Income Taxes The Company has determined income tax expense and other deferred income tax information based on the asset and liability method. Deferred income tax liabilities are provided on temporary differences between assets and liabilities for financial and tax reporting purposes as measured by enacted tax rates expected to apply when temporary differences are settled or realized. A valuation allowance is established for the portion of deferred tax assets for which it is not more likely than not that a tax benefit will be realized. Tax benefits are recognized only for tax positions that are more likely than not to be sustained upon examination by tax authorities. The amount recognized is measured as the largest amount of benefit that is greater than 50% likely to be realized upon ultimate settlement. Unrecognized tax benefits are tax benefits claimed in the Company’s tax returns that do not meet these recognition and measurement standards. The Company believes that its income tax liabilities, including related interest, are adequate in relation to the potential for additional tax assessments. There is a risk, however, that the amounts ultimately paid upon resolution of audits could be materially different from the amounts previously included in income tax expense and, therefore, could have a material impact on the Company’s tax provision, net income, and cash flows. The Company reviews its liabilities quarterly, and may adjust such liabilities due to proposed assessments by tax authorities, changes in facts and circumstances, issuance of new regulations or new case law, negotiations between tax authorities of different countries concerning transfer prices, the resolution of audits, or the expiration of statutes of limitations. Adjustments are most likely to occur in the year during which major audits are closed. The Tax Cuts and Jobs Act (“Tax Act”), enacted on December 22, 2017, created a new requirement that certain income (i.e., Global intangible low taxed income (“GILTI”)) earned by controlled foreign corporations (“CFC”) must be included currently in the gross income of the CFCs’ U.S. shareholder. GILTI is the excess of the shareholder’s “net CFC tested income” over the net deemed tangible income return, which is currently defined as the excess of (1) 10% of the aggregate of the U.S. shareholder’s pro rata share of the qualified business asset investment of each CFC with respect to which it is a U.S. shareholder over (2) the amount of certain interest expense taken into account in the determination of net CFC-tested income. Under U.S. GAAP, the Company is allowed to make an accounting policy choice of either (1) treating taxes due on future U.S. inclusions in taxable income related to GILTI as a current-period expense when incurred (the “period cost method”) or (2) factoring such amounts into a company’s measurement of its deferred taxes (the “deferred method”). The Company has determined that it will follow the period cost method (option 1 above). The Company recorded a tax expense of $4.6 million in 2024 for the GILTI provisions of the Tax Act. Research and Development For the years ended December 31, 2024, 2023 and 2022, the Company spent $116.6 million , $108.2 million, and $91.3 million, respectively, on research activities relating to the development of new products and new product applications. All such expenditures were funded by the Company, expensed as incurred and recorded to “Selling and administrative expenses” in the Consolidated Statements of Operations. Derivative Financial Instruments All derivative financial instruments are reported on the balance sheet at fair value. For derivative instruments that are not designated as hedges, any gain or loss on the derivatives is recognized in earnings in the current period. A derivative instrument may be designated as a hedge of the exposure to: (1) changes in the fair value of an asset, liability, or firm commitment, (2) variability in expected future cash flows, if the hedging relationship is expected to be highly effective in offsetting changes in fair value or cash flows attributable to the hedged risk during the period of designation or (3) as a hedge of a net investment in a foreign operation. If a derivative is designated as a fair value hedge, the gain or loss on the derivative and the offsetting loss or gain on the hedged asset, liability, or firm commitment are recognized in earnings. For derivative instruments designated as a cash flow hedge, the effective portion of the gain or loss on the derivative instrument is reported as a component of accumulated other comprehensive income and reclassified to earnings in the same period that the hedged transaction affects earnings. For derivative instruments designated as net investment in a foreign operation, gains or losses are reported as currency translation adjustments. The ineffective portion of the gain or loss is immediately recognized in earnings. Gains or losses on derivative instruments recognized in earnings are reported in the same line item as the associated hedged transaction in the Consolidated Statements of Operations. Hedge accounting is discontinued prospectively when (1) it is determined that a derivative is no longer effective in offsetting changes in the fair value or cash flows of a hedged item; (2) the derivative is sold, terminated, or exercised; (3) the hedged item no longer meets the definition of a firm commitment; or (4) it is unlikely that a forecasted transaction will occur within two months of the originally specified time period. When hedge accounting is discontinued because it is determined that the derivative no longer qualifies as an effective fair-value hedge, the derivative continues to be carried on the balance sheet at its fair value, and the changes in the fair value of the hedged asset or liability is recorded to the Consolidated Statements of Operations. When cash flow hedge accounting is discontinued because the derivative is sold, terminated, or exercised, the net gain or loss remains in accumulated other comprehensive income and is reclassified into earnings in the same period that the hedged transaction affects earnings or until it becomes unlikely that a hedged forecasted transaction will occur within two months of the originally scheduled time period. When hedge accounting is discontinued because a hedged item no longer meets the definition of a firm commitment, the derivative continues to be carried on the Consolidated Balance Sheet at its fair value, and any asset or liability that was recorded pursuant to recognition of the firm commitment is removed from the balance sheet and recognized as a gain or loss currently in earnings. When hedge accounting is discontinued because it is probable that a forecasted transaction will not occur within two months of the originally specified time period, the derivative continues to be carried on the balance sheet at its fair value, and gains and losses reported in accumulated other comprehensive income are recognized immediately in the Consolidated Statements of Operations. Comprehensive Income The Company’s comprehensive income consists of net income (loss) and other comprehensive income (loss), consisting of (i) unrealized foreign currency net gains and losses on the translation of the assets and liabilities of its foreign operations; (ii) realized and unrealized foreign currency gains and losses on intercompany notes of a long-term nature and hedges of net investments in foreign operations, net of income taxes; (iii) unrealized gains and losses on cash flow hedges, net of income taxes; and (iv) pension and other postretirement prior service cost and actuarial gains or losses, net of income taxes. See Note 15 “Accumulated Other Comprehensive Income (Loss).” Restructuring Charges The Company incurs costs in connection with workforce reductions, facility consolidations and other actions. Such costs include employee termination benefits (one-time arrangements and benefits attributable to prior service), termination of contractual obligations, non-cash asset charges and other direct incremental costs. A liability is established through a charge to operations for (i) one-time employee termination benefits when management commits to a plan of termination; (ii) employee termination benefits that accumulate or vest based on prior service when it becomes probable that such termination benefits will be paid and the amount of the payment can be reasonably estimated; and (iii) contract termination costs when the contract is terminated or the Company becomes contractually obligated to make such payment. Other direct incremental costs are charged to operations as incurred. Charges recorded in connection with restructuring plans are included in “Other operating expense, net” in the Consolidated Statements of Operations. Business Combinations The Company accounts for business combinations by applying the acquisition method. The Company’s consolidated financial statements include the operating results of acquired entities from the respective dates of acquisition. The Company recognizes and measures the identifiable assets acquired, liabilities assumed, and any non-controlling interest as of the acquisition date at fair value. The excess, if any, of total consideration transferred in a business combination over the fair value of identifiable assets acquired, liabilities assumed, and any non-controlling interest is recognized as goodwill in the Consolidated Balance Sheets. Costs incurred by the Company to effect a business combination other than costs related to the issuance of debt or equity securities are included in the Consolidated Statements of Operations in the period the costs are incurred. Earnings per Share The calculation of earnings per share (“EPS”) is based on the weighted-average number of the Company’s shares outstanding for the applicable period. The calculation of diluted earnings per share reflects the effect of all dilutive potential shares that were outstanding during the respective periods, unless the effect of doing so is antidilutive. The Company uses the treasury stock method to calculate the effect of outstanding share-based compensation awards. Leases The Company has operating and financing leases for real estate, vehicles, IT equipment, office equipment and production equipment. The Company determines if an arrangement is a lease and identifies the classification of the lease as a financing lease or an operating lease at inception. Operating leases are recorded as operating lease right-of-use assets (“ROU assets”) in “Other assets” and operating lease liabilities in “Accrued liabilities” and “Other liabilities” in the Consolidated Balance Sheets. Financing leases are recorded as financing ROU assets in “Property, plant and equipment” and lease liabilities in “Short-term borrowings and current maturities of long-term debt” and “Long-term debt, less current maturities” in the Consolidated Balance Sheets. At the date of commencement, lease liabilities are recorded at the present value of the future minimum lease payments over the lease term. The lease term is equal to the initial term at commencement plus any renewal or extension options that the Company is reasonably certain will be exercised. ROU assets at the date of commencement are equal to the amount of the initial lease liability, the initial direct costs incurred by the Company and any prepaid lease payments less any incentives received. An incremental borrowing rate is used in the determination of the present value of future lease payments. Incremental borrowing rates for a lease are based on the lease term, lease currency and the Company’s credit spread.

New Accounting Standards

New Accounting Standards	12 Months Ended
	Dec. 31, 2024
Accounting Standards Update and Change in Accounting Principle [Abstract]
New Accounting Standards	New Accounting Standards Recently Adopted Accounting Standard Updates (“ASU”) In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segments expenses. The amendments in this update are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. The amendments in this update were applied retrospectively to all prior periods presented in the financial statements. The segment expense categories and amounts disclosed in the prior periods were based on the significant segment expense categories identified and disclosed in Note 24 “Segment Reporting.” The adoption has modified our disclosures but has not had a material effect on our consolidated financial statements. Recently Issued Accounting Pronouncements In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which addresses investor requests for more transparency about income tax information through improvements to income tax disclosures primarily related to the rate reconciliation and income taxes paid information. The amendments in this update are effective for annual periods beginning after December 15, 2024. Early adoption is permitted for annual statements that have not yet been issued or made available for issuance. The amendments in this update should be applied on a prospective basis. Retrospective application is permitted. The adoption will modify our disclosures but is not expected to have a material effect on our consolidated financial statements. In November 2024, the FASB issued ASU 2024-03, Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires disclosure of additional disaggregated information about significant expenses within relevant income statement captions, such as purchases of inventory, employee compensation, depreciation, amortization, and depletion. The amendment is effective for fiscal years beginning after December 15, 2026. Early adoption is permitted. The amendment should be applied prospectively; however, retrospective application is permitted. Management is currently evaluating this ASU to determine its impact on the Company’s disclosures.

Discontinued Operations

Discontinued Operations	12 Months Ended
	Dec. 31, 2024
Discontinued Operations and Disposal Groups [Abstract]
Discontinued Operations	Discontinued Operations Discontinued operations consist of two formerly-owned businesses, Specialty Vehicle Technologies (“SVT” or “Club Car”) and High Pressure Solutions (“HPS”). The results of operations, financial positions and cash flows of these businesses are reported as discontinued operations for all periods presented in these consolidated financial statements. Specialty Vehicle Technologies On April 9, 2021, the Company entered into an agreement to sell Club Car to private equity firm Platinum Equity Advisors, LLC (“Platinum Equity”) for $1.68 billion in cash. The sale was substantially completed on June 1, 2021 and concluded in the third quarter of 2022. High Pressure Solutions On February 14, 2021, the Company entered into an agreement to sell its majority interest in High Pressure Solutions to private equity firm American Industrial Partners. In exchange for its majority interest of 55%, the Company received net cash proceeds of $278.3 million and retained a 45% common equity interest in the newly-formed entity comprising the HPS business. The Company expects to maintain this minority investment indefinitely and is unable to estimate when this interest may be disposed. This sale was substantially completed on April 1, 2021. Financial information of discontinued operations The results of operations of SVT and HPS are presented as discontinued operations for the year ended December 31, 2022 as summarized below: Specialty Vehicle Technologies High Pressure Solutions Total Revenues $ 6.6 $ — $ 6.6 Cost of sales 6.5 — 6.5 Gross Profit 0.1 — 0.1 Selling and administrative expenses 0.1 — 0.1 Gain on sale (2.8) — (2.8) Other operating expense, net 0.7 1.6 2.3 Income from Discontinued Operations Before Income Taxes 2.1 (1.6) 0.5 Provision for income taxes (13.2) (1.5) (14.7) Income from Discontinued Operations, Net of Tax $ 15.3 $ (0.1) $ 15.2 The significant non-cash operating items and capital expenditures reflected in cash flows of discontinued operations for the year ended December 31, 2022 include a gain on sale of $2.8 million related to Specialty Vehicle Technologies.

Acquisitions

Acquisitions	12 Months Ended
	Dec. 31, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Acquisitions	Acquisitions 2024 Acquisitions On February 1, 2024, the Company completed the acquisition of Friulair S.r.l. (“Friulair”) for initial cash consideration of $143.3 million and contingent consideration of up to approximately $11.0 million. The business is a manufacturer of dryers, filters, aftercoolers, and accessories for the treatment of compressed air and its chiller product line. The acquisition is intended to increase the scale of the Company’s air dryer business and will add new chiller production capabilities. Friulair has been reported within the Industrial Technologies and Services segment. The goodwill arising from the acquisition is primarily attributable to revenue and cost synergies, anticipated growth of new and existing customers, and the assembled workforce. Substantially all of this goodwill is not expected to be deductible for tax purposes. On April 1, 2024, the Company completed the acquisition of Controlled Fluidics, LLC (“Controlled Fluidics”) for initial cash consideration of $49.9 million and contingent consideration of up to $2.0 million. The business specializes in thermoplastic, high-performance plastic bonding and custom plastic assembly products for life sciences, medical, aerospace, and industrial applications. The acquisition will complement Ingersoll Rand’s current life sciences offerings and increase the Company’s market share in high-growth, sustainable end markets. Controlled Fluidics has been reported within the Precision and Science Technologies segment. On April 2, 2024, the Company completed the acquisition of Ethafilter s.r.l. (“Ethafilter”) for cash consideration of $15.5 million. The business primarily produces filters and filter elements that can be used with all major brands in the compressed air sector. The acquisition will expand Ingersoll Rand’s product portfolio, extend its reach in highly attractive end markets with the addition of sterile filter technology, and drive ongoing growth from aftermarket services and offerings. Ethafilter has been reported within the Industrial Technologies and Services segment. On May 1, 2024, the Company completed the acquisition of Air Systems, LLC (“Air Systems”) for cash consideration of $34.9 million. The business is a provider of compressed air services. Air Systems has been reported within the Industrial Technologies and Services segment. On May 31, 2024, the Company completed the acquisition of Complete Air and Power Solutions (“CAPS”) for cash consideration of $99.3 million. The business is a provider of compressed air and power generation services. The acquisition is expected to expand the Company’s channel within Australia. CAPS has been reported within the Industrial Technologies and Services segment. On May 31, 2024, the Company completed the acquisition of Fruvac Ltd. (“Fruitland Manufacturing”) for cash consideration of $28.0 million. The business is a manufacturer of mobile and truck mounted vacuum pumps, systems, and peripheral parts. The acquisition is expected to expand the Company’s capabilities to include low flow applications in the mobile vacuum market. Fruitland Manufacturing has been reported within the Industrial Technologies and Services segment. On June 1, 2024, the Company completed the acquisition of Del PD Pumps & Gear Pvt Ltd. (“Del Pumps”) for cash consideration of $25.2 million. The business is a manufacturer of rotary, twin, and triple gear pumps for the loading, unloading, transfer, and pressurization of liquids. The acquisition will complement the Company’s portfolio of mission critical, high margin pumping solutions across life science, food and beverage, medical, natural gas, and wastewater treatment industries. Del Pumps has been reported within the Precision and Science Technologies segment. On June 3, 2024, the Company completed the acquisition of Astronaut Topco, LP and Astronaut Topco GP, LLC (collectively “ILC Dover”) for initial cash consideration of $2,349.7 million and contingent consideration of up to $75.0 million. ILC Dover’s offerings include solutions for biopharmaceutical, pharmaceutical, and medical device markets as well as products for the space industry and will be reported in the Precision and Science Technologies segment. The amount allocated to definite-lived intangible assets represents the estimated fair values of customer relationships of $621.0 million and technology of $142.0 million and will be amortized over the weighted average useful lives of 14 years and 8 years, respectively. The amount allocated to indefinite-lived intangible assets represents the estimated fair value of tradenames of $207.5 million and goodwill of $1,309.8 million. The goodwill arising from the acquisition is primarily attributable to revenue and cost synergies, anticipated growth of new and existing customers, and the assembled workforce. The majority of this goodwill is not expected to be deductible for tax purposes. On October 1, 2024, the Company completed the acquisition of Air Power Systems Co LLC (“APSCO”) for cash consideration of $113.2 million. The business is a provider of hydraulic and pneumatic products and engineered solutions serving diverse specialty work truck vehicles. APSCO’s offerings include hydraulic coolers, systems, and components in addition to pneumatic consoles, cylinders, valves, and switches. The acquisition will expand Ingersoll Rand’s position in the dry and liquid bulk markets with energy efficient, innovative solutions. APSCO has been reported within the Industrial Technologies and Services segment. The majority of this goodwill is expected to be deductible for tax purposes. On October 1, 2024, the Company completed the acquisition of Blutek S.r.l. (“Blutek”) for cash consideration of $9.6 million. The business specializes in the design and production of highly engineered solutions for compressed air and nitrogen generation in mission-critical environments. The acquisition will increase Ingersoll Rand’s ability to compete in high specification projects, adding technology capabilities, expertise, and aftermarket potential in high-growth end markets including biogas and carbon capture. Blutek has been reported within the Industrial Technologies and Services segment. On October 1, 2024, the Company completed the acquisition of UT Pumps & Systems Private Ltd. (“UT Pumps”) for cash consideration of $11.7 million. The business is a manufacturer of screw pumps and triplex plunger pumps. The acquisition adds new pump technology to Ingersoll Rand’s portfolio. Its high-pressure pumps are mainly focused on attractive end markets including water, wastewater, food and beverage, pharmaceuticals, general industrial, and chemicals. UT Pumps has been reported within the Precision and Science Technologies segment. On October 31, 2024, the Company completed the acquisition of Penn Valley Pump Co., LLC (“Penn Valley Pumps”) for cash consideration of $33.2 million. The business is a manufacturer of positive displacement pumps with its Double Disc Pump technology for use in the municipal, industrial, chemical, and food industries. Penn Valley Pumps has been reported within the Precision and Science Technologies segment. Other acquisitions completed during the year ended December 31, 2024 include several sales and service businesses and manufacturers of vacuum pumps and accessories, substantially all of which have been reported within the Industrial Technologies and Services segment. The aggregate consideration for these acquisitions was $55.6 million. The following table summarizes the allocation of consideration for all businesses acquired in 2024 to the fair values of identifiable assets acquired and liabilities assumed at the acquisition dates. Initial accounting for Friulair is substantially complete and all other businesses acquired in 2024 are preliminary, and amounts assigned to acquired assets and liabilities assumed are subject to change as information necessary to complete the analysis is obtained. ILC Dover Friulair APSCO All others Total Consideration Accounts receivable $ 41.4 $ 14.2 $ 6.4 $ 37.8 $ 99.8 Inventories 84.0 13.2 7.5 46.3 151.0 Other current assets 35.1 0.5 0.5 4.7 40.8 Property, plant and equipment 90.8 7.2 2.3 18.5 118.8 Goodwill 1,309.8 69.2 51.6 237.6 1,668.2 Other intangible assets 973.1 84.5 48.1 80.5 1,186.2 Other noncurrent assets 15.8 — 3.5 6.0 25.3 Total current liabilities (31.3) (11.6) (3.7) (54.4) (101.0) Deferred tax liabilities (151.5) (24.6) — (8.0) (184.1) Other noncurrent liabilities (17.5) (2.8) (3.0) (5.8) (29.1) Total consideration $ 2,349.7 $ 149.8 $ 113.2 $ 363.2 $ 2,975.9 Acquisition Revenues and Operating Income The revenues and operating income included in the consolidated financial statements for these acquisitions subsequent to their acquisition date were $349.6 million and $5.6 million, respectively, for the year ended December 31, 2024. 2023 Acquisitions On January 3, 2023, the Company completed the acquisition of SPX FLOW’s Air Treatment business (“Air Treatment”) for cash consideration of $519.0 million. The business is a manufacturer of desiccant and refrigerated dryers, filtration systems and purifiers for dehydration in compressed air. The acquisition is intended to expand the Company’s offerings of compressor system components through globally recognized brands. The Air Treatment business has been reported within the Industrial Technologies and Services segment. The goodwill arising from the acquisition is attributable to revenue and cost synergies, anticipated growth of new and existing customers, and the assembled workforce. Substantially all of this goodwill is not expected to be deductible for tax purposes. On February 1, 2023, the Company acquired Paragon Tank Truck Equipment (“Paragon”), a provider of solutions used for loading and unloading dry bulk and liquid tanks on and off of trucks, for cash consideration of $42.2 million. Paragon has been reported within the Industrial Technologies and Services segment. On April 1, 2023, the Company acquired EcoPlant Technological Innovation Ltd. (“EcoPlant”), for initial cash consideration of $29.5 million and contingent consideration of up to $17.0 million. EcoPlant is a provider of a software-as-a-service platform that dynamically controls compressed air systems to optimize performance and resource consumption. EcoPlant has been reported within the Industrial Technologies and Services segment. On August 18, 2023, the Company completed the acquisition of Howden Roots LLC (“Roots”), for cash consideration of $292.5 million. Roots is a leading manufacturer of engineered rotary and centrifugal blowers with an iconic brand developed over more than 160 years. The acquisition is intended to expand the Company’s blower product portfolio and benefit from Roots’ robust technical capabilities and exposure to growing sustainability-related applications. Roots has been reported within the Industrial Technologies and Services segment. The goodwill arising from the acquisition is attributable to revenue and cost synergies, anticipated growth of new and existing customers, and the assembled workforce. This goodwill is expected to be deductible for tax purposes. The Company acquired 10 additional businesses in 2023 for aggregate consideration of $83.3 million. These primarily consist of manufacturers and distributors of existing and adjacent offerings in the Industrial Technologies and Services segment. Of the goodwill recognized on our 2023 acquisitions, $159.9 million is expected to be deductible for tax purposes. The following table summarizes the allocation of consideration for all businesses acquired in 2023 to the fair values of identifiable assets acquired and liabilities assumed at the acquisition dates. Initial accounting for all 2023 acquisitions is complete. Air Treatment Roots All Others Total Accounts receivable $ 26.1 $ 14.5 $ 11.7 $ 52.3 Inventories 43.9 34.2 21.0 99.1 Other current assets 2.1 2.9 6.2 11.2 Property, plant and equipment 18.4 42.0 5.0 65.4 Goodwill 279.9 105.6 126.7 512.2 Other intangible assets 238.6 116.9 25.4 380.9 Other noncurrent assets 7.6 3.1 0.4 11.1 Total current liabilities (35.9) (26.9) (19.5) (82.3) Deferred tax liabilities (54.8) — (3.9) (58.7) Other noncurrent liabilities (6.9) (2.3) (4.5) (13.7) Total consideration $ 519.0 $ 290.0 $ 168.5 $ 977.5 Acquisition Revenues and Operating Income The revenues included in the consolidated financial statements for these acquisitions subsequent to their acquisition date were $408.0 million and $293.7 million, respectively, for the years ended December 31, 2024 and 2023. The operating income included in the consolidated financial statements for these acquisitions subsequent to their acquisition date was $58.8 million and $16.1 million, respectively, for the years ended December 31, 2024 and 2023. 2022 Acquisitions On February 1, 2022, the Company acquired Houdstermaatschappij Jorc B.V. (“Jorc”), a manufacturer of condensate management products, for aggregate cash consideration of $30.2 million. Jorc has been reported in the Industrial Technologies and Services segment from the date of acquisition. On September 1, 2022, the Company acquired Westwood Technical Limited (“Westwood Technical”), a control and instrumentation specialist based in the United Kingdom with unique Industrial Internet of Things (IIoT) capabilities, for aggregate cash consideration of $8.1 million and contingent consideration of up to $9.3 million. Westwood Technical has been reported in the Precision and Science Technologies segment from the date of acquisition. On September 1, 2022, the Company acquired Holtec Gas Systems LLC (“Holtec”), a nitrogen generator manufacturer, for cash consideration of $13.0 million. Holtec has been reported in the Industrial Technologies and Services segment from the date of acquisition. On September 1, 2022, the Company acquired Hydro Prokav Pumps (India) Private Limited (“Hydro Prokav”) for cash consideration of $14.0 million. Hydro Prokav has been reported in the Precision and Science Technologies segment from the date of acquisition. On October 1, 2022, the Company acquired Dosatron International LLC (“Dosatron International”), a technology solutions provider of water powered dosing pumps and systems, for cash consideration of $89.5 million and contingent consideration of up to $14.7 million. Dosatron International has been reported in the Precision and Science Technologies segment from the date of acquisition. On November 1, 2022, the Company acquired Pedro Gil Construcciones Mecanicas, S.L. (“Pedro Gil”), a manufacturer of positive displacement blowers, pumps and vacuum systems in the Spanish market, for aggregate cash consideration of $18.4 million. Pedro Gil has been reported in the Industrial Technologies and Services segment from the date of acquisition. On December 1, 2022, the Company acquired Everest Blowers Private Limited and Everest Blower Systems Private Limited (collectively, “Everest Group”), the Indian market leader for customized blower and vacuum pump solutions, for $75.3 million aggregate cash consideration and estimated contingent consideration of $12.1 million. Everest Group has been reported in the Industrial Technologies and Services segment from the date of acquisition. Other acquisitions completed during the year ended December 31, 2022 include multiple sales and service businesses and a manufacturer in the Industrial Technologies and Services segment. The aggregate consideration for these acquisitions was $19.9 million. The following table summarizes the allocation of consideration for all businesses acquired in 2022 to the fair values of identifiable assets acquired and liabilities assumed at the acquisition dates. Initial accounting for all 2022 acquisitions is complete. Dosatron International All others Total Consideration Accounts receivable $ 1.8 $ 16.2 $ 18.0 Inventories 6.2 20.4 26.6 Other current assets 0.1 1.3 1.4 Property, plant and equipment 0.3 8.9 9.2 Goodwill 57.4 151.9 209.3 Other intangible assets 41.9 43.0 84.9 Other noncurrent assets 13.8 0.9 14.7 Total current liabilities (3.5) (30.7) (34.2) Deferred tax liabilities (13.8) (9.7) (23.5) Other noncurrent liabilities — (1.9) (1.9) Total consideration $ 104.2 $ 200.3 $ 304.5 Acquisition Revenues and Operating Income The revenues included in the consolidated financial statements for these acquisitions subsequent to their acquisition date were $132.3 million, $124.4 million and $38.4 million, respectively, for the years ended December 31, 2024, 2023 and 2022. The operating income included in the consolidated financial statements for these acquisitions subsequent to their acquisition date was $17.0 million, $19.5 million and $3.4 million, respectively, for the years ended December 31, 2024, 2023 and 2022.

Restructuring

Restructuring	12 Months Ended
	Dec. 31, 2024
Restructuring and Related Activities [Abstract]
Restructuring	Restructuring 2024 and 2023 Actions The Company continues to undertake restructuring actions to optimize our cost structure. Charges incurred from actions taken in 2024 and 2023 include workforce restructuring, facility consolidation and other exit and disposal costs. 2022 Actions Subsequent to the acquisition of and merger with the Industrial business of Ingersoll-Rand plc (“Ingersoll Rand Industrial”) in 2020 (the “Merger”), the Company announced a restructuring program (“2020 Plan”) to create efficiencies and synergies, reduce the number of facilities and optimize operating margin within the merged Company. Charges incurred in 2022 relate to the 2020 Plan. For the years ended December 31, 2024, 2023 and 2022, “Restructuring charges, net” were recognized within “Other operating expense, net” in the Consolidated Statements of Operations and consisted of the following. 2024 2023 2022 Industrial Technologies and Services $ 20.6 $ 15.1 $ 20.1 Precision and Science Technologies 7.9 4.1 8.7 Corporate 2.7 0.7 0.5 Restructuring charges, net $ 31.2 $ 19.9 $ 29.3 The following table summarizes the activity associated with the Company’s restructuring programs (included in “Accrued liabilities” in the Consolidated Balance Sheets) for the years ended December 31, 2024 and 2023. 2024 2023 Balance at beginning of period $ 15.5 $ 14.9 Charged to expense - termination benefits 27.1 13.0 Charged to expense - other (1) 2.5 4.2 Payments (21.6) (17.1) Foreign currency translation and other (1.2) 0.5 Balance at end of period $ 22.3 $ 15.5 (1) Excludes $1.6 million and $2.7 million of non-cash charges that impacted restructuring expense but not the restructuring liabilities during the years ended December 31, 2024 and 2023, respectively.

Allowance for Credit Losses

Allowance for Credit Losses	12 Months Ended
	Dec. 31, 2024
Receivables [Abstract]
Allowance for Credit Losses	Allowance for Credit Losses The following table summarized the activity associated with allowance for credit losses for the years ended December 31, 2024, 2023 and 2022. 2024 2023 2022 Balance at beginning of period $ 53.8 $ 47.2 $ 42.3 Provision charged to expense 7.5 9.4 10.1 Write-offs, net of recoveries (3.3) (3.3) (3.2) Foreign currency translation and other (0.7) 0.5 (2.0) Balance at end of period $ 57.3 $ 53.8 $ 47.2

Inventories

Inventories	12 Months Ended
	Dec. 31, 2024
Inventory Disclosure [Abstract]
Inventories	Inventories Inventories as of December 31, 2024 and 2023 consisted of the following. 2024 2023 Raw materials, including parts and subassemblies $ 675.1 $ 590.7 Work-in-process 116.3 145.1 Finished goods 342.8 337.8 1,134.2 1,073.6 LIFO reserve (79.2) (72.5) Inventories $ 1,055.0 $ 1,001.1 At December 31, 2024 and 2023, 34% and 37%, respectively, of total inventory is accounted for on a last-in, first-out (“LIFO”) basis.

Property, Plant and Equipment

Property, Plant and Equipment	12 Months Ended
	Dec. 31, 2024
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment	Property, Plant and Equipment Property, plant and equipment, net as of December 31, 2024 and 2023 consisted of the following. 2024 2023 Land and land improvements $ 62.3 $ 67.7 Buildings 385.6 337.1 Machinery and equipment 792.6 655.8 Office furniture and equipment 76.8 71.0 Construction in progress 92.3 80.6 1,409.6 1,212.2 Accumulated depreciation (567.5) (500.8) Property, plant and equipment, net $ 842.1 $ 711.4

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets	12 Months Ended
	Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Other Intangible Assets	Goodwill and Other Intangible Assets Goodwill The changes in the carrying amount of goodwill attributable to each reportable segment for the years ended December 31, 2024 and 2023 are as follows. Industrial Technologies and Services Precision and Science Technologies Total Balance as of December 31, 2022 $ 4,222.5 $ 1,841.7 $ 6,064.2 Acquisitions 509.1 2.4 511.5 Foreign currency translation and other (1) 21.9 12.1 34.0 Balance as of December 31, 2023 4,753.5 1,856.2 6,609.7 Acquisitions 263.9 1,404.3 1,668.2 Foreign currency translation and other (1) (86.7) (43.1) (129.8) Balance as of December 31, 2024 $ 4,930.7 $ 3,217.4 $ 8,148.1 (1) Includes measurement period adjustments. The Company acquired multiple businesses during the year ended December 31, 2024. The excess of the purchase price over the estimated fair values of intangible assets, identifiable assets and assumed liabilities was recorded as goodwill. The allocation of the purchase price was preliminary for certain of these acquisitions and is subject to refinement based on final fair values of the identified assets acquired and liabilities assumed. The goodwill attributable to these businesses is as follows. 2024 Acquisitions Industrial Technologies and Services Precision and Science Technologies Total ILC Dover $ — $ 1,309.8 $ 1,309.8 Friulair 69.2 — 69.2 APSCO 51.6 — 51.6 Other acquisitions 143.1 94.5 237.6 $ 263.9 $ 1,404.3 $ 1,668.2 The Company acquired several businesses during the year ended December 31, 2023. The excess of the purchase price over the estimated fair values of intangible assets, identifiable assets and assumed liabilities was recorded as goodwill. The goodwill attributable to these businesses is as follows. 2023 Acquisitions Industrial Technologies and Services Precision and Science Technologies Total Air Treatment $ 279.9 $ — $ 279.9 Roots 106.6 — 106.6 Other acquisitions 122.6 2.4 125.0 $ 509.1 $ 2.4 $ 511.5 As of December 31, 2024 and 2023, goodwill included a total of $220.6 million of accumulated impairment losses within the Industrial Technologies and Services segment related to impairments recognized in and prior to 2015. Goodwill Impairment Tests Consistent with our accounting policy described in Note 1, we performed our annual goodwill impairment testing as of the first day of our fiscal fourth quarters of 2024, 2023 and 2022. For the years ended December 31, 2024, 2023 and 2022, each reporting unit’s fair value was in excess of its net carrying value, and therefore, no goodwill impairment was recorded. Other Intangible Assets Other intangible assets as of December 31, 2024 and 2023 consisted of the following. December 31, 2024 December 31, 2023 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount Amortized intangible assets: Customer lists and relationships $ 4,010.1 $ (1,830.1) $ 2,180.0 $ 3,279.3 $ (1,585.4) $ 1,693.9 Technology 549.1 (243.3) 305.8 413.8 (178.9) 234.9 Tradenames 63.6 (32.4) 31.2 52.2 (27.9) 24.3 Backlog 4.3 (4.2) 0.1 3.0 (1.3) 1.7 Other 128.5 (112.1) 16.4 117.1 (104.1) 13.0 Unamortized intangible assets: Tradenames 1,839.3 — 1,839.3 1,643.3 — 1,643.3 Total other intangible assets $ 6,594.9 $ (2,222.1) $ 4,372.8 $ 5,508.7 $ (1,897.6) $ 3,611.1 Amortization of intangible assets was $373.0 million, $367.5 million and $347.6 million for the years ended December 31, 2024, 2023 and 2022, respectively. Amortization of intangible assets is anticipated to be approximately $375 million in 2025, $315 million in each of 2026 and 2027, $275 million in 2028 and $220 million in 2029 based upon currency exchange rates as of December 31, 2024. Other Intangible Asset Impairment Tests Consistent with our accounting policy described in Note 1, we performed our annual indefinite-lived intangible asset impairment testing as of the first day of our fiscal fourth quarters of 2024, 2023 and 2022. For the years ended December 31, 2024, 2023 and 2022, each tradename’s fair value was in excess of its net carrying value, and therefore, no impairment was recorded. During the fourth quarter of 2024, the Company decided to rationalize a business within the Precision and Science Technologies segment. Consistent with our accounting policy described in Note 1, the Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate an assets carrying amount may not be recoverable. As a result, the Company recognized an impairment of $13.9 million to reduce the carrying value of a technology asset.

Supply Chain Finance Program

Supply Chain Finance Program	12 Months Ended
	Dec. 31, 2024
Payables and Accruals [Abstract]
Supply Chain Finance Program	Supply Chain Finance Program The Company has agreements with financial institutions to facilitate a supply chain finance program (the “SCF Program”). Under the SCF Program, qualifying suppliers may elect to sell their receivables from the Company to the financial institution. Participating suppliers negotiate arrangements for sale of their receivables directly with the financial institution, and the terms of the Company’s payment obligations are not impacted by a supplier’s participation in the SCF Program. Once a qualifying supplier elects to participate in the SCF Program and reaches an agreement with the financial institution, the supplier elects which individual Company invoices they sell to the financial institution. However, all of the Company’s payments to participating suppliers are paid to the financial institution on the invoice due date, regardless of whether the individual invoice is sold by the supplier to the financial institution. The Company has not pledged any assets as security or provided other forms of guarantees. All outstanding amounts related to suppliers participating in the SCF Program are recorded within “Accounts payable” in our Consolidated Balance Sheets, and the associated payments are included in “Net cash provided by operating activities from continuing operations” within our Consolidated Statements of Cash Flows. The following table summarizes the activity associated with the Company’s SCF Program for the years ended December 31, 2024 and 2023. 2024 2023 Confirmed obligations outstanding at beginning of period $ 24.3 $ 9.7 Invoices confirmed 117.0 112.9 Confirmed invoices paid (116.8) (98.3) Confirmed obligations outstanding at end of period $ 24.5 $ 24.3

Accrued Liabilities

Accrued Liabilities	12 Months Ended
	Dec. 31, 2024
Payables and Accruals [Abstract]
Accrued Liabilities	Accrued Liabilities Accrued liabilities as of December 31, 2024 and 2023 consisted of the following: 2024 2023 Salaries, wages and related fringe benefits $ 229.5 $ 262.4 Contract liabilities 318.6 331.2 Product warranty 67.9 61.9 Operating lease liabilities 56.3 41.6 Restructuring 22.3 15.5 Taxes 72.5 78.4 Accrued interest 33.2 33.1 Other 171.9 171.4 Total accrued liabilities $ 972.2 $ 995.5 A reconciliation of the changes in the accrued product warranty liability for the years ended December 31, 2024 and 2023 is as follows. 2024 2023 Balance at beginning of period $ 61.9 $ 46.2 Product warranty accruals 37.5 44.4 Acquired warranty 0.7 2.2 Settlements (30.7) (31.2) Foreign currency translation and other (1.5) 0.3 Balance at end of period $ 67.9 $ 61.9

Debt

Debt	12 Months Ended
	Dec. 31, 2024
Debt Disclosure [Abstract]
Debt	Debt Debt as of December 31, 2024 and 2023 consisted of the following. 2024 2023 Short-term borrowings $ 1.7 $ 1.0 Long-term debt Dollar Term Loan B, due February 2027 (1)(2) $ — $ 347.7 Dollar Term Loan, due February 2027 (1)(2) — 892.3 5.197% Senior Notes due June 2027 (1) 699.9 — 5.400% Senior Notes due August 2028 (1) 498.6 498.2 5.176% Senior Notes due June 2029 (1) 750.0 — 5.314% Senior Notes due June 2031 (1) 500.0 — 5.700% Senior Notes due August 2033 (1) 993.4 992.6 5.450% Senior Notes due June 2034 (1) 749.5 — 5.700% Senior Notes due June 2054 (1) 597.6 — Finance leases and other long-term debt 14.1 15.2 Swap valuation adjustments (0.3) — Unamortized debt issuance costs (47.0) (23.4) Total long-term debt, net, including current maturities 4,755.8 2,722.6 Current maturities of long-term debt 1.4 29.6 Total long-term debt, net $ 4,754.4 $ 2,693.0 (1) This amount is net of unamortized discounts. Total unamortized discounts were $11.0 million and $9.9 million as of December 31, 2024 and 2023 , respectively. (2) The weighted-average interest rate was 7.18% for the five month period prior to the loan repayment in May 2024, as discussed below. Senior Notes New Senior Notes On May 10, 2024, the Company issued $3,300.0 million in aggregate principal amount of senior unsecured notes comprised of $700.0 million aggregate principal amount of 5.197% Senior Notes due 2027 (the “2027 Notes”), $750.0 million aggregate principal amount of 5.176% Senior Notes due 2029 (the “2029 Notes”), $500.0 million aggregate principal amount of 5.314% Senior Notes due 2031 (the “2031 Notes”), $750.0 million aggregate principal amount of 5.450% Senior Notes due 2034 (the “2034 Notes”) and $600.0 million aggregate principal amount of 5.700% Senior Notes due 2054 (the “2054 Notes” and, together with the 2027 Notes, 2029 Notes, 2031 Notes and 2034 Notes, the “New Notes,” and collectively with the Existing Senior Notes, the “Senior Notes”). The Company used the net proceeds of the 2034 Notes and the 2054 Notes to repay in full all indebtedness under, and terminate all commitments and discharge and release all guarantees in respect of, the Company’s former Senior Secured Credit Facilities (as described below) and used the remaining net proceeds of such New Notes for general corporate purposes. The Company used the net proceeds of the 2027 Notes, the 2029 Notes and the 2031 Notes to partially fund the cash consideration of the acquisition of ILC Dover, with any remaining cash consideration funded with cash on hand. The New Notes were issued pursuant to a base indenture, dated as of August 14, 2023 (the “Base Indenture”), between the Company and Deutsche Bank Trust Company Americas, as trustee (the “Trustee”), as supplemented by the third supplemental indenture (the “Supplemental Indenture” and, together with the Base Indenture, the “New Indenture”) dated as of May 10, 2024, between the Company and the Trustee. The interest payment dates for the New Notes are June 15 and December 15 of each year, with interest payable in arrears. The New Notes mature on June 15 in their respective year of maturity. Prior to (i) May 15, 2027, in the case of the 2027 Notes, (ii) May 15, 2029, in the case of the 2029 Notes, (iii) April 15, 2031, in the case of the 2031 Notes, (iv) March 15, 2034, in the case of the 2034 Notes, and (v) December 15, 2053, in the case of the 2054 Notes, the Company may redeem the New Notes of a series at its option, in whole or in part, at any time from time to time, at a “make-whole” premium, plus accrued and unpaid interest thereon to, but not including, the redemption date. On or after (i) May 15, 2027, in the case of the 2027 Notes, (ii) May 15, 2029, in the case of the 2029 Notes, (iii) April 15, 2031, in the case of the 2031 Notes, (iv) March 15, 2034, in the case of the 2034 Notes, and (v) December 15, 2053, in the case of the 2054 Notes, the Company may redeem the New Notes of a series at its option, in whole or in part, at any time from time to time, at a price equal to 100% of the principal amount of the New Notes of such series to be redeemed, plus accrued and unpaid interest thereon to, but not including, the redemption date. Existing Senior Notes On August 14, 2023, the Company completed its issuance of $1,500.0 million in aggregate principal amount of senior unsecured notes comprised of $500.0 million aggregate principal amount of 5.400% Senior Notes due August 2028 (the “2028 Senior Notes”) and $1,000.0 million aggregate principal amount of 5.700% Senior Notes due August 2033 (the “2033 Senior Notes” and, together with the 2028 Senior Notes, the “Existing Notes”). The Company used the proceeds of the offering of the Existing Notes to repay a portion of the amounts outstanding under its former Senior Secured Credit Facilities. The Existing Notes were issued pursuant to the Base Indenture, as supplemented by a 2028 Supplemental Indenture No. 1 with respect to the 2028 Senior Notes and a 2033 Senior Notes Supplemental Indenture No. 1 with respect to the 2033 Senior Notes, each dated as of August 14, 2023, between the Company and the Trustee (collectively, the “Existing Indenture”). The interest payment dates for the Senior Notes are February 14 and August 14 of each year, with interest payable in arrears. Prior to (i) July 14, 2028, in the case of the 2028 Senior Notes, and (ii) May 14, 2033, in the case of the 2033 Senior Notes, the Company may redeem the Senior Notes of a series at its option, in whole or in part, at any time from time to time, at a “make-whole” premium, plus accrued and unpaid interest thereon to, but not including, the redemption date. On or after (i) July 14, 2028, in the case of the 2028 Senior Notes, and (ii) May 14, 2033, in the case of the 2033 Senior Notes, the Company may redeem the Senior Notes of a series at its option, in whole or in part, at any time from time to time, at a price equal to 100% of the principal amount of the Senior Notes of such series to be redeemed, plus accrued and unpaid interest thereon to, but not including, the redemption date. All Senior Notes The Senior Notes are senior unsecured obligations of the Company and rank equally in right of payment with all of the Company’s other senior unsecured indebtedness from time to time outstanding, senior in right of payment to all of the Company’s subordinated indebtedness from time to time outstanding, and effectively junior to all of the indebtedness and other liabilities of the Company’s subsidiaries from time to time outstanding and to all of the Company’s secured indebtedness from time to time outstanding to the extent of the value of the assets securing such secured indebtedness. Additionally, if the Company experiences certain types of change of control transactions, the Company must offer to repurchase the Senior Notes at 101% of the aggregate principal amount of the Senior Notes repurchased (or such higher amount as the Company may determine) plus accrued and unpaid interest thereon to, but not including, the date of repurchase. The Existing Indenture and New Indenture contain covenants that limit the Company’s (and its subsidiaries’) ability to, among other things: (i) create liens on certain assets; (ii) consolidate, merge, sell or otherwise dispose of all or substantially all of its consolidated assets; and (iii) enter into sale and leaseback transactions with respect to certain assets, as well as customary events of default and covenants for an issuer of investment grade debt securities. Former Senior Secured Credit Facilities The former Senior Secured Credit Facilities provided senior secured financing consisting of (i) a senior secured term loan facility denominated in U.S. dollars (as refinanced and otherwise modified from time to time prior to February 28, 2020, the “Original Dollar Term Loan”), (ii) a senior secured term loan facility denominated in U.S. dollars (entered into at the time of the Merger, the “Dollar Term Loan B”), and (iii) a senior secured revolving credit facility (as refinanced and otherwise modified from time to time, the “Revolving Credit Facility”). The Revolving Credit Facility was available to be drawn in U.S. dollars (“USD”), Euros (“EUR”), Great British Pounds (“GBP”) and other reasonably accepted foreign currencies, subject to certain sublimits for the foreign currencies. On April 21, 2023, the Company entered into Amendment No. 9 to the Credit Agreement, which (a) extended the maturity date for the revolving credit commitments from June 28, 2024 to April 21, 2028, (b) increased the aggregate revolving credit commitments from $1,100.0 million to $2,000.0 million, and (c) made certain other corresponding changes and updates. The amendment resulted in the write-off of unamortized debt issuance costs of $0.9 million which was recognized in “Loss on extinguishment of debt” in the Condensed Consolidated Statements of Operations. In August 2023, the Company repaid a portion of the Dollar Term Loan B and in May 2024, the Company repaid the remaining portion of the Dollar Term Loan B and Dollar Term Loan. These repayments resulted in the write-off of unamortized discounts and debt issuance costs of $3.0 million and $12.6 million, respectively, for the years ended December 31, 2024 and 2023, which was recognized in “Loss on extinguishment of debt” in the Consolidated Statements of Operations. New Revolving Credit Facility On May 10, 2024, the Company entered into a credit agreement (the “New Revolving Credit Facility”), with the lenders party thereto and Citibank, N.A., as administrative agent. The New Revolving Credit Facility provides for a senior unsecured revolving facility in an aggregate committed amount of $2,600 million, a portion of which is available for the issuance of letters of credit in U.S. dollars, EUR or GBP. The New Revolving Credit Facility will mature on May 10, 2029, subject to up to two additional one-year extensions pursuant to the terms of the New Revolving Credit Facility. Borrowings under the New Revolving Credit Facility (other than borrowings in EUR or GBP) bear interest at a rate determined, at the Company’s option, based on either (i) an alternate base rate or (ii) a Term SOFR rate with a 0.10% per annum Term SOFR adjustment, plus, in each case, an applicable margin that varies depending on the credit rating of the Company. Borrowings under the New Revolving Credit Facility in EUR (if any) bear interest at a EURIBOR rate, plus, in each case, an applicable margin that varies depending on the credit rating of the Company. Borrowings under the New Revolving Credit Facility in GBP (if any) bear interest at a daily simple SONIA rate plus, in each case, an applicable margin that varies depending on the credit rating of the Company. The financial covenant in the New Revolving Credit Facility requires the Company to maintain, as of the last day of each fiscal quarter (beginning with the second fiscal quarter of 2024), a ratio of adjusted consolidated total net debt to consolidated adjusted earnings before interest, taxes, depreciation and amortization (“EBITDA”) of not more than 3.50 to 1.00, provided that the Company may elect to increase such ratio to 4.00 to 1.00 following a qualified acquisition up to two times, each for a period of four fiscal quarters beginning with the quarter during which such qualified acquisition is consummated (and if the second election occurs during the first increase period, such increase will be effective for a total of eight consecutive fiscal quarters). As of December 31, 2024, the aggregate amount of commitments under the New Revolving Credit Facility was $2,600.0 million and the capacity under the New Revolving Credit Facility to issue letters of credit was $200.0 million. As of December 31, 2024, the Company had no outstanding borrowings under the New Revolving Credit Facility, no outstanding letters of credit under the New Revolving Credit Facility and unused availability under the New Revolving Credit Facility of $2,600.0 million. As of December 31, 2024, we were in compliance with all covenants under our Senior Notes and New Revolving Credit Facility. Commercial Paper Program On August 13, 2024, the Company established a commercial paper program (the “Commercial Paper Program”), pursuant to which it may issue short-term, unsecured commercial paper notes in a maximum aggregate principal amount of $2,600 million, with maturities of up to 397 days from the date of issuance. The proceeds of the notes issued under the Commercial Paper Program may be used for various purposes including acquisitions. The Company had no outstanding borrowings under the Commercial Paper Program as of December 31, 2024. Fair Value of Debt The fair value of the Company’s debt instruments was $4.9 billion and $2.8 billion at December 31, 2024 and 2023, respectively. The Company measures the fair value of its debt instruments for disclosure purposes based upon observable market prices quoted on public exchanges for similar assets. These fair value inputs are considered Level 2 within the fair value hierarchy. See Note 20, “Fair Value Measurements” for information on the fair value hierarchy. Total Debt Maturities Total debt maturities for the five years subsequent to December 31, 2024 and thereafter are $3.1 million, $1.7 million, $701.5 million, $501.5 million, $751.5 million and $2,856.5 million, respectively.

Benefit Plans

Benefit Plans	12 Months Ended
	Dec. 31, 2024
Retirement Benefits [Abstract]
Benefit Plans	Benefit Plans Pension and Postretirement Benefit Plans The Company sponsors a number of pension and postretirement plans worldwide. Pension plan benefits are provided to employees under defined benefit pay-related and service-related plans, which are non-contributory in nature. The Company’s funding policy for the U.S. defined benefit pension plans is to contribute at least the minimum required contribution required by Employee Retirement Income Security Act (“ERISA”), as amended by the Pension Protection Act of 2016 (as amended by MAP-21, HAFTA, and BBA 15). The Company intends to make contributions, as necessary, to prevent benefit restrictions in the plans. The Company’s annual contributions to the non-U.S. pension plans are consistent with the requirements of applicable local laws. The Company also provides postretirement healthcare and life insurance benefits to a limited group of current and retired employees, primarily in the United States. All of the Company’s postretirement benefit plans are unfunded. The following table provides a reconciliation of the changes in the benefit obligations and in the fair value of the plan assets for the periods described below. Pension Benefits Other Postretirement Benefits U.S. Plans Non-U.S. Plans 2024 2023 2024 2023 2024 2023 Reconciliation of Benefit Obligations: Beginning balance $ 294.0 $ 319.8 $ 263.2 $ 247.5 $ 18.3 $ 21.0 Service cost 0.1 0.1 2.9 2.6 — — Interest cost 13.4 15.7 10.7 11.1 0.8 0.9 Participant contributions — — 0.2 — — — Plan amendments — — — 0.3 (10.9) — Actuarial losses (gains) (1) (18.1) 6.0 (11.3) 3.3 0.2 (1.0) Benefit payments (22.2) (16.1) (14.5) (13.6) (2.4) (2.7) Acquisitions — — 10.2 — — — Plan settlements (2.5) (31.5) — — — — Other — — 0.6 — — — Effect of foreign currency exchange rate changes — — (10.6) 12.0 (0.1) 0.1 Benefit obligations ending balance $ 264.7 $ 294.0 $ 251.4 $ 263.2 $ 5.9 $ 18.3 Reconciliation of Fair Value of Plan Assets: Beginning balance $ 237.5 $ 263.6 $ 206.0 $ 196.4 Actual return on plan assets (6.0) 18.7 (7.1) 6.7 Employer contributions 0.1 2.8 6.5 6.6 Participant contributions — — 0.2 — Acquisitions — — 8.5 — Benefit payments (22.2) (16.1) (14.5) (13.6) Plan settlements (2.5) (31.5) — — Other — — 0.6 — Effect of foreign currency exchange rate changes — — (5.6) 9.9 Fair value of plan assets ending balance $ 206.9 $ 237.5 $ 194.6 $ 206.0 Funded Status as of Period End $ (57.8) $ (56.5) $ (56.8) $ (57.2) $ (5.9) $ (18.3) (1) Actuarial losses (gains) primarily resulted from changes in discount rates. Amounts recognized as a component of accumulated other comprehensive income (loss) as of December 31, 2024 and 2023 that have not been recognized as a component of net periodic benefit cost are presented in the following table. Pension Benefits Other Postretirement Benefits U.S. Plans Non-U.S. Plans 2024 2023 2024 2023 2024 2023 Net actuarial losses (gains) $ (10.8) $ (11.0) $ 7.6 $ (1.1) $ (3.2) $ (4.3) Prior service cost — — 2.7 2.9 (10.9) 0.1 Amounts included in accumulated other comprehensive income (loss) $ (10.8) $ (11.0) $ 10.3 $ 1.8 $ (14.1) $ (4.2) Pension and other postretirement benefit liabilities and assets are included in the following captions in the Consolidated Balance Sheets as of December 31, 2024 and 2023. 2024 2023 Other assets $ 18.5 $ 18.8 Accrued liabilities (6.4) (6.2) Pension and other postretirement benefits (132.6) (144.6) The following table provides information for pension plans with an accumulated benefit obligation in excess of plan assets as of December 31, 2024 and 2023. U.S. Pension Plans Non-U.S. Pension Plans 2024 2023 2024 2023 Projected benefit obligations $ 264.7 $ 294.0 $ 119.7 $ 105.4 Accumulated benefit obligation 264.7 294.0 112.7 86.4 Fair value of plan assets 206.9 237.5 42.8 17.0 The accumulated benefit obligation for all U.S. defined benefit pension plans was $264.7 million and $294.0 million as of December 31, 2024 and 2023, respectively. The accumulated benefit obligation for all non-U.S. defined benefit pension plans was $243.3 million and $254.8 million as of December 31, 2024 and 2023, respectively. The following tables provide the components of net periodic benefit cost (income) and other amounts recognized in other comprehensive income (loss), before income tax effects, for the years ended December 31, 2024, 2023 and 2022. U.S. Pension Plans 2024 2023 2022 Net Periodic Benefit Cost: Service cost $ 0.1 $ 0.1 $ 4.4 Interest cost 13.4 15.7 11.3 Expected return on plan assets (12.7) (13.2) (13.0) Amortization of net actuarial loss — 0.1 — Net periodic benefit cost 0.8 2.7 2.7 Loss (gain) due to settlement 0.4 (0.4) (0.5) Total net periodic benefit cost recognized $ 1.2 $ 2.3 $ 2.2 Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss): Net actuarial loss $ 0.6 $ 0.5 $ 0.4 Amortization of net actuarial gain (loss) (0.4) 0.3 0.5 Total recognized in other comprehensive income (loss) $ 0.2 $ 0.8 $ 0.9 Total recognized in net periodic benefit cost and other comprehensive income (loss) $ 1.4 $ 3.1 $ 3.1 Non-U.S. Pension Plans 2024 2023 2022 Net Periodic Benefit Cost (Income): Service cost $ 2.9 $ 2.6 $ 3.3 Interest cost 10.7 11.1 5.9 Expected return on plan assets (11.2) (11.0) (11.8) Amortization of prior service cost 0.2 0.1 0.1 Amortization of net actuarial loss (1.3) (1.7) 0.3 Total net periodic benefit cost (income) recognized $ 1.3 $ 1.1 $ (2.2) Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss): Net actuarial loss (gain) $ 7.0 $ 7.5 $ (33.3) Amortization of net actuarial gain (loss) 1.3 1.7 (0.3) Prior service cost — 0.3 — Amortization of prior service cost (0.2) (0.1) (0.1) Effect of foreign currency exchange rate changes 0.4 0.3 (3.2) Total recognized in other comprehensive income (loss) $ 8.5 $ 9.7 $ (36.9) Total recognized in net periodic benefit cost (income) and other comprehensive income (loss) $ 9.8 $ 10.8 $ (39.1) Other Postretirement Benefits 2024 2023 2022 Net Periodic Benefit Cost (Income): Interest cost $ 0.8 $ 0.9 $ 0.7 Amortization of prior service cost 0.1 0.1 — Amortization of net actuarial loss (0.8) (1.1) — Total net periodic benefit cost (income) recognized $ 0.1 $ (0.1) $ 0.7 Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss): Net actuarial loss (gain) $ 0.2 $ (1.0) $ (5.0) Amortization of net actuarial loss 0.8 1.1 — Prior service cost (10.9) — — Amortization of prior service cost (0.1) (0.1) — Total recognized in other comprehensive income (loss) $ (10.0) $ — $ (5.0) Total recognized in net periodic benefit cost (income) and other comprehensive income (loss) $ (9.9) $ (0.1) $ (4.3) The discount rate selected to measure the present value of the Company’s benefit obligations was derived by examining the rates of high-quality, fixed income securities whose cash flows or duration match the timing and amount of expected benefit payments under a plan. The Company selects the expected long-term rate of return on plan assets in consultation with the plans’ advisors. This rate is intended to reflect the expected average rate of earnings on the funds invested or to be invested to provide plan benefits and the Company’s most recent plan assets target allocations. In estimating the expected long-term rate of return on plan assets, appropriate consideration is given to historical performance of the major asset classes held or anticipated to be held by the plans and to current forecasts of future rates of return for those asset classes. Because assets are held in qualified trusts, expected returns are not adjusted for taxes. The following actuarial assumptions were used to determine net periodic benefit cost (income) and benefit obligations for the years ended December 31, 2024, 2023 and 2022. U.S. Pension Plans Non-U.S. Pension Plans 2024 2023 2022 2024 2023 2022 Weighted-average actuarial assumptions used to determine net periodic benefit cost: Discount rate 5.0 % 5.2 % 2.7 % 4.2 % 4.5 % 1.6 % Expected long-term rate of return on plan assets 5.8 % 5.4 % 3.5 % 5.5 % 5.5 % 4.4 % Rate of compensation increases N/A N/A 3.0 % 5.0 % 4.3 % 4.3 % Weighted-average actuarial assumptions used to determine benefit obligations: Discount rate 5.5 % 5.0 % 5.2 % 4.5 % 4.2 % 4.5 % Rate of compensation increases N/A N/A N/A 5.0 % 5.0 % 4.3 % The following actuarial assumptions were used to determine other postretirement benefit plans costs and obligations for the years ended December 31, 2024, 2023 and 2022. Other Postretirement Benefits 2024 2023 2022 Discount rate used to determine net periodic benefit cost 4.9% - 5.1% 4.9% - 5.2% 2.4% - 3.0% Discount rate used to determine benefit obligations 4.4% - 5.4% 4.9% - 5.1% 4.9% - 5.2% Weighted-average actuarial assumptions used to determine other postretirement benefit plans costs and obligations: Healthcare cost trend rate assumed for next year 5.1 % 6.8 % 6.8 % Rate to which the cost trend rate is assumed to decline (the ultimate trend rate) 4.0 % 4.4 % 4.5 % Year that the date reaches the ultimate trend rate 2040 2035 2034 The following table reflects the estimated benefit payments for the next five years and for the years 2030 through 2034. The estimated benefit payments for the non-U.S. pension plans were calculated using foreign exchange rates as of December 31, 2024. Pension Benefits Other Postretirement Benefits U.S. Plans Non-U.S. Plans 2025 $ 26.4 $ 14.7 $ 2.4 2026 25.1 14.9 0.4 2027 24.9 14.5 0.4 2028 23.9 15.1 0.3 2029 23.4 17.1 0.3 Aggregate 2030-2034 98.3 86.0 1.3 In 2025, the Company expects to contribute $5.2 million to the U.S. pension plans, $7.3 million to the non-U.S. pension plans, and $2.4 million to the other postretirement benefit plans. Plan Asset Investment Strategy The Company’s overall investment strategy and objectives for its pension plan assets is to (i) meet current and future benefit payment needs through diversification across asset classes, investing strategies and investment managers to achieve an optimal balance between risk and return and between income and growth of assets through capital appreciation, (ii) secure participant retirement benefits, (iii) minimize reliance on contributions as a source of benefit security, and (iv) maintain sufficient liquidity to pay benefit obligations and proper expenses. The composition of the actual investments in various securities changes over time based on short and long-term investment opportunities. None of the plan assets of Ingersoll Rand’s defined benefit plans are invested in the Company’s common stock. The Company uses both active and passive investment strategies. Plan Asset Risk Management The target financial objectives for the pension plans are established in conjunction with periodic comprehensive reviews of each plan’s liability structure. The Company’s asset allocation policy is based on detailed asset and liability model (“ALM”) analyses. A formal ALM study of each major plan is undertaken every 2-5 years or whenever there has been a material change in plan demographics, benefit structure, or funded status. In order to determine the recommended asset allocation, the advisors model varying return and risk levels for different theoretical portfolios, using a relative measure of excess return over treasury bills, divided by the standard deviation of the return (the “Sharpe Ratio”). The Sharpe Ratio for different portfolio options was used to compare each portfolio’s potential return, on a risk-adjusted basis. The Company selected a recommended portfolio that achieved the targeted composite return with the least amount of risk. The Company’s primary pension plans are in the U.S. and UK which together comprise 76% of the total benefit obligations and 87% of total plan assets as of December 31, 2024. The following table presents the long-term target allocations for these plans as of December 31, 2024. U.S. Plans UK Plan Asset category: Equity 16 % 12 % Fixed income 83 % 56 % Real estate and other 1 % 32 % Total 100 % 100 % Fair Value Measurements The following tables present the fair values of the Company’s pension plan assets as of December 31, 2024 and 2023 by asset category within the ASC 820 hierarchy (as defined in Note 21 “Fair Value Measurements”). December 31, 2024 Quoted Prices in Active Markets for Identical Assets Significant Observable Inputs Significant Unobservable Inputs Investments Measured at NAV (5) Total Asset Category Cash and cash equivalents (1) $ 5.1 $ — $ — $ — $ 5.1 Equity funds: U.S. small-cap — — — 0.9 0.9 U.S. mid-cap — — — 2.6 2.6 U.S. large-cap — 2.5 — 11.6 14.1 International equity (2) — 23.2 — 26.5 49.7 Total equity funds — 25.7 — 41.6 67.3 Fixed income funds: Corporate bonds - international — 23.8 — 15.8 39.6 UK index-linked gilts — 66.0 — — 66.0 U.S. fixed income - government securities — — — 20.5 20.5 U.S. fixed income - short duration — — — 1.8 1.8 U.S. fixed income - intermediate duration — — — 25.2 25.2 U.S. fixed income - long duration — — — 122.7 122.7 Global fixed income — — — 1.8 1.8 Total fixed income funds — 89.8 — 187.8 277.6 Other types of investments: International real estate (3) — 11.6 — — 11.6 Other (4) — 38.1 1.8 39.9 Total $ 5.1 $ 127.1 $ 38.1 $ 231.2 $ 401.5 December 31, 2023 Quoted Prices in Active Markets for Identical Assets Significant Observable Inputs Significant Unobservable Inputs Investments Measured at NAV (5) Total Asset Category Cash and cash equivalents (1) $ 7.1 $ — $ — $ — $ 7.1 Equity funds: U.S. small-cap — — — 3.7 3.7 U.S. large-cap — 2.0 — 17.5 19.5 International equity (2) 14.2 10.5 — 17.2 41.9 Total equity funds 14.2 12.5 — 38.4 65.1 Fixed income funds: Corporate bonds - international — 26.9 — 15.8 42.7 UK index-linked gilts — 78.7 — — 78.7 U.S. fixed income - government securities — — — 43.2 43.2 U.S. fixed income - short duration — — — 1.3 1.3 U.S. fixed income - intermediate duration — — — 30.9 30.9 U.S. fixed income - long corporate — — — 122.3 122.3 Global fixed income — — — 7.2 7.2 Total fixed income funds — 105.6 — 220.7 326.3 Other types of investments: International real estate (3) — 15.4 — — 15.4 Other (4) — 29.6 — 29.6 Total $ 21.3 $ 133.5 $ 29.6 $ 259.1 $ 443.5 (1) Cash and cash equivalents consist of traditional domestic and foreign highly liquid short-term securities with the goal of providing liquidity and preservation of capital while maximizing return on assets. (2) The International category consists of investment funds focused on companies operating in developed and emerging markets outside of the U.S. These investments target broad diversification across large and mid/small-cap companies and economic sectors. (3) International real estate consists primarily of equity and debt investments made, directly or indirectly, in various interests in unimproved and improved real properties. (4) Other investments consist of insurance and reinsurance contracts securing the retirement benefits. The fair value of these contracts was calculated at the discount value of premiums paid by the Company, less expenses charged by the insurance providers. The insurance providers with which the Company has placed these contracts are well-known financial institutions with an established history of providing insurance services. (5) Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy. Defined Contribution Plans The Company also sponsors defined contribution plans at various locations throughout the world. Benefits are determined and funded regularly based on terms of the plans or as stipulated in a collective bargaining agreement. The Company’s full-time salaried and hourly employees in the U.S. are eligible to participate in Company-sponsored defined contribution savings plans, which are qualified plans under the requirements of Section 401(k) of the Internal Revenue Code. The Company’s contributions to the savings plans are in the form of cash. The Company’s total contributions to all worldwide defined contribution plans for the years ended December 31, 2024, 2023, and 2022 were $49.1 million, $47.0 million and $46.6 million, respectively. Other Benefit Plans There are various other employment contracts, deferred compensation arrangements, covenants not to compete, and change in control agreements with certain employees and former employees. The Company offers a long-term service award program for qualified employees at certain of its non-U.S. locations. Under this program, qualified employees receive a service gratuity (“Jubilee”) payment once they have achieved a certain number of years of service. The liabilities associated with such arrangements are not material to the Company’s consolidated financial statements.

Stockholders' Equity and Noncon

Stockholders' Equity and Noncontrolling Interests	12 Months Ended
	Dec. 31, 2024
Equity [Abstract]
Stockholders' Equity and Noncontrolling Interests	Stockholders’ Equity and Noncontrolling Interests Stockholders’ Equity As of December 31, 2024 and 2023, 1,000,000,000 shares of voting common stock were authorized. Shares of common stock outstanding wer e 402,880,079 and 403,347,394 as of December 31, 2024 and 2023, respectively. The Company is governed by the General Corporation Law of the State of Delaware. All authorized shares of voting common stock have a par value of $0.01. Shares of common stock reacquired are considered issued and reported as Treasury shares. Noncontrolling Interests The Company has a controlling interest of approximately 75% of the common shares of Ingersoll-Rand India Limited. The remaining shares are owned by unaffiliated shareholders and traded on India stock exchanges regulated by Securities and Exchange Board of India. Share Repurchase Program On August 24, 2021, the Board of Directors of Ingersoll Rand authorized a share repurchase program pursuant to which the Company may repurchase up to $750.0 million of its common stock, and on April 25, 2024, the Company announced that our Board of Directors approved an incremental $1.0 billion increase to the share repurchase authorization (the “Repurchase Program”). Under the repurchase program, Ingersoll Rand is authorized to repurchase shares through open market purchases, privately-negotiated transactions or otherwise in accordance with all applicable securities laws and regulations, including through Rule 10b5-1 trading plans and under Rule 10b-18 of the Securities Exchange Act of 1934, as amended. Under the Repurchase Program, the Company repurchased 2,665,262 shares, 3,963,243 shares, and 5,673,937 shares during the years ended December 31, 2024, 2023, and 2022, respectively, at an average price per share of $93.80, $62.98, and $45.36 for an aggregate value of $250.0 million, $249.6 million, and $257.3 million, respectively.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income (Loss)	12 Months Ended
	Dec. 31, 2024
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Accumulated Other Comprehensive Income (Loss)	Accumulated Other Comprehensive Income (Loss) The Company’s other comprehensive income (loss) consists of (i) unrealized foreign currency net gains and losses on the translation of the assets and liabilities of its foreign operations; (ii) realized and unrealized foreign currency gains and losses on intercompany notes of a long-term nature and certain hedges of net investments in foreign operations, net of income taxes; (iii) unrealized gains and losses on cash flow hedges, net of income taxes; and (iv) pension and other postretirement prior service cost and actuarial gains or losses, net of income taxes. See Note 13 “Benefit Plans” and Note 20 “Hedging Activities, Derivative Instruments and Credit Risk.” The before tax income (loss) and related income tax effect are as follows. Foreign Currency Translation Adjustments, Net Cash Flow Hedges Pension and Other Postretirement Benefit Plans Total Balance as of December 31, 2021 $ (29.9) $ — $ (11.7) $ (41.6) Before tax income (loss) (237.1) 21.3 41.0 (174.8) Income tax effect (15.8) (5.3) (14.2) (35.3) Other comprehensive income (loss) (252.9) 16.0 26.8 (210.1) Balance as of December 31, 2022 $ (282.8) $ 16.0 $ 15.1 $ (251.7) Before tax income (loss) 23.0 (5.1) (10.5) 7.4 Income tax effect 11.8 1.3 3.6 16.7 Other comprehensive income (loss) 34.8 (3.8) (6.9) 24.1 Balance as of December 31, 2023 $ (248.0) $ 12.2 $ 8.2 $ (227.6) Before tax income (loss) (218.6) (14.1) 1.3 (231.4) Income tax effect (13.0) 5.0 (1.5) (9.5) Other comprehensive loss (231.6) (9.1) (0.2) (240.9) Balance as of December 31, 2024 $ (479.6) $ 3.1 $ 8.0 $ (468.5) The tables above include only the other comprehensive income (loss), net of tax, attributable to Ingersoll Rand Inc. Other comprehensive income (loss), net, attributable to noncontrolling interest holders was $2.7 million, $1.7 million and $(7.2) million for the years ended December 31, 2024, 2023 and 2022, respectively, and related entirely to foreign currency translation adjustments. Changes in accumulated other comprehensive income (loss) by component for the periods described below are presented in the following table (1) . Foreign Currency Translation Adjustments, Net Cash Flow Hedges Pension and Other Postretirement Benefit Plans Total Balance as of December 31, 2021 $ (29.9) $ — $ (11.7) $ (41.6) Other comprehensive income (loss) before reclassifications (244.3) 13.9 26.9 (203.5) Amounts reclassified from accumulated other comprehensive income (loss) (8.6) 2.1 (0.1) (6.6) Other comprehensive income (loss) (252.9) 16.0 26.8 (210.1) Balance as of December 31, 2022 $ (282.8) $ 16.0 $ 15.1 $ (251.7) Other comprehensive income (loss) before reclassifications 49.0 7.9 (4.7) 52.2 Amounts reclassified from accumulated other comprehensive income (loss) (14.2) (11.7) (2.2) (28.1) Other comprehensive income (loss) 34.8 (3.8) (6.9) 24.1 Balance as of December 31, 2023 $ (248.0) $ 12.2 $ 8.2 $ (227.6) Other comprehensive income (loss) before reclassifications (218.3) 2.7 0.8 (214.8) Amounts reclassified from accumulated other comprehensive income (loss) (13.3) (11.8) (1.0) (26.1) Other comprehensive loss (231.6) (9.1) (0.2) (240.9) Balance as of December 31, 2024 $ (479.6) $ 3.1 $ 8.0 $ (468.5) (1) All amounts are net of tax. Amounts in parentheses indicate debits. Reclassifications out of accumulated other comprehensive income (loss) for the years ended December 31, 2024, 2023 and 2022 are presented in the following table. Amount Reclassified from Accumulated Other Comprehensive Income (Loss) Details about Accumulated Other Comprehensive Income (Loss) Components 2024 2023 2022 Affected Line(s) in the Statement Where Net Income is Presented Cash flow hedges (interest rate swaps and caps) $ (15.7) $ (15.6) $ 2.8 Interest expense Provision (benefit) for income taxes 3.9 3.9 (0.7) Provision for income taxes Cash flow hedges (interest rate swaps and caps), net of tax $ (11.8) $ (11.7) $ 2.1 Net investment hedges $ (17.7) $ (19.0) $ (11.5) Interest expense Provision for income taxes 4.4 4.8 2.9 Provision for income taxes Net investment hedges, net of tax $ (13.3) $ (14.2) $ (8.6) Amortization of defined benefit pension and other postretirement benefit items (1) $ (1.4) $ (2.9) $ (0.1) Cost of sales and Selling and administrative expenses Provision for income taxes 0.4 0.7 — Provision for income taxes Amortization of defined benefit pension and other postretirement benefit items, net of tax $ (1.0) $ (2.2) $ (0.1) Total reclassifications for the period $ (26.1) $ (28.1) $ (6.6) (1) These components are included in the computation of net periodic benefit cost. See Note 13 “Benefit Plans” for additional details.

Revenue from Contracts with Cus

Revenue from Contracts with Customers	12 Months Ended
	Dec. 31, 2024
Revenue from Contract with Customer [Abstract]
Revenue from Contracts with Customers	Revenue from Contracts with Customers Overview The Company recognizes revenue when it has satisfied its obligation and control is transferred to the customer. The amount of revenue recognized includes adjustments for any variable consideration, such as rebates, sales discounts and liquidated damages, which are included in the transaction price, and allocated to each performance obligation. The variable consideration is estimated throughout the course of the contract using the Company’s best estimates. Judgements impacting variable consideration related to material rebate and sales discount programs, and significant contracts containing liquidated damage clauses are governed by management review processes. The majority of the Company’s revenues are derived from short duration contracts and revenue is recognized at a single point in time when control is transferred to the customer, generally at shipment or when delivery has occurred or services have been rendered. The Company has certain long duration engineered to order (“ETO”) contracts that require highly-engineered solutions designed to customer specific applications. For contracts where the contractual deliverables have no alternative use and the contract termination clauses provide for the recovery of cost plus a reasonable margin, revenue is recognized over time based on the Company’s progress in satisfying the contractual performance obligations, generally measured as the ratio of actual costs incurred to date to the estimated total costs to complete the contract. For contracts with termination provisions that do not provide for recovery of cost and a reasonable margin, revenue is recognized at a point in time, generally at shipment or delivery to the customer. Identification of performance obligations, determination of alternative use, assessment of contractual language regarding termination provisions, and estimation of total project costs are all significant judgments required in the application of ASC 606. Contractual specifications and requirements may be modified. The Company considers contract modifications to exist when the modification either creates new or changes the existing enforceable rights and obligations. In the event a contract modification is for goods or services that are not distinct in the contract, and therefore, form part of a single performance obligation that is partially satisfied as of the modification date, the effect of the contract modification on the transaction price and the Company’s measure of progress for the performance obligation to which it relates, is recognized on a cumulative catch-up basis. Taxes assessed by a government authority that are both imposed on and concurrent with a specific revenue-producing transaction, that are collected by the Company from a customer, are excluded from revenue. Sales commissions are due at either collection of payment from customers or recognition of revenue. Applying the practical expedient from ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred if the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs are included in “Selling and administrative expenses” in the Consolidated Statements of Operations. Disaggregation of Revenue The following table provides disaggregated revenue by reportable segment for the years ended December 31, 2024 and 2023. Industrial Technologies and Services Precision and Science Technologies Total 2024 2023 2024 2023 2024 2023 Primary Geographic Markets United States $ 2,461.2 $ 2,328.0 $ 651.1 $ 567.2 $ 3,112.3 $ 2,895.2 Other Americas 452.9 373.1 88.3 29.0 541.2 402.1 Total Americas 2,914.1 2,701.1 739.4 596.2 3,653.5 3,297.3 EMEIA 1,854.9 1,800.8 520.0 466.7 2,374.9 2,267.5 China 680.8 785.7 113.8 138.9 794.6 924.6 Other Asia Pacific 368.3 345.2 43.7 41.5 412.0 386.7 Total Asia Pacific 1,049.1 1,130.9 157.5 180.4 1,206.6 1,311.3 Total $ 5,818.1 $ 5,632.8 $ 1,416.9 $ 1,243.3 $ 7,235.0 $ 6,876.1 Product Categories Original equipment (1) $ 3,494.0 $ 3,425.9 $ 1,110.2 $ 990.9 $ 4,604.2 $ 4,416.8 Aftermarket (2) 2,324.1 2,206.9 306.7 252.4 2,630.8 2,459.3 Total $ 5,818.1 $ 5,632.8 $ 1,416.9 $ 1,243.3 $ 7,235.0 $ 6,876.1 Pattern of Revenue Recognition Revenue recognized at point in time (3) $ 5,295.6 $ 5,147.2 $ 1,376.4 $ 1,236.2 $ 6,672.0 $ 6,383.4 Revenue recognized over time (4) 522.5 485.6 40.5 7.1 563.0 492.7 Total $ 5,818.1 $ 5,632.8 $ 1,416.9 $ 1,243.3 $ 7,235.0 $ 6,876.1 (1) Revenues from sales of capital equipment within the Industrial Technologies and Services segment and sales of components to original equipment manufacturers in the Precision and Science Technologies segment. (2) Revenues from sales of spare parts, accessories, other components and services in support of maintaining customer owned, installed base of the Company’s original equipment. (3) Revenues from short and long duration product and service contracts recognized at a point in time when control is transferred to the customer generally when product delivery has occurred and services have been rendered. (4) Revenues primarily from long duration ETO product contracts, certain multi-year service contracts, and certain contracts for the delivery of a significant volume of substantially similar products recognized over time as contractual performance obligations are completed. Performance Obligations The majority of the Company’s contracts have a single performance obligation as the promise to transfer goods and/or services. For contracts with multiple performance obligations, the Company utilizes observable prices to determine standalone selling price or cost plus margin if a standalone price is not available. The Company has elected to account for shipping and handling activities as fulfillment costs and not a separate performance obligation. If control transfers and related revenue is recognized for the related good before the shipping and handling activities occur, the related costs of those shipping and handling activities are accrued. The Company’s primary performance obligations include delivering standard or configured to order (“CTO”) goods to customers, designing and manufacturing a broad range of equipment customized to a customer’s specifications in ETO arrangements, rendering of services (maintenance and repair contracts), and certain extended or service type warranties. For incidental items that are immaterial in the context of the contract, costs are expensed as incurred or accrued at delivery. As of December 31, 2024, for contracts with an original duration greater than one year, the Company expects to recognize revenue in the future related to unsatisfied (or partially satisfied) performance obligations of $742.6 million in the next twelve months and $788.6 million in periods thereafter. The performance obligations that are unsatisfied (or partially satisfied) are primarily related to orders for goods or services that were placed prior to the end of the reporting period and have not been delivered to the customer, on-going work on ETO contracts where revenue is recognized over time and service contracts with an original duration greater than one year. Contract Balances The following table provides the contract balances as of December 31, 2024 and 2023 presented in the Consolidated Balance Sheets. December 31, 2024 December 31, 2023 Accounts receivable, net $ 1,335.4 $ 1,234.2 Contract assets 111.2 85.6 Contract liabilities - current 318.6 331.2 Contract liabilities - noncurrent 0.9 1.0 Accounts receivable, net – Amounts due where the Company’s right to receive cash is unconditional. Customer receivables are recorded at face amount less an allowance for credit losses. The Company maintains an allowance for credit losses as a result of customers’ inability to make required payments. Management evaluates the aging of customer receivable balances, the financial condition of its customers, historical trends and the time outstanding of specific balances to estimate the amount of customer receivables that may not be collected in the future and records the appropriate provision. Contract assets – The Company’s rights to consideration for the satisfaction of performance obligations subject to constraints apart from timing. Contract assets are transferred to receivables when the right to collect consideration becomes unconditional. Contract assets are presented net of progress billings and related advances from customers. Contract liabilities – Advance payments received from customers for contracts for which revenue is not yet recognized. Contract liability balances are generally recognized in revenue within twelve months. Of the $332.2 million in contract liabilities as of December 31, 2023, we recognized substantially all as revenue in the year ended December 31, 2024. Contract assets and liabilities are reported on the Consolidated Balance Sheets on a contract-by-contract basis at the end of each reporting period. Contract assets and liabilities are presented net on a contract level, where required. Payments from customers are generally due 30 to 60 days after invoicing. Invoicing for sales of standard products generally coincides with shipment or delivery of goods. Invoicing for CTO and ETO contracts typically follows a schedule for billing at contractual milestones. Payment milestones normally include down payments upon the contract signing, completion of product design, completion of customer’s preliminary inspection, shipment or delivery, completion of installation, and customer’s on-site inspection. The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets) and customer advances and deposits (contract liabilities) on the Consolidated Balance Sheets. The Company has elected the practical expedient from ASC 606-10-32-18 and does not adjust the transaction price for the effects of a financing component if, at contract inception, the period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Income before income taxes for the years ended December 31, 2024, 2023 and 2022 consisted of the following. 2024 2023 2022 U.S. $ 383.7 $ 356.0 $ 267.5 Non-U.S. 749.1 675.1 474.7 Income before income taxes $ 1,132.8 $ 1,031.1 $ 742.2 The following table details the components of the Provision for income taxes for the years ended December 31, 2024, 2023 and 2022. 2024 2023 2022 Current: U.S. federal $ 87.5 $ 111.5 $ 66.5 U.S. state and local 22.8 23.7 21.5 Non-U.S. 185.3 181.7 147.4 Deferred: U.S. federal (9.7) (44.0) (37.3) U.S. state and local (5.7) (6.9) (5.5) Non-U.S. (17.7) (26.0) (43.0) Provision for income taxes $ 262.5 $ 240.0 $ 149.6 Certain prior period amounts within this Note have been reclassified to conform to the current period presentation. The U.S. federal corporate statutory rate is reconciled to the Company’s effective income tax rate for the years ended December 31, 2024, 2023 and 2022 as follows. 2024 2023 2022 U.S. federal corporate statutory rate 21.0 % 21.0 % 21.0 % State and local taxes, less federal tax benefit 1.4 1.3 2.0 Net effects of foreign tax rate differential 2.5 1.8 1.5 Withholding tax 1.3 1.5 2.1 Repatriation cost (1.5) (2.0) (3.2) Global Intangible Low-Tax Income (“GILTI”) 0.4 0.7 0.3 ASC 740-30 (formerly APB 23) 1.5 1.7 1.9 Valuation allowance changes 0.4 1.7 0.5 Uncertain tax positions 0.9 0.9 0.2 Equity compensation (1.3) (0.6) (0.6) Nondeductible acquisition costs 0.3 0.4 0.4 Foreign Derived Intangible Income (“FDII”) deduction (1.1) (1.4) (1.6) Tax credits (0.6) (0.7) (1.1) Income not subject to tax (0.3) (1.6) (3.5) Amortization of goodwill and other intangible assets (1.3) (0.8) — Interest on equity (1.8) (0.7) (0.4) Return to provision adjustment (0.2) 0.1 — Loss on sale 1.1 — — Other, net 0.5 — 0.7 Effective income tax rate 23.2 % 23.3 % 20.2 % The principal items that gave rise to deferred income tax assets and liabilities as of December 31, 2024 and 2023 are as follows. 2024 2023 Deferred Tax Assets: Reserves and accruals $ 83.4 $ 80.1 Allowance for credit losses 7.4 7.8 Inventory reserve 9.0 5.9 Pension and postretirement benefit plans 20.0 25.3 Tax loss carryforwards 112.4 81.3 Deferred taxes recorded in other comprehensive income 1.4 13.4 Foreign tax credit carryforwards 50.7 57.9 Other 22.4 32.2 Total deferred tax assets 306.7 303.9 Valuation allowance (125.6) (115.7) Deferred Tax Liabilities: LIFO inventory (20.3) (20.2) Investment in partnership (30.2) (35.7) Property, plant and equipment (50.0) (42.5) Intangible assets (770.4) (635.4) Unremitted foreign earnings (41.8) (35.5) Total deferred tax liabilities (912.7) (769.3) Net deferred income tax liability $ (731.6) $ (581.1) The Company believes that it is more likely than not that it will realize its deferred tax assets through the reduction of future taxable income, other than for the deferred tax assets reflected below. Tax attributes and related valuation allowances as of December 31, 2024 were as follows. Tax Benefit Valuation Allowance Carryforward Period Ends Tax Attributes to be Carried Forward U.S. federal net operating loss $ 13.3 $ (0.1) 2032-2038 U.S. federal capital loss 0.6 (0.6) 2029 U.S. federal tax credit 50.8 (50.8) 2025-2034 Alternative minimum tax credit 0.5 (0.1) Unlimited U.S. state and local net operating losses 4.9 (2.1) 2026-2041 U.S. state capital loss 0.3 (0.1) 2028 Non U.S. net operating losses 62.6 (36.5) Unlimited Non U.S. capital losses 0.6 (0.6) Unlimited Excess interest 30.0 (29.7) Unlimited Other deferred tax assets 5.0 (5.0) Unlimited Total tax carryforwards $ 168.6 $ (125.6) A reconciliation of the changes in the valuation allowance for deferred tax assets for the years ended December 31, 2024, 2023 and 2022 are as follows. 2024 2023 2022 Beginning balance $ 115.7 $ 107.3 $ 106.4 Revaluation or additions due to acquisitions or mergers (1) 22.9 — — Charged to tax expense (10.8) 6.4 3.1 Charged to other accounts (2.2) 2.0 (2.2) Ending balance $ 125.6 $ 115.7 $ 107.3 (1) Revaluation for the tax year ended December 31, 2024 relates to the inclusion of ILC Dover’s opening balance sheet beginning valuation allowance. Total unrecognized tax benefits were $26.4 million, $19.1 million and $10.8 million for the years ended December 31, 2024, 2023 and 2022, respectively. The net increase in this balance primarily relates to current year additions to previously established reserves. Included in total unrecognized benefits at December 31, 2024 is $26.4 million of unrecognized tax benefits that would affect the Company’s effective tax rate if recognized. The balance of total unrecognized tax benefits is not expected to significantly increase or decrease within the next twelve months. Below is a tabular reconciliation of the changes in total unrecognized tax benefits during the years ended December 31, 2024, 2023 and 2022. 2024 2023 2022 Beginning balance $ 19.1 $ 10.8 $ 21.1 Gross increases for tax positions of prior years 0.8 0.4 0.4 Gross decreases for tax positions of prior years (0.3) — (3.7) Gross increases for tax positions of current year 8.1 7.9 4.1 Settlements — — (9.9) Lapse of statute of limitations (0.6) (0.2) (0.1) Changes due to currency fluctuations (0.7) 0.2 (1.1) Ending balance $ 26.4 $ 19.1 $ 10.8 The Company includes interest expense and penalties related to unrecognized tax benefits as part of the provision for income taxes. The Company’s income tax liabilities at December 31, 2024 and 2023 include accrued interest and penalties of $3.2 million and $2.0 million, respectively. The statutes of limitations for U.S. Federal tax returns are open beginning with the 2020 tax year, and state returns are open beginning with the 2014 tax year. The Company is currently under audit for the 2020 tax year. The Internal Revenue Service (“IRS”) has largely completed its examination of the 2020 tax year and no material adjustments were proposed. The Company was notified during 2024 of a new U.S. Federal income tax audit for the tax years 2021 and 2022. There are no known issues as the audit will start in 2025. The Company is subject to income tax in 48 jurisdictions outside the U.S. The statute of limitations varies by jurisdiction with 2013 being the oldest year still open. The Company’s significant operations outside the U.S. are located in the United Kingdom, Germany, China, Ireland, Switzerland, and Singapore. In Germany, a tax audit covering tax years 2011-2014 was closed in Q4 2024. Note that any other liabilities arising from pre-merger tax years for legacy Ingersoll Rand Industrial entities would be indemnified.

Leases

Leases	12 Months Ended
	Dec. 31, 2024
Leases [Abstract]
Leases	Leases The components of lease expense for the years ended December 31, 2024 and 2023 are as follows. 2024 2023 Operating lease cost $ 64.5 $ 53.7 Finance lease cost Amortization of right-of-use assets $ 1.5 $ 1.5 Interest on lease liabilities 0.9 0.9 Total finance lease cost $ 2.4 $ 2.4 Short-term lease cost $ 2.2 $ 1.9 Supplemental cash flow information related to leases for the years ended December 31, 2024 and 2023 is as follows. 2024 2023 Supplemental Cash Flows Information Cash Paid for Amounts Included in the Measurement of Lease Liabilities Operating cash flows from operating leases $ 63.8 $ 53.7 Operating cash flows from finance leases 0.9 1.0 Financing cash flows from finance leases 1.3 1.2 Leased Assets Obtained in Exchange for New Operating Lease Liabilities 96.2 62.5 Supplemental balance sheet information related to leases is as follows. December 31, 2024 December 31, 2023 Operating leases Other assets $ 226.6 $ 164.4 Accrued liabilities $ 56.3 $ 41.6 Other liabilities 165.5 116.9 Total operating lease liabilities $ 221.8 $ 158.5 Finance Leases Property, plant and equipment $ 11.1 $ 12.3 Short-term borrowings and current maturities of long-term debt $ 1.3 $ 1.3 Long-term debt, less current maturities 12.6 13.6 Total finance lease liabilities $ 13.9 $ 14.9 Weighted Average Remaining Lease Term (in years) Operating leases 5.2 5.1 Finance leases 9.4 10.3 Weighted Average Discount Rate Operating leases 4.1 % 3.6 % Finance leases 6.5 % 6.4 % Maturities of lease liabilities as of December 31, 2024 are as follows. Operating Leases Finance Leases 2025 $ 63.6 $ 2.2 2026 55.1 2.1 2027 41.3 2.1 2028 29.4 2.1 2029 17.7 2.1 Thereafter 39.2 8.5 Total lease payments $ 246.3 $ 19.1 Less imputed interest (24.5) (5.2) Total $ 221.8 $ 13.9
Leases	Leases The components of lease expense for the years ended December 31, 2024 and 2023 are as follows. 2024 2023 Operating lease cost $ 64.5 $ 53.7 Finance lease cost Amortization of right-of-use assets $ 1.5 $ 1.5 Interest on lease liabilities 0.9 0.9 Total finance lease cost $ 2.4 $ 2.4 Short-term lease cost $ 2.2 $ 1.9 Supplemental cash flow information related to leases for the years ended December 31, 2024 and 2023 is as follows. 2024 2023 Supplemental Cash Flows Information Cash Paid for Amounts Included in the Measurement of Lease Liabilities Operating cash flows from operating leases $ 63.8 $ 53.7 Operating cash flows from finance leases 0.9 1.0 Financing cash flows from finance leases 1.3 1.2 Leased Assets Obtained in Exchange for New Operating Lease Liabilities 96.2 62.5 Supplemental balance sheet information related to leases is as follows. December 31, 2024 December 31, 2023 Operating leases Other assets $ 226.6 $ 164.4 Accrued liabilities $ 56.3 $ 41.6 Other liabilities 165.5 116.9 Total operating lease liabilities $ 221.8 $ 158.5 Finance Leases Property, plant and equipment $ 11.1 $ 12.3 Short-term borrowings and current maturities of long-term debt $ 1.3 $ 1.3 Long-term debt, less current maturities 12.6 13.6 Total finance lease liabilities $ 13.9 $ 14.9 Weighted Average Remaining Lease Term (in years) Operating leases 5.2 5.1 Finance leases 9.4 10.3 Weighted Average Discount Rate Operating leases 4.1 % 3.6 % Finance leases 6.5 % 6.4 % Maturities of lease liabilities as of December 31, 2024 are as follows. Operating Leases Finance Leases 2025 $ 63.6 $ 2.2 2026 55.1 2.1 2027 41.3 2.1 2028 29.4 2.1 2029 17.7 2.1 Thereafter 39.2 8.5 Total lease payments $ 246.3 $ 19.1 Less imputed interest (24.5) (5.2) Total $ 221.8 $ 13.9

Stock-Based Compensation Plans

Stock-Based Compensation Plans	12 Months Ended
	Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]
Stock-Based Compensation Plans	Stock-Based Compensation Plans The Company has outstanding stock-based compensation awards granted under the 2013 Stock Incentive Plan (“2013 Plan”) and the 2017 Omnibus Incentive Plan, (as amended by the First Amendment, dated April 27, 2021, “2017 Plan”). Following the Company’s initial public offering, the Company grants stock-based compensation awards pursuant to the 2017 Plan and ceased granting new awards pursuant to the 2013 Plan. 2017 Omnibus Incentive Plan In May 2017, the Company’s Board approved the 2017 Plan, and in February 2020, the Company’s stockholders approved the amendment and restatement of the 2017 Plan. Under the terms of the Plan, the Company’s Board may grant up to 19.6 million stock based and other incentive awards. Any shares of common stock subject to outstanding awards granted under the Company’s 2013 plan that, after the effective date of the 2017 Plan, expire or are otherwise forfeited or terminated in accordance with their terms are also available for grant under the 2017 Plan. All stock options were granted to employees, directors and advisors with an exercise price equal to the fair value of the Company’s per share common stock at the date of grant. Stock option awards typically vest over four years or five years and expire ten years from the date of grant. 2013 Stock Incentive Plan The Company adopted the 2013 Plan on October 14, 2013 as amended on April 27, 2015 under which the Company had the ability to grant stock-based compensation awards to employees, directors and advisors. The total number of shares available for grant under the 2013 Plan and reserved for issuance was 20.9 million shares. All stock options were granted to employees, directors and advisors with an exercise price equal to the fair value of the Company’s per share common stock at the date of grant. Stock option awards vested over either five years, four years, or three years with 50% of each award vesting based on time and 50% of each award vesting based on the achievement of certain financial targets. Stock-Based Compensation Expense Stock-based compensation expense for the years ended December 31, 2024, 2023 and 2022 is included in “Cost of sales” and “Selling and administrative expenses” in the Consolidated Statements of Operations and is only related to continuing operations. 2024 2023 2022 Equity awards granted under the 2013 Plan and 2017 Plan (1) $ 58.8 $ 51.1 $ 80.0 Increase (decrease) in the liability for stock appreciation rights (“SAR”) — 0.8 (1.1) Total stock-based compensation expense $ 58.8 $ 51.9 $ 78.9 (1) In 2022, of the $80.0 million of expense for equity awards granted under the 2013 Plan and 2017 Plan, $39.5 million related to the $150 million equity grant to nearly 16,000 employees worldwide announced in the third quarter of 2020. As of December 31, 2024, there was $110.6 million of total unrecognized compensation expense related to outstanding stock option, restricted stock unit and performance share unit awards granted to employees and non-employee directors, as well as 300,000 conditional stock options awarded during the third quarter of 2022 to our Chairman and CEO in which the service date precedes the grant date, and will be granted upon achievement of certain performance targets. These 300,000 stock options have not been included in the Stock Option Awards section below since the grant date has not occurred. SARs, granted under the 2013 Plan, were settled in cash and were accounted for as liability awards. As of December 31, 2024 and 2023, there were no SARs outstanding. Stock Option Awards A summary of the Company’s stock option activity for the year ended December 31, 2024 is presented in the following table (underlying shares in thousands). Shares Weighted-Average Exercise Price Wtd. Avg. Remaining Contractual Term (years) Aggregate Intrinsic Value of In-The-Money Options Outstanding at December 31, 2023 5,282 $ 31.09 Granted 610 90.55 Exercised or Settled (1,615) 19.96 Forfeited (88) 65.08 Expired (4) 40.22 Outstanding at December 31, 2024 4,185 43.33 5.5 $ 197.4 Vested at December 31, 2024 2,708 29.34 4.1 $ 165.5 The per-share weighted average grant date fair value of stock options granted during the years ended December 31, 2024, 2023 and 2022 was $38.97, $25.28 and $21.24, respectively. The intrinsic value of stock options exercised was $114.8 million, $75.0 million and $27.7 million during the years ended December 31, 2024, 2023 and 2022, respectively. The following assumptions were used to estimate the fair value of options granted during the years ended December 31, 2024, 2023 and 2022. 2024 2023 2022 Expected life of options (in years) 6.3 - 7.5 6.3 - 7.5 6.3 Risk-free interest rate 3.7% - 4.3% 3.8% - 4.6% 1.9% - 3.9% Assumed volatility 34.9% - 35.2% 35.6% - 36.6% 37.1% - 38.3% Expected dividend rate 0.1% 0.0% - 0.1% 0.1% - 0.2% Restricted Stock Unit Awards Restricted stock units are typically granted in the first quarter of the year to employees and non-employee directors based on the market price of the Company’s common stock on the grant date and recognized in compensation expense over the vesting period. Eligible employees were also granted restricted stock units, during the third quarter of 2020, that vested ratably over two years, subject to the passage of time and the employee’s continued employment during such period. In some instances, such as death, awards may vest concurrently with or following an employee’s termination. A summary of the Company’s restricted stock unit activity for the year ended December 31, 2024 is presented in the following table (underlying shares in thousands). Shares Weighted-Average Grant-Date Fair Value Non-vested as of December 31, 2023 957 $ 52.18 Granted 433 90.94 Vested (469) 47.96 Forfeited (87) 68.20 Non-vested as of December 31, 2024 834 73.00 Performance Share Unit Awards (“PSUs”) Annually, during the first quarter, the Company grants TSR PSUs to certain employees in which the number of shares issued at the end of the performance period is determined by the Company’s total shareholder return percentile rank versus the S&P 500 index for the three year performance period. The grant date fair value of these awards is determined using a Monte Carlo simulation pricing model and compensation cost is recognized straight-line over a three year period. During the third quarter of 2022, the Company granted Special TSR PSUs to its Chairman and CEO under which the market condition is achieved on the first date during the five year performance period on which the sum of (i) the 60-day volume-weighted average closing price of the Company’s common stock, plus (ii) the cumulative value of any dividends paid during the five year performance period equals or exceeds $81.85. Vesting of this award is conditional upon the service condition even though the market condition was achieved prior to the end of the performance period. The grant date fair value of these awards was determined using a Monte Carlo simulation pricing model and compensation cost is recognized straight-line over a five year period. The Company also granted its Chairman and CEO Special EPS PSUs that are eligible to vest based on the level of compounded annual growth rate of the Company’s Adjusted EPS during the five year performance period. The grant date fair value of these awards is based on the market price of the Company’s common stock on the grant date and recognized as a compensation expense over a 4.3 year period. A summary of the Company’s performance stock unit activity for the year ended December 31, 2024 is presented in the following table (underlying shares in thousands). Shares Weighted-Average Grant-Date Fair Value Non-vested as of December 31, 2023 1,380 $ 49.53 Granted 87 132.98 Change in units based on performance 122 55.84 Vested (244) 55.84 Forfeited (6) 71.81 Non-vested as of December 31, 2024 1,339 54.28 The following assumptions were used to estimate the fair value of performance share units granted during the year ended December 31, 2024, 2023 and 2022 using the Monte Carlo simulation pricing model. 2024 2023 2022 Expected term (in years) 2.8 2.9 2.9 - 5.0 Risk-free interest rate 4.5% 4.4% 1.7% - 3.4% Assumed volatility 28.9% 31.8% 35.0% - 36.4% Expected dividend rate 0.1 % 0.1 % 0.2 %

Hedging Activities, Derivative

Hedging Activities, Derivative Instruments and Credit Risk	12 Months Ended
	Dec. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Hedging Activities, Derivative Instruments and Credit Risk	Hedging Activities, Derivative Instruments and Credit Risk Hedging Activities The Company is exposed to certain market risks during the normal course of its business arising from adverse changes in interest rates and foreign currency exchange rates. The Company selectively uses derivative financial instruments (“derivatives”), including cross-currency interest rate swap and foreign currency forward contracts, and interest rate swap and cap contracts, to manage the risks from fluctuations in foreign currency exchange rates and interest rates, respectively. The Company does not purchase or hold derivatives for trading or speculative purposes. Fluctuations in interest rates and foreign currency exchange rates can be volatile, and the Company’s risk management activities do not totally eliminate these risks. Consequently, these fluctuations could have a significant effect on the Company’s financial results. The Company manages its debt centrally, considering tax consequences and its overall financing strategies. The Company manages its exposure to interest rate risk by using interest rate derivatives as cash flow hedges of variable rate debt or fair value hedges of fixed rate debt in order to adjust the relative fixed and variable proportion. The Company’s exposure to interest rate risk results primarily from its fixed rate to floating rate interest rate swap contracts. A substantial portion of the Company’s operations is conducted by its subsidiaries outside of the United States in currencies other than the USD. Almost all of the Company’s non-U.S. subsidiaries conduct their business primarily in their local currencies, which are also their functional currencies. The USD, the EUR, GBP, Chinese Renminbi, and Indian rupee are the principal currencies in which the Company and its subsidiaries enter into transactions. The Company is exposed to the impacts of changes in foreign currency exchange rates on the translation of its non-U.S. subsidiaries’ assets, liabilities and earnings into USD. The Company manages this exposure by having certain U.S. subsidiaries borrow in currencies other than the USD or utilizing cross-currency interest rate swaps as net investment hedges. The Company and its subsidiaries are also subject to the risk that arises when they, from time to time, enter into transactions in currencies other than their functional currency. To mitigate this risk, the Company and its subsidiaries typically settle intercompany trading balances at least quarterly. The Company also selectively uses forward currency contracts to manage this risk. These contracts for the sale or purchase of European and other currencies generally mature within one year. Derivative Instruments The following table summarizes the notional amounts, fair values and classification of the Company’s outstanding derivatives by risk category and instrument type within the Consolidated Balance Sheets as of December 31, 2024 and 2023. December 31, 2024 Derivative Classification Notional Amount (1) Fair Value (1) Other Current Assets Fair Value (1) Other Assets Fair Value (1) Accrued Liabilities Fair Value (1) Other Liabilities Derivatives Designated as Hedging Instruments Interest rate swap contracts Fair value $ 750.0 $ — $ 1.4 $ 0.9 $ 0.9 Cross-currency interest rate swap contracts Net investment 1,074.3 11.5 15.8 — — Derivatives Not Designated as Hedging Instruments Foreign currency forwards Fair value $ 124.3 $ 1.8 $ — $ — $ — Foreign currency forwards Fair value 69.0 — — 1.2 — December 31, 2023 Derivative Classification Notional Amount (1) Fair Value (1) Other Current Assets Fair Value (1) Other Assets Fair Value (1) Accrued Liabilities Fair Value (1) Other Liabilities Derivatives Designated as Hedging Instruments Interest rate swap contracts Cash flow $ 528.5 $ 8.2 $ 1.2 $ — $ — Cross-currency interest rate swap contracts Net investment 1,054.2 15.7 — — 63.1 (1) Notional amounts represent the gross contract amounts of the outstanding derivatives excluding the total notional amount of positions that have been effectively closed through offsetting positions. The net gains and net losses associated with positions that have been effectively closed through offsetting positions but not yet settled are included in the asset and liability derivatives fair value columns, respectively. Payments to settle cross-currency swaps and payments of interest rate cap premiums are classified as financing cash flows in the Condensed Consolidated Statements of Cash Flows. All other cash flows related to derivatives are classified as operating cash flows in the Condensed Consolidated Statements of Cash Flows. There were no off-balance sheet derivative instruments as of December 31, 2024 or 2023. Interest Rate Swap Contracts Designated as Fair Value Hedges As of December 31, 2024, the Company was the variable rate payor on four interest rate swap contracts that effectively convert a total of $400.0 million of the Company’s fixed rate borrowings to variable rate borrowings. These contracts expire in May 2029. These swap agreements qualify as hedging instruments and have been designated as fair value hedges of $400.0 million of the 2029 Notes, and were considered to be perfectly effective under the shortcut method. As of December 31, 2024, the Company was the variable rate payor on two interest rate swap contracts that effectively convert a total of $250.0 million of the Company’s fixed rate borrowings to variable rate borrowings. These contracts expire in April 2031. These swap agreements qualify as hedging instruments and have been designated as fair value hedges of $250.0 million of the 2031 Notes, and were considered to be perfectly effective under the shortcut method. As of December 31, 2024, the Company was the variable rate payor on one interest rate swap contract that effectively convert a total of $100.0 million of the Company’s fixed rate borrowings to variable rate borrowings. This contract expires in March 2034. This swap agreement qualifies as a hedging instrument and has been designated as a fair value hedge of $100.0 million of the 2034 Notes, and were considered to be perfectly effective under the shortcut method. December 31, 2024 December 31, 2023 Long-term debt: Carrying amount of hedged debt $ 749.7 $ — Cumulative hedging adjustments, included in carrying amount (0.3) — Interest Rate Swap and Cap Contracts Designated as Cash Flow Hedges In April 2024, the Company entered into forward-starting interest rate swap agreements to hedge against changes in future cash flows resulting from changes in interest rates from the trade date through the forecasted issuance date of debt. During the year ended December 31, 2024, the Company entered into and terminated cash flow hedges with notional value of $750.0 million in connection with the 2034 Notes and $500.0 million in connection with the 2054 Notes, both of which were issued on May 10, 2024. The swaps were terminated on May 7, 2024, with a loss of $2.1 million on the swaps associated with the 2034 Notes and $2.3 million on the swaps associated with the 2054 Notes. These losses will be amortized as an increase to interest expense over the term of the respective notes. The Company was previously the fixed rate payor on two interest rate swap contracts that effectively fix the SOFR-based index used to determine the interest rates charged on a total of $528.5 million of the Company’s SOFR-based variable rate borrowings. These contracts carry a fixed rate of 3.2%. The Company and its counterparties terminated these contracts in May 2024. Prior to their termination, these swap agreements qualified as hedging instruments and were designated as cash flow hedges of forecasted interest payments. The forecasted interest payments are still expected to occur as specified in the Company’s hedge designations; therefore, the unrecognized gain at the time of termination will be reclassified into earnings over the remaining period of the original term of the contracts, ending in June 2025. The unrecognized gain remaining in accumulated other comprehensive income (“AOCI”) as of December 31, 2024 was $4.8 million, all of which is expected to be reclassified into earnings as a reduction to interest expense during the next 12 months. The Company was previously a party to interest rate cap contracts that effectively limited the SOFR-based interest rates charged on a portion of the Company’s variable rate borrowings to 4.0%. The Company and its counterparties terminated these contracts in August 2023. Prior to their termination, these cap contracts qualified as hedging instruments and were designated as cash flow hedges of forecasted interest payments. These forecasted interest payments are still expected to occur as specified in the Company’s hedge designations; therefore, the unrecognized gain at the time of termination will be reclassified into earnings over the remaining period of original term of the contracts, ending in June 2025. The unrecognized gain remaining in AOCI as of December 31, 2024 was $1.3 million, all of which is expected to be reclassified into earnings during the next 12 months. Gains on derivatives designated as cash flow hedges included in the Consolidated Statements of Comprehensive Income (Loss) for the years ended December 31, 2024, 2023 and 2022 are presented in the table below. 2024 2023 2022 Gain recognized in OCI on derivatives $ 1.6 $ 10.5 $ 18.3 Gain (loss) reclassified from AOCI into income (effective portion) (1) 15.7 15.6 (2.8) (1) Gains (losses) on derivatives reclassified from AOCI into income were included in “Interest expense” in the Consolidated Statements of Operations. Cross-Currency Interest Rate Swap Contracts Designated as Net Investment Hedges As of December 31, 2024, the Company was the fixed rate payor on three cross-currency interest rate swap contracts that replace a fixed rate of 5.4% on a total of $428.9 million with a fixed rate of 3.7% on a total of €400.0 million. These contracts expire in May 2027 and have been designated as net investment hedges of our Euro denominated subsidiaries and require an exchange of the notional amounts at maturity. As of December 31, 2024, the Company was the fixed rate payor on three cross-currency interest rate swap contracts that replace a fixed rate of 5.7% on a total of $322.7 million with a fixed rate of 4.1% on a total of €300.0 million. These contracts expire in May 2029 and have been designated as net investment hedges of our Euro denominated subsidiaries and require an exchange of the notional amounts at maturity. As of December 31, 2024, the Company was the fixed rate payor on three cross-currency interest rate swap contracts that replace a fixed rate of 5.7% on a total of $322.7 million with a fixed rate of 4.1% on a total of €300.0 million. These contracts expire in May 2031 and have been designated as net investment hedges of our Euro denominated subsidiaries and require an exchange of the notional amounts at maturity. The Company was previously the fixed rate payor on two cross-currency interest rate swap contracts that replaced a fixed rate of 3.2% on a total of $528.5 million with a fixed rate of 1.6% on a total of €500.0 million. These contracts were designated as net investment hedges of our Euro denominated subsidiaries until May 10, 2024 when they were terminated for $10.0 million. The payments to settle the termination of the cross currency interest rate swaps are included in “Payments to settle cross-currency swaps” within our Condensed Consolidated Statements of Cash Flows. The recorded AOCI at the termination of the cross-currency interest rate swaps will remain in AOCI until there is a substantial liquidation of the Company’s net investment in subsidiaries with EUR functional currencies. The Company was previously a party to three cross-currency interest rate swap contracts where we receive SOFR on a total of $525.7 million and pay EURIBOR on a total of €500.0 million. These contracts were designated as net investment hedges of our Euro denominated subsidiaries until May 10, 2024 when they were terminated for $9.9 million. The payments to settle the termination of the cross currency interest rate swaps are included in “Payments to settle cross-currency swaps” within our Condensed Consolidated Statements of Cash Flows. The recorded AOCI at the termination of the cross-currency interest rate swaps will remain in AOCI until there is a substantial liquidation of the Company’s net investment in subsidiaries with EUR functional currencies. Gains (losses) on derivatives designated as net investment hedges included in the Condensed Consolidated Statements of Comprehensive Income (Loss) for the years ended December 31, 2024, 2023 and 2022 are presented in the table below. 2024 2023 2022 Gain (loss) recognized in OCI on derivatives $ 72.5 $ (17.5) $ 0.6 Gain reclassified from AOCI into income (effective portion) (1) 17.7 19.0 11.5 (1) Gains (losses) on derivatives reclassified from AOCI into income were included in “Interest expense” in the Consolidated Statements of Operations. Foreign Currency Forwards Not Designated as Hedging Instruments The Company had nine foreign currency forward contracts outstanding as of December 31, 2024 with notional amounts ranging from $7.7 million to $68.2 million. These contracts are sometimes used to hedge the change in fair value of recognized foreign currency denominated assets or liabilities caused by changes in currency exchange rates. The changes in the fair value of these contracts generally offset the changes in the fair value of a corresponding amount of the hedged items, both of which are included within “Other operating expense, net” in the Consolidated Statements of Operations. The Company’s foreign currency forward contracts are subject to master netting arrangements or agreements between the Company and each counterparty for the net settlement of all contracts through a single payment in a single currency in the event of default on or termination of any one contract with that certain counterparty. It is the Company’s practice to recognize the gross amounts in the Consolidated Balance Sheets. The amount available to be netted is not material. The Company’s gains (losses) on derivative instruments not designated as accounting hedges and total net foreign currency transaction gains (losses) for the years ended December 31, 2024, 2023 and 2022 were as follows. 2024 2023 2022 Foreign currency forward contracts gains 0.1 0.3 3.4 Total foreign currency transaction gains (losses), net (3.2) (5.1) 5.9 Foreign Currency Denominated Debt Designated as a Net Investment Hedge In February 2020, the Company designated its Euro Term Loan, which had a principal balance at that time of €601.2 million, as a hedge of the Company’s net investment in subsidiaries with a functional currency of euro. This loan was repaid in June 2022 and the hedge has been discontinued. The Company’s gains, net of income tax, associated with changes in the value of debt for the year ended December 31, 2022 was $36.4 million. Credit Risk Credit risk related to derivatives arises when amounts receivable from a counterparty exceed those payable. Because the notional amount of the derivative instruments only serves as a basis for calculating amounts receivable or payable, the risk of loss with any counterparty is limited to a fraction of the notional amount. The Company minimizes the credit risk related to derivatives by transacting only with multiple, high-quality counterparties that are major financial institutions with investment-grade credit ratings. The Company has not experienced any financial loss as a result of counterparty nonperformance in the past. The majority of the derivative contracts to which the Company is a party, settle monthly or quarterly, or mature within one year. Because of these factors, the Company believes it has minimal credit risk related to derivative contracts as of December 31, 2024. Concentrations of credit risk with respect to trade receivables are limited due to the wide variety of customers and industries to which the Company’s products and services are sold, as well as their dispersion across many different geographic areas . As a result, the Company does not believe it has any significant concentrations of credit risk as of December 31, 2024 or 2023.

Fair Value Measurements

Fair Value Measurements	12 Months Ended
	Dec. 31, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements A financial instrument is defined as cash or cash equivalents, evidence of an ownership interest in an entity, or a contract that creates a contractual obligation or right to deliver or receive cash or another financial instrument from another party. The Company’s financial instruments consist primarily of cash and cash equivalents, trade accounts receivables, trade accounts payables, deferred compensation assets and obligations, derivatives and debt instruments. The carrying values of cash and cash equivalents, trade accounts receivables, trade accounts payables, and variable rate debt instruments are a reasonable estimate of their respective fair values. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or more advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy is based on three levels of inputs, of which the first two are considered observable and the last unobservable, that may be used to measure fair value as follows. Level 1 Quoted prices (unadjusted) in active markets for identical assets or liabilities as of the reporting date. Level 2 Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities as of the reporting date. Level 3 Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Refer to Note 1 “Summary of Significant Accounting Policies” for a discussion of the valuation assumptions utilized in the valuation of goodwill and indefinite-lived intangible assets. The following table summarizes the Company’s financial assets and liabilities measured at fair value on a recurring basis. December 31, 2024 Level 1 Level 2 Level 3 Total Financial Assets Trading securities held in deferred compensation plan (1) $ 21.0 $ — $ — $ 21.0 Interest rate swaps (2) — 1.4 — 1.4 Cross-currency interest rate swaps (3) — 27.3 — 27.3 Foreign currency forwards (4) — 1.8 — 1.8 Total $ 21.0 $ 30.5 $ — $ 51.5 Financial Liabilities Deferred compensation plan (1) $ 28.7 $ — $ — $ 28.7 Interest rate swaps (2) — 1.8 — 1.8 Contingent consideration (5) — — 22.2 22.2 Foreign currency forwards (4) — 1.2 — 1.2 Total $ 28.7 $ 3.0 $ 22.2 $ 53.9 December 31, 2023 Level 1 Level 2 Level 3 Total Financial Assets Trading securities held in deferred compensation plan (1) $ 16.8 $ — $ — $ 16.8 Interest rate swaps (5) — 9.4 — 9.4 Cross-currency interest rate swaps (3) — 15.7 — 15.7 Total $ 16.8 $ 25.1 $ — $ 41.9 Financial Liabilities Deferred compensation plan (1) $ 24.7 $ — $ — $ 24.7 Cross-currency interest rate swaps (3) — 63.1 — 63.1 Contingent consideration (5) — — 42.2 42.2 Total $ 24.7 $ 63.1 $ 42.2 $ 130.0 (1) Based on the quoted price of publicly traded mutual funds and other equity securities which are classified as trading securities and accounted for using the mark-to-market method. (2) Measured as the present value of all expected future cash flows based on the SOFR-based swap yield curves. The present value calculation uses discount rates that have been adjusted to reflect the credit quality of the Company and its counterparties. (3) Measured as the present value of all expected future cash flows on each leg of the contracts. The model utilizes inputs of observable market data including interest yield curves and foreign currency exchange rates. The present value calculation uses cross-currency basis-adjusted discount factors that have been adjusted to reflect the credit quality of the Company and its counterparties. (4) Based on calculations that use readily observable market parameters as their basis, such as spot and forward rates. (5) Measured as the present value of expected consideration payable for completed acquisitions, generally derived using probability-weighted analysis of achieving projected revenue or EBITDA targets. Contingent Consideration Certain of the Company’s acquisitions may result in payments of consideration in future periods that are contingent upon the achievement of certain targets, generally measures of revenue and EBITDA. As part of the initial accounting for the acquisition, a liability is recorded for the estimated fair value of the contingent consideration on the acquisition date. The fair value of the contingent consideration is re-measured at each reporting period, and the change in fair value is recognized within “Other operating expense, net” in the Consolidated Statements of Operations. This fair value measurement of contingent consideration is categorized within Level 3 of the fair value hierarchy, as the measurement amount is based primarily on significant inputs that are not observable in the market. The following table provides a reconciliation of the activity for contingent consideration for the years ended December 31, 2024 and 2023. 2024 2023 Balance at beginning of period $ 42.2 $ 43.9 Acquisitions 6.7 13.5 Changes in fair value (15.3) 7.3 Payments (10.0) (23.2) Foreign currency translation and other (1.4) 0.7 Balance at end of period $ 22.2 $ 42.2

Contingencies

Contingencies	12 Months Ended
	Dec. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Contingencies	Contingencies The Company is a party to various legal proceedings, lawsuits and administrative actions, which are of an ordinary or routine nature for a company of its size and sector. The Company believes that such proceedings, lawsuits and administrative actions will not materially adversely affect its operations, financial condition, liquidity or competitive position. A more detailed discussion of certain of these proceedings, lawsuits and administrative actions is set forth below. Asbestos and Silica Related Litigation Prior to the divestiture described below, “Accrued liabilities” and “Other liabilities” of the Condensed Consolidated Balance Sheets included a total litigation reserve of $126.9 million as of December 31, 2023, with regards to potential liability arising from the Company’s asbestos-related litigation. The Company had an insurance recovery receivable for probable asbestos related recoveries of $157.7 million as of December 31, 2023, which was included in “Other assets” in the Condensed Consolidated Balance Sheets. On June 5, 2024, the Company entered into a Membership Interest Purchase Agreement (the “Purchase Agreement”) with Onyx TopCo LLC (the “Buyer”), a wholly owned subsidiary of Delticus Holdings LLC (“Delticus”), which is an entity owned by entities affiliated with Third Point LLC. Under the Purchase Agreement, the Company transferred 100% of the equity interests of three wholly-owned subsidiaries that hold asbestos liabilities and certain assets, including the related insurance assets, to the Buyer, effective as of June 10, 2024. In connection with the divestiture (the “Asbestos Portfolio Sale”), the divested entities were capitalized with a total of $188.5 million, including $143.5 million from insurance settlement proceeds, $35.0 million from affiliates of Delticus, and $10.0 million from Ingersoll Rand. As these subsidiaries were the obligors for the Company’s asbestos-related liabilities and policyholders of the related insurance assets, the rights and obligations related to these items transferred upon the sale. The divested subsidiaries have agreed to indemnify us and our affiliates for their asbestos-related liabilities, which encompassed all of our consolidated asbestos-related liabilities and contingent liabilities immediately prior to the sale. The Purchase Agreement contains customary representations and warranties with respect to the divested subsidiaries, the Company, and Delticus. Pursuant to the Purchase Agreement, the Company and Delticus will each indemnify the other for breaches of representation and warranties or breaches of covenants, subject to certain limitations as set forth in the agreement. In connection with the sale, the Company and its Board of Directors received a solvency opinion from an independent advisory firm that the divested entities were solvent and adequately capitalized immediately prior to, at the time of, and after giving effect to, the sale. Following the completion of the transfer, the Company no longer has any obligation with respect to pending and future asbestos claims. As such, the divested entities have been deconsolidated from the financial results of the Company as we no longer maintain control of the entities. Therefore, all associated assets and liabilities are no longer reported on the Consolidated Balance Sheet. The transaction resulted in a pre-tax loss of $58.8 million, recorded to “Other operating expense, net.” Additionally, the Company recorded a tax benefit as a result of the reversal of previously recorded net deferred tax liabilities of $7.6 million, resulting in an after-tax loss of $51.2 million recorded in the second quarter of 2024. The following table summarizes the impacts of the divestiture. Assets divested: Cash and cash equivalents $ 153.5 Insurance recovery receivable 13.9 Liabilities divested: Asbestos indemnity liability - current (12.3) Asbestos indemnity liability - noncurrent (111.4) Loss on Asbestos Sale, before transaction costs 43.7 Transaction costs 15.1 Loss on Asbestos Sale 58.8 Income tax benefit (7.6) Loss on Asbestos Sale, net of tax $ 51.2 Environmental Matters The Company has been identified as a potentially responsible party (“PRP”) with respect to several sites designated for cleanup under U.S. federal “Superfund” or similar state laws that impose liability for cleanup of certain waste sites and for related natural resource damages. Persons potentially liable for such costs and damages generally include the site owner or operator and persons that disposed or arranged for the disposal of hazardous substances found at those sites. Although these laws impose joint and several liability on PRPs, in application the PRPs typically allocate the investigation and cleanup costs based upon the volume of waste contributed by each PRP. Based on currently available information, the Company was only a small contributor to these waste sites, and the Company has, or is attempting to negotiate, de minimis settlements for their cleanup. The cleanup of the remaining sites is substantially complete and the Company’s future obligations entail a share of the sites’ ongoing operating and maintenance expense. The Company is also addressing several on-site cleanups for which it is the primary responsible party. The Company has undiscounted liabilities of $13.6 million and $16.7 million as of December 31, 2024 and 2023, respectively, on its Consolidated Balance Sheets to the extent costs are known or can be reasonably estimated for its remaining financial obligations for the environmental matters discussed above and does not anticipate that any of these matters will result in material additional costs beyond amounts accrued. Based upon consideration of currently available information, the Company does not anticipate any material adverse effect on its results of operations, financial condition, liquidity or competitive position as a result of compliance with federal, state, local or foreign environmental laws or regulations, or cleanup costs relating to these matters.

Other Operating Expense, Net

Other Operating Expense, Net	12 Months Ended
	Dec. 31, 2024
Other Income and Expenses [Abstract]
Other Operating Expense, Net	Other Operating Expense, Net The components of “Other operating expense, net” for the years ended December 31, 2024, 2023 and 2022 were as follows. 2024 2023 2022 Other Operating Expense, Net Foreign currency transaction losses (gains), net $ 3.2 $ 5.1 $ (5.9) Restructuring charges, net (1) 31.2 19.9 29.3 Acquisition and other transaction related expenses (2) 47.1 52.2 38.7 Loss on asbestos sale (3) 58.8 — — Other, net (1.7) 0.5 2.8 Total other operating expense, net $ 138.6 $ 77.7 $ 64.9 (1) See Note 5 “Restructuring.” (2) Represents costs associated with successful and abandoned acquisitions, including third-party expenses, post-closure integration costs and non-cash charges and credits arising from fair value purchase accounting adjustments. (3) See Note 22 “Contingencies.”

Segment Reporting

Segment Reporting	12 Months Ended
	Dec. 31, 2024
Segment Reporting [Abstract]
Segment Reporting	Segment Reporting A description of the Company’s two reportable segments, including the specific products manufactured and sold follows below. In the Industrial Technologies and Services segment, the Company designs, manufactures, markets and services a broad range of compression and vacuum equipment as well as fluid transfer equipment and loading systems. The Company’s compression and vacuum products are used worldwide in industrial manufacturing, transportation, chemical processing, food and beverage production, clean energy, environmental and other applications. In addition to equipment sales, the Company offers a broad portfolio of service options tailored to customer needs and complete range of aftermarket parts, air treatment equipment, controls and other accessories. The Company’s engineered loading systems and fluid transfer equipment ensure the safe handling and transfer of crude oil, liquefied natural gas, compressed natural gas, chemicals, and bulk materials. In the Precision and Science Technologies segment, the Company designs, manufactures and markets a broad range of specialized positive displacement pumps, fluid management equipment, single-use powder handling systems, and contract design and production services for silicone, thermoplastic, and specialty components and assemblies for medical devices. These products are used in medical, laboratory, industrial manufacturing, water and wastewater, chemical processing, clean energy, food and beverage, agriculture and other markets. The Company’s products are used for a diverse set of applications including precision dosing, liquid and solid transfer, dispensing, gas compression, gas sampling, pressure management, flow control, and powder handling, amongst other applications. The Company sells primarily through a broad global network of specialized and national distributors and original equipment manufacturers who integrate the Company’s products into their devices and systems. Ingersoll Rand’s Chief Operating Decision Maker (“CODM”) is our Chief Executive Officer. The CODM evaluates the performance of the Company’s segments based on Segment Adjusted EBITDA. The CODM closely monitors the Segment Adjusted EBITDA of each segment to evaluate past performance and actions required to improve profitability. Inter-segment sales and transfers are not significant. Certain administrative expenses related to the Company’s corporate offices and shared service centers in the United States and Europe, which includes transaction processing, accounting and other business support functions, are allocated to the segments and are included in Segment selling and administrative expenses. Certain other administrative expenses, including senior management compensation, treasury, internal audit, tax compliance, certain information technology, and other corporate functions, are not allocated to the segments to determine Segment Adjusted EBITDA. The following table provides summarized information about the Company’s operations by reportable segment and reconciles Segment Adjusted EBITDA to Income from Continuing Operations Before Income Taxes for the years ended December 31, 2024, 2023 and 2022. Industrial Technologies and Services Precision and Science Technologies Total 2024 2023 2022 2024 2023 2022 2024 2023 2022 Revenue $ 5,818.1 $ 5,632.8 $ 4,705.1 1,416.9 1,243.3 1,211.2 $ 7,235.0 $ 6,876.1 $ 5,916.3 Segment cost of sales (1) 3,193.3 3,225.0 2,785.5 736.2 648.8 652.4 3,929.5 3,873.8 3,437.9 Segment selling and administrative expenses (2) 868.5 818.5 702.5 264.6 222.5 212.6 1,133.1 1,041.0 915.1 Other segment items (3) 1.5 2.0 3.1 (2.7) (0.8) (1.3) (1.2) 1.2 1.8 Segment Adjusted EBITDA $ 1,754.8 $ 1,587.3 $ 1,214.0 418.8 372.8 347.5 2,173.6 1,960.1 1,561.5 (1) Segment cost of sales excludes adjustments to LIFO inventories, depreciation and amortization expense, restructuring and related business transformation costs, acquisition and other transaction related expenses and non-cash charges. (2) Segment selling and administrative expenses excludes depreciation and amortization expense, restructuring and related business transformation costs, acquisition and other transaction related expenses and non-cash charges. (3) Other miscellaneous segment expenses. 2024 2023 2022 Total Segment Adjusted EBITDA 2,173.6 1,960.1 1,561.5 Less items to reconcile Segment Adjusted EBITDA to Income from Continuing Operations Before Income Taxes: Corporate expenses not allocated to segments 155.5 173.3 126.7 Interest expense 213.2 156.7 103.2 Depreciation and amortization expense (1) 478.0 455.4 429.4 Impairment of other intangible assets 13.9 — — Restructuring and related business transformation costs (2) 32.3 22.9 32.3 Acquisition and other transaction related expenses and non-cash charges (3) 59.8 63.9 40.7 Stock-based compensation (4) 58.8 51.9 85.6 Foreign currency transaction losses (gains), net 3.2 5.1 (5.9) Loss on extinguishment of debt 3.0 13.5 1.1 Adjustments to LIFO inventories 6.7 12.0 36.1 Cybersecurity incident costs 0.5 2.3 — Loss on asbestos sale 58.8 — — Gain on settlement of post-acquisition contingencies (5) — — (6.2) Interest income on cash and cash equivalents (43.3) (28.8) (8.0) Other adjustments (6) 0.4 0.8 (15.7) Income from Continuing Operations Before Income Taxes $ 1,132.8 $ 1,031.1 $ 742.2 (1) Depreciation and amortization expense excludes $4.0 million, $3.7 million and $3.4 million of depreciation of rental equipment for the years ended December 31, 2024, 2023 and 2022, respectively. (2) Restructuring and related business transformation costs consist of the following. 2024 2023 2022 Restructuring charges $ 31.2 $ 19.9 $ 29.3 Facility reorganization, relocation and other costs 1.1 3.0 3.0 Total restructuring and related business transformation costs $ 32.3 $ 22.9 $ 32.3 (3) Represents costs associated with successful and abandoned acquisitions, including third-party expenses, post-closure integration costs and non-cash charges and credits arising from fair value purchase accounting adjustments. (4) Represents stock-based compensation expense recognized for the year ended December 31, 2022 of $78.9 million and associated employer taxes of $6.7 million. (5) Represents gains from settling post-acquisition contingencies related to the Merger outside of the measurement period. (6) Includes (i) pension and other postretirement benefits (“OPEB”) plan costs other than service cost and (ii) other miscellaneous adjustments. The following tables provide summarized information about the Company’s reportable segments. Depreciation and Amortization Expense 2024 2023 2022 Industrial Technologies and Services $ 296.0 $ 313.8 $ 294.7 Precision and Science Technologies 177.1 135.4 133.6 Corporate and other 8.9 9.9 4.5 Total depreciation and amortization expense $ 482.0 $ 459.1 $ 432.8 Capital Expenditures 2024 2023 2022 Industrial Technologies and Services $ 83.0 $ 83.9 $ 66.3 Precision and Science Technologies 21.3 18.5 17.7 Corporate and other 44.8 3.0 10.6 Total capital expenditures $ 149.1 $ 105.4 $ 94.6 Identifiable Assets 2024 2023 Industrial Technologies and Services $ 10,369.6 $ 10,138.8 Precision and Science Technologies 5,884.1 3,464.7 Corporate and other 1,756.1 1,960.0 Total identifiable assets $ 18,009.8 $ 15,563.5 The following table presents property, plant and equipment, net by geographic region for the years ended December 31, 2024, and 2023. 2024 2023 United States $ 381.8 $ 286.0 Other Americas 38.1 12.8 Total Americas 419.9 298.8 EMEIA (1) 256.5 245.7 China 152.3 160.9 Other Asia Pacific 13.4 6.0 Total Asia Pacific 165.7 166.9 Total $ 842.1 $ 711.4 (1) Europe, Middle East, India and Africa (“EMEIA”)

Earnings Per Share

Earnings Per Share	12 Months Ended
	Dec. 31, 2024
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share The calculation of earnings per share is based on the weighted-average number of the Company’s shares outstanding for the applicable period. The calculation of diluted earnings per share reflects the effect of all potentially dilutive shares that were outstanding during the respective periods, unless the effect of doing so is antidilutive. The Company uses the treasury stock method to calculate the dilutive effect of outstanding share-based compensation awards. The number of weighted-average shares outstanding used in the computations of basic and diluted earnings per share for the years ended December 31, 2024, 2023 and 2022 were as follows. 2024 2023 2022 Weighted-average shares outstanding - Basic 403.4 404.8 405.3 Dilutive effect of outstanding share-based compensation awards 3.8 4.2 4.9 Weighted-average shares outstanding - Diluted 407.2 409.0 410.2 For the years ended December 31, 2024, 2023 and 2022, there were 0.5 million, 1.3 million and 1.8 million anti-dilutive shares that were not included in the computation of diluted earnings per share, respectively.

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2024
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events On February 3, 2025, the Company completed the acquisition of four businesses for aggregate purchase consideration of approximately $168 million, subject to customary post-closing purchase price adjustments. On February 11, 2025, the Company entered into two cross-currency interest rate swap contracts on a total of €250.0 million. These contracts have been designated as net investment hedges of our Euro denominated subsidiaries and require an exchange of the notional amounts at maturity.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Pay vs Performance Disclosure
Net income attributable to Ingersoll Rand Inc.	$ 838.6	$ 778.7	$ 604.7

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Dec. 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Insider Trading Policies and Pr

Insider Trading Policies and Procedures	12 Months Ended
	Dec. 31, 2024
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted	true

Cybersecurity Risk Management a

Cybersecurity Risk Management and Strategy Disclosure	12 Months Ended
	Dec. 31, 2024
Cybersecurity Risk Management, Strategy, and Governance [Line Items]
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]	The Company has implemented controls based on the National Institute of Standards and Technology Cybersecurity Framework (the “NIST CSF”) and the Sarbanes-Oxley Act of 2002. Our Information Technology organization is led by the Chief Information Officer (“CIO”) who is responsible for cybersecurity risk management. The Audit Committee of the Board of Directors is tasked with oversight of our overall enterprise risk management program, including cybersecurity, and receives recurring cybersecurity updates throughout the year with at least two cybersecurity reports to the full Board of Directors annually. Directors with experience in cybersecurity and technology play crucial oversight roles for our digital and cybersecurity strategies. Our cybersecurity program is overseen by the Company’s Chief Information Security Officer (“CISO”) and is designed to protect and preserve the confidentiality, integrity and availability of our information technology assets. Risks and controls are monitored by the CISO and CIO and their evaluation of our overall program drives the nature and scope of our cybersecurity investments. Our CISO reports directly to the CIO and has 20 years of IT experience including leadership roles at various companies with enterprise responsibility for IT audit, IT infrastructure, and cybersecurity. The CISO reports to the Audit Committee on the effectiveness of the Company’s cybersecurity program controls aligned to the NIST CSF framework. We periodically engage external subject matter experts who provide independent qualitative and quantitative assessments of the cybersecurity program maturity and response readiness. We also use processes to oversee and identify material risks from cybersecurity threats associated with our use of third-party technology and systems. In addition, the Company leverages a monthly cybersecurity awareness training program for all employees that is further reinforced through frequent phishing simulations.
Cybersecurity Risk Management Processes Integrated [Flag]	true
Cybersecurity Risk Management Processes Integrated [Text Block]	The Company has implemented controls based on the National Institute of Standards and Technology Cybersecurity Framework (the “NIST CSF”) and the Sarbanes-Oxley Act of 2002. Our Information Technology organization is led by the Chief Information Officer (“CIO”) who is responsible for cybersecurity risk management. The Audit Committee of the Board of Directors is tasked with oversight of our overall enterprise risk management program, including cybersecurity, and receives recurring cybersecurity updates throughout the year with at least two cybersecurity reports to the full Board of Directors annually. Directors with experience in cybersecurity and technology play crucial oversight roles for our digital and cybersecurity strategies.
Cybersecurity Risk Management Third Party Engaged [Flag]	true
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]	true
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]	false
Cybersecurity Risk Board of Directors Oversight [Text Block]	The Audit Committee of the Board of Directors is tasked with oversight of our overall enterprise risk management program, including cybersecurity, and receives recurring cybersecurity updates throughout the year with at least two cybersecurity reports to the full Board of Directors annually. Directors with experience in cybersecurity and technology play crucial oversight roles for our digital and cybersecurity strategies.
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]	Our cybersecurity program is overseen by the Company’s Chief Information Security Officer (“CISO”) and is designed to protect and preserve the confidentiality, integrity and availability of our information technology assets. Risks and controls are monitored by the CISO and CIO and their evaluation of our overall program drives the nature and scope of our cybersecurity investments.
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]	The Audit Committee of the Board of Directors is tasked with oversight of our overall enterprise risk management program, including cybersecurity, and receives recurring cybersecurity updates throughout the year with at least two cybersecurity reports to the full Board of Directors annually.
Cybersecurity Risk Role of Management [Text Block]	Our cybersecurity program is overseen by the Company’s Chief Information Security Officer (“CISO”) and is designed to protect and preserve the confidentiality, integrity and availability of our information technology assets. Risks and controls are monitored by the CISO and CIO and their evaluation of our overall program drives the nature and scope of our cybersecurity investments. Our CISO reports directly to the CIO and has 20 years of IT experience including leadership roles at various companies with enterprise responsibility for IT audit, IT infrastructure, and cybersecurity. The CISO reports to the Audit Committee on the effectiveness of the Company’s cybersecurity program controls aligned to the NIST CSF framework. We periodically engage external subject matter experts who provide independent qualitative and quantitative assessments of the cybersecurity program maturity and response readiness. We also use processes to oversee and identify material risks from cybersecurity threats associated with our use of third-party technology and systems. In addition, the Company leverages a monthly cybersecurity awareness training program for all employees that is further reinforced through frequent phishing simulations.
Cybersecurity Risk Management Positions or Committees Responsible [Flag]	true
Cybersecurity Risk Management Positions or Committees Responsible [Text Block]	Our cybersecurity program is overseen by the Company’s Chief Information Security Officer (“CISO”) and is designed to protect and preserve the confidentiality, integrity and availability of our information technology assets.
Cybersecurity Risk Management Expertise of Management Responsible [Text Block]	Our CISO reports directly to the CIO and has 20 years of IT experience including leadership roles at various companies with enterprise responsibility for IT audit, IT infrastructure, and cybersecurity.
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]	Quarterly updates are provided by the CISO to the Cybersecurity Governance Committee comprised of cross functional senior management regarding the effectiveness of cybersecurity program and its ability to monitor the prevention, detection, mitigation, and remediation of cybersecurity incidents. Our Cybersecurity Governance Committee is responsible for monitoring and coordinating enterprise cybersecurity policy and strategy, and for providing guidance to key management and oversight bodies. Our cybersecurity program includes a risk-based incident response plan that provides a documented framework for handling incidents including coordination across multiple parts of the Company.
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]	true

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2024
Accounting Policies [Abstract]
Overview and Basis of Presentation	Overview and Basis of Presentation Ingersoll Rand Inc. is a global provider of mission-critical flow creation products and life science and industrial solutions. The accompanying consolidated financial statements include the accounts of Ingersoll Rand Inc. and its consolidated subsidiaries (collectively referred to herein as “Ingersoll Rand” or the “Company”).
Principles of Consolidation	Principles of Consolidation The accompanying consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). All intercompany transactions and accounts have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. The Company regularly evaluates the estimates and assumptions related to the allowance for credit losses, inventory valuation, warranty reserves, fair value of stock-based awards, goodwill, intangible asset, and long-lived asset valuations, employee benefit plan liabilities, over time revenue recognition, income tax liabilities and deferred tax assets and related valuation allowances, uncertain tax positions, restructuring reserves, and litigation and other loss contingencies. Actual results could differ materially and adversely from those estimates and assumptions, and such results could affect the Company’s consolidated net income, financial position, or cash flows.
Foreign Currency Translation	Foreign Currency Translation Assets and liabilities of the Company’s foreign subsidiaries, where the functional currency is not the U.S. Dollar (“USD”), are translated at the exchange rate in effect at the balance sheet date, while revenues and expenses are translated at average rates prevailing during the year. Adjustments resulting from the translation of the assets and liabilities of foreign operations into USD are excluded from the determination of net income, and are reported in accumulated other comprehensive loss, a separate component of stockholders’ equity, and included as a component of other comprehensive income (loss). Assets and liabilities of subsidiaries that are denominated in currencies other than the subsidiaries’ functional currency are remeasured into the functional currency using end of period exchange rates, or historical rates for certain balances, where applicable. Gains and losses related to these remeasurements are recorded within the Consolidated Statements of Operations as a component of “Other operating expense, net.”
Revenue Recognition	Revenue Recognition
Cost of Sales	Cost of Sales Cost of sales includes the costs the Company incurs, including purchased materials, labor and overhead related to manufactured products and aftermarket parts sold during a period. Depreciation related to manufacturing equipment and facilities is included in cost of sales. Purchased materials represent the majority of costs of sales, with steel, aluminum, copper and partially finished castings representing the most significant materials inputs. Cost of sales for services includes the direct costs the Company incurs including direct labor, parts and other overhead costs including depreciation of equipment and facilities to deliver repair, maintenance, and other field services to the Company’s customers.
Selling and Administrative Expenses	Selling and Administrative Expenses Selling and administrative expenses consist of (i) employee related salary, stock-based compensation expense, benefits and other expenses for selling, administrative functions and other activities not associated with the manufacture of products or delivery of services to customers; (ii) the costs of marketing and direct costs of selling products and services to customers including internal and external sales commissions; (iii) facilities costs including office rent, maintenance, depreciation, and insurance for selling and administrative activities; (iv) research and development expenditures; (v) professional and consultant fees; and (vi) other miscellaneous expenses.
Cash and Cash Equivalents	Cash and Cash Equivalents
Accounts Receivable	Accounts Receivable Trade accounts receivable consist of amounts owed for products shipped to or services performed for customers. Reviews of customers’ creditworthiness are performed prior to order acceptance or order shipment. Trade accounts receivable are recorded net of an allowance for expected credit losses. The allowance for credit losses is based on the Company’s assessment of losses that will result from its customers’ inability or unwillingness to pay amounts owed to the Company. The allowance is determined using a combination of factors, including historical credit loss experience and the length of time that the trade receivables are past due, supplemented by the Company’s knowledge of customer-specific information, current market conditions and reasonable and supportable forecasts of future events and economic conditions.
Inventories	Inventories Inventories, which consist primarily of raw materials and finished goods, are carried at the lower of cost or net realizable value. Fixed manufacturing overhead is allocated to the cost of inventory based on the normal capacity of production facilities. Unallocated overhead during periods of abnormally low production levels is recognized as cost of sales in the period in which it is incurred.
Property, Plant and Equipment	Property, Plant and Equipment Property, plant and equipment includes the historical cost of land, buildings, equipment, and significant improvements to existing plant and equipment or in the case of acquisitions, a fair market value of assets at the time of acquisition. Repair and maintenance costs that do not extend the useful life of an asset are recorded as an expense as incurred. Depreciation is provided using the straight-line method over the estimated useful lives of the assets, which are generally as follows: buildings — 10 to 30 years, machinery and equipment — 7 to 10 years, and office furniture and equipment — 3 to 10 years.
Goodwill and Indefinite-Lived Intangible Assets	Goodwill and Indefinite-Lived Intangible Assets Goodwill is recorded as the difference, if any, between the aggregate consideration paid for an acquisition and the fair value of the net tangible and intangible assets acquired, liabilities assumed, and non-controlling interests, if any. Intangible assets, including goodwill, are assigned to the Company’s reporting units based upon their fair value at the time of acquisition. Goodwill and indefinite-lived intangibles such as tradenames are not subject to amortization but are assessed for impairment annually, or more frequently if events or changes in circumstances indicate that the asset might be impaired or that there is a probable reduction in the fair value of a reporting unit below its aggregate carrying value. The Company tests goodwill for impairment annually in the fourth quarter of each year using data as of October 1 of that year and whenever events or changes in circumstances indicate the carrying value may not be recoverable. The impairment test consists of comparing the fair value of the reporting unit to the carrying value of the reporting unit. An impairment charge is recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value; provided, the loss recognized cannot exceed the total amount of goodwill allocated to the reporting unit. If applicable, the Company considers income tax effects from any tax deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss. The Company determined fair values for each of the reporting units using a combination of the income and market multiple approaches which are weighted 75% and 25%, respectively. Under the income approach, fair value is determined based on the present value of estimated future cash flows, discounted at an appropriate risk-adjusted rate. The Company uses its internal forecasts to estimate future cash flows and includes an estimate of long-term future growth rates based on its most recent views of the long-term outlook for each reporting unit. Actual results may differ from those assumed in the Company’s forecasts. The Company derives its discount rates using a capital asset pricing model and analyzing published rates for industries relevant to its reporting units to estimate the cost of equity financing. The Company uses discount rates that are commensurate with the risks and uncertainty inherent in the respective businesses and in its internally developed forecasts. Under the market approach, the Company applies performance multiples from comparable public companies, adjusted for relative risk, profitability, and growth considerations, to the reporting units to estimate fair value. The Company tests intangible assets with indefinite lives annually for impairment using a relief from royalty discounted cash flow fair value model. The quantitative impairment test for indefinite-lived intangible assets involves a comparison of the estimated fair value of the intangible asset with its carrying value. If the carrying value of the intangible asset exceeds its fair value, an impairment loss is recognized in an amount equal to that excess. The relief from royalty method requires the Company to estimate forecasted revenues and determine appropriate discount rates, royalty rates, and terminal growth rates.
Long-Lived Assets Including Intangible Assets With Finite Useful Lives	Long-Lived Assets Including Intangible Assets With Finite Useful Lives Intangible assets with finite useful lives are amortized on a straight-line basis over their estimated useful lives, which vary depending on the type of intangible assets. In determining the estimated useful lives of definite-lived intangibles, we consider the nature, competitive position, life cycle position and historical and expected future operating cash flows of each acquired assets, as well as our commitment to support these assets through continued investment and legal infringement protection. The Company reviews long-lived assets, including identified intangible assets with finite useful lives and subject to amortization for impairment, whenever events or changes in circumstances indicate that the related carrying amounts may not be recoverable. Determining whether an impairment loss occurred requires comparing the carrying amount to the sum of undiscounted cash flows expected to be generated by the asset. Such events and circumstances include the occurrence of an adverse change in the market involving the business employing the related long-lived assets or a situation in which it is more likely than not that the Company will dispose of such assets. If the comparison indicates that there is impairment, the impairment loss to be recognized as a non-cash charge to earnings is measured by the amount by which the carrying amount of the assets exceeds their fair value and the impaired assets are written down to their fair value or, if fair value is not readily determinable, to an estimated fair value based on discounted expected future cash flows. Assets to be disposed are reported at the lower of the carrying amount or fair value, less costs to dispose.
Warranty Reserves	Warranty Reserves Most of the Company’s product sales are covered by warranty provisions that generally provide for the repair or replacement of qualifying defective items for a specified period after the time of sale, typically 12 months. The Company establishes reserves for estimated product warranty costs at the time revenue is recognized based upon historical warranty experience and additionally for any known product warranty issues. The Company’s warranty obligation has been and may in the future be affected by product failure rates, repair or field replacement costs, and additional costs incurred in correcting any product failure.
Stock-Based Compensation	Stock-Based Compensation Stock-based compensation is measured for all stock-based equity awards made to employees and non-employee directors based on the estimated fair value as of the grant date. The determination of the fair values of stock-based awards at the grant date requires judgment, including estimating the expected term of the relevant stock-based payment awards and the expected volatility of the Company’s stock. The fair value of each stock option grant under the stock-based compensation plans is estimated on the date of grant or modification using the Black-Scholes-Merton option-pricing model. The expected stock volatility assumption was based on an average of the historical volatility over the expected term of the stock options. Forfeitures of stock options are accounted for as they occur. Restricted stock units and performance share units with internal performance metrics (i.e. EPS) are valued at the share price on the date of grant. The grant date fair value of performance share units with external performance metrics (i.e. TSR) is determined using a Monte Carlo simulation pricing model.
Pension and Other Postretirement Benefits	Pension and Other Postretirement Benefits The Company sponsors a number of pension plans and other postretirement benefit plans worldwide. The calculation of the pension and other postretirement benefit obligations and net periodic benefit cost under these plans requires the use of actuarial valuation methods and assumptions. These assumptions include the discount rates used to value the projected benefit obligations, future rate of compensation increases, expected rates of return on plan assets and expected healthcare cost trend rates. The discount rates selected to measure the present value of the Company’s benefit obligations as of December 31, 2024 and 2023 were derived by examining the rates of high-quality, fixed income securities whose cash flows or duration match the timing and amount of expected benefit payments under the plans. In accordance with GAAP, actual results that differ from the Company’s assumptions are recorded in accumulated other comprehensive income (loss) and amortized through net periodic benefit cost over future periods. While management believes that the assumptions are appropriate, differences in actual experience or changes in assumptions may affect the Company’s pension and other postretirement benefit obligations and future net periodic benefit cost.
Income Taxes	Income Taxes The Company has determined income tax expense and other deferred income tax information based on the asset and liability method. Deferred income tax liabilities are provided on temporary differences between assets and liabilities for financial and tax reporting purposes as measured by enacted tax rates expected to apply when temporary differences are settled or realized. A valuation allowance is established for the portion of deferred tax assets for which it is not more likely than not that a tax benefit will be realized. Tax benefits are recognized only for tax positions that are more likely than not to be sustained upon examination by tax authorities. The amount recognized is measured as the largest amount of benefit that is greater than 50% likely to be realized upon ultimate settlement. Unrecognized tax benefits are tax benefits claimed in the Company’s tax returns that do not meet these recognition and measurement standards. The Company believes that its income tax liabilities, including related interest, are adequate in relation to the potential for additional tax assessments. There is a risk, however, that the amounts ultimately paid upon resolution of audits could be materially different from the amounts previously included in income tax expense and, therefore, could have a material impact on the Company’s tax provision, net income, and cash flows. The Company reviews its liabilities quarterly, and may adjust such liabilities due to proposed assessments by tax authorities, changes in facts and circumstances, issuance of new regulations or new case law, negotiations between tax authorities of different countries concerning transfer prices, the resolution of audits, or the expiration of statutes of limitations. Adjustments are most likely to occur in the year during which major audits are closed. The Tax Cuts and Jobs Act (“Tax Act”), enacted on December 22, 2017, created a new requirement that certain income (i.e., Global intangible low taxed income (“GILTI”)) earned by controlled foreign corporations (“CFC”) must be included currently in the gross income of the CFCs’ U.S. shareholder. GILTI is the excess of the shareholder’s “net CFC tested income” over the net deemed tangible income return, which is currently defined as the excess of (1) 10% of the aggregate of the U.S. shareholder’s pro rata share of the qualified business asset investment of each CFC with respect to which it is a U.S. shareholder over (2) the amount of certain interest expense taken into account in the determination of net CFC-tested income.
Research and Development	Research and Development For the years ended December 31, 2024, 2023 and 2022, the Company spent $116.6 million , $108.2 million, and $91.3 million, respectively, on research activities relating to the development of new products and new product applications. All such expenditures were funded by the Company, expensed as incurred and recorded to “Selling and administrative expenses” in the Consolidated Statements of Operations.
Derivative Financial Instruments	Derivative Financial Instruments All derivative financial instruments are reported on the balance sheet at fair value. For derivative instruments that are not designated as hedges, any gain or loss on the derivatives is recognized in earnings in the current period. A derivative instrument may be designated as a hedge of the exposure to: (1) changes in the fair value of an asset, liability, or firm commitment, (2) variability in expected future cash flows, if the hedging relationship is expected to be highly effective in offsetting changes in fair value or cash flows attributable to the hedged risk during the period of designation or (3) as a hedge of a net investment in a foreign operation. If a derivative is designated as a fair value hedge, the gain or loss on the derivative and the offsetting loss or gain on the hedged asset, liability, or firm commitment are recognized in earnings. For derivative instruments designated as a cash flow hedge, the effective portion of the gain or loss on the derivative instrument is reported as a component of accumulated other comprehensive income and reclassified to earnings in the same period that the hedged transaction affects earnings. For derivative instruments designated as net investment in a foreign operation, gains or losses are reported as currency translation adjustments. The ineffective portion of the gain or loss is immediately recognized in earnings. Gains or losses on derivative instruments recognized in earnings are reported in the same line item as the associated hedged transaction in the Consolidated Statements of Operations. Hedge accounting is discontinued prospectively when (1) it is determined that a derivative is no longer effective in offsetting changes in the fair value or cash flows of a hedged item; (2) the derivative is sold, terminated, or exercised; (3) the hedged item no longer meets the definition of a firm commitment; or (4) it is unlikely that a forecasted transaction will occur within two months of the originally specified time period. When hedge accounting is discontinued because it is determined that the derivative no longer qualifies as an effective fair-value hedge, the derivative continues to be carried on the balance sheet at its fair value, and the changes in the fair value of the hedged asset or liability is recorded to the Consolidated Statements of Operations. When cash flow hedge accounting is discontinued because the derivative is sold, terminated, or exercised, the net gain or loss remains in accumulated other comprehensive income and is reclassified into earnings in the same period that the hedged transaction affects earnings or until it becomes unlikely that a hedged forecasted transaction will occur within two months of the originally scheduled time period. When hedge accounting is discontinued because a hedged item no longer meets the definition of a firm commitment, the derivative continues to be carried on the Consolidated Balance Sheet at its fair value, and any asset or liability that was recorded pursuant to recognition of the firm commitment is removed from the balance sheet and recognized as a gain or loss currently in earnings. When hedge accounting is discontinued because it is probable that a forecasted transaction will not occur within two months of the originally specified time period, the derivative continues to be carried on the balance sheet at its fair value, and gains and losses reported in accumulated other comprehensive income are recognized immediately in the Consolidated Statements of Operations.
Comprehensive Income	Comprehensive Income
Restructuring Charges	Restructuring Charges The Company incurs costs in connection with workforce reductions, facility consolidations and other actions. Such costs include employee termination benefits (one-time arrangements and benefits attributable to prior service), termination of contractual obligations, non-cash asset charges and other direct incremental costs. A liability is established through a charge to operations for (i) one-time employee termination benefits when management commits to a plan of termination; (ii) employee termination benefits that accumulate or vest based on prior service when it becomes probable that such termination benefits will be paid and the amount of the payment can be reasonably estimated; and (iii) contract termination costs when the contract is terminated or the Company becomes contractually obligated to make such payment. Other direct incremental costs are charged to operations as incurred. Charges recorded in connection with restructuring plans are included in “Other operating expense, net” in the Consolidated Statements of Operations.
Business Combinations	Business Combinations The Company accounts for business combinations by applying the acquisition method. The Company’s consolidated financial statements include the operating results of acquired entities from the respective dates of acquisition. The Company recognizes and measures the identifiable assets acquired, liabilities assumed, and any non-controlling interest as of the acquisition date at fair value. The excess, if any, of total consideration transferred in a business combination over the fair value of identifiable assets acquired, liabilities assumed, and any non-controlling interest is recognized as goodwill in the Consolidated Balance Sheets. Costs incurred by the Company to effect a business combination other than costs related to the issuance of debt or equity securities are included in the Consolidated Statements of Operations in the period the costs are incurred.
Earnings per Share	Earnings per Share The calculation of earnings per share (“EPS”) is based on the weighted-average number of the Company’s shares outstanding for the applicable period. The calculation of diluted earnings per share reflects the effect of all dilutive potential shares that were outstanding during the respective periods, unless the effect of doing so is antidilutive. The Company uses the treasury stock method to calculate the effect of outstanding share-based compensation awards.
Leases	Leases The Company has operating and financing leases for real estate, vehicles, IT equipment, office equipment and production equipment. The Company determines if an arrangement is a lease and identifies the classification of the lease as a financing lease or an operating lease at inception. Operating leases are recorded as operating lease right-of-use assets (“ROU assets”) in “Other assets” and operating lease liabilities in “Accrued liabilities” and “Other liabilities” in the Consolidated Balance Sheets. Financing leases are recorded as financing ROU assets in “Property, plant and equipment” and lease liabilities in “Short-term borrowings and current maturities of long-term debt” and “Long-term debt, less current maturities” in the Consolidated Balance Sheets. At the date of commencement, lease liabilities are recorded at the present value of the future minimum lease payments over the lease term. The lease term is equal to the initial term at commencement plus any renewal or extension options that the Company is reasonably certain will be exercised. ROU assets at the date of commencement are equal to the amount of the initial lease liability, the initial direct costs incurred by the Company and any prepaid lease payments less any incentives received. An incremental borrowing rate is used in the determination of the present value of future lease payments. Incremental borrowing rates for a lease are based on the lease term, lease currency and the Company’s credit spread.
Recently Adopted Accounting Standards Updates ("ASU") & Recently Issued Accounting Pronouncements	Recently Adopted Accounting Standard Updates (“ASU”) In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segments expenses. The amendments in this update are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. The amendments in this update were applied retrospectively to all prior periods presented in the financial statements. The segment expense categories and amounts disclosed in the prior periods were based on the significant segment expense categories identified and disclosed in Note 24 “Segment Reporting.” The adoption has modified our disclosures but has not had a material effect on our consolidated financial statements. Recently Issued Accounting Pronouncements In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which addresses investor requests for more transparency about income tax information through improvements to income tax disclosures primarily related to the rate reconciliation and income taxes paid information. The amendments in this update are effective for annual periods beginning after December 15, 2024. Early adoption is permitted for annual statements that have not yet been issued or made available for issuance. The amendments in this update should be applied on a prospective basis. Retrospective application is permitted. The adoption will modify our disclosures but is not expected to have a material effect on our consolidated financial statements. In November 2024, the FASB issued ASU 2024-03, Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires disclosure of additional disaggregated information about significant expenses within relevant income statement captions, such as purchases of inventory, employee compensation, depreciation, amortization, and depletion. The amendment is effective for fiscal years beginning after December 15, 2026. Early adoption is permitted. The amendment should be applied prospectively; however, retrospective application is permitted. Management is currently evaluating this ASU to determine its impact on the Company’s disclosures.

Discontinued Operations (Tables

Discontinued Operations (Tables)	12 Months Ended
	Dec. 31, 2024
Discontinued Operations and Disposal Groups [Abstract]
Schedule of Discontinued Operations	The results of operations of SVT and HPS are presented as discontinued operations for the year ended December 31, 2022 as summarized below: Specialty Vehicle Technologies High Pressure Solutions Total Revenues $ 6.6 $ — $ 6.6 Cost of sales 6.5 — 6.5 Gross Profit 0.1 — 0.1 Selling and administrative expenses 0.1 — 0.1 Gain on sale (2.8) — (2.8) Other operating expense, net 0.7 1.6 2.3 Income from Discontinued Operations Before Income Taxes 2.1 (1.6) 0.5 Provision for income taxes (13.2) (1.5) (14.7) Income from Discontinued Operations, Net of Tax $ 15.3 $ (0.1) $ 15.2 The following table summarizes the impacts of the divestiture. Assets divested: Cash and cash equivalents $ 153.5 Insurance recovery receivable 13.9 Liabilities divested: Asbestos indemnity liability - current (12.3) Asbestos indemnity liability - noncurrent (111.4) Loss on Asbestos Sale, before transaction costs 43.7 Transaction costs 15.1 Loss on Asbestos Sale 58.8 Income tax benefit (7.6) Loss on Asbestos Sale, net of tax $ 51.2

Acquisitions (Tables)

Acquisitions (Tables)	12 Months Ended
	Dec. 31, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed	The following table summarizes the allocation of consideration for all businesses acquired in 2024 to the fair values of identifiable assets acquired and liabilities assumed at the acquisition dates. Initial accounting for Friulair is substantially complete and all other businesses acquired in 2024 are preliminary, and amounts assigned to acquired assets and liabilities assumed are subject to change as information necessary to complete the analysis is obtained. ILC Dover Friulair APSCO All others Total Consideration Accounts receivable $ 41.4 $ 14.2 $ 6.4 $ 37.8 $ 99.8 Inventories 84.0 13.2 7.5 46.3 151.0 Other current assets 35.1 0.5 0.5 4.7 40.8 Property, plant and equipment 90.8 7.2 2.3 18.5 118.8 Goodwill 1,309.8 69.2 51.6 237.6 1,668.2 Other intangible assets 973.1 84.5 48.1 80.5 1,186.2 Other noncurrent assets 15.8 — 3.5 6.0 25.3 Total current liabilities (31.3) (11.6) (3.7) (54.4) (101.0) Deferred tax liabilities (151.5) (24.6) — (8.0) (184.1) Other noncurrent liabilities (17.5) (2.8) (3.0) (5.8) (29.1) Total consideration $ 2,349.7 $ 149.8 $ 113.2 $ 363.2 $ 2,975.9 The following table summarizes the allocation of consideration for all businesses acquired in 2023 to the fair values of identifiable assets acquired and liabilities assumed at the acquisition dates. Initial accounting for all 2023 acquisitions is complete. Air Treatment Roots All Others Total Accounts receivable $ 26.1 $ 14.5 $ 11.7 $ 52.3 Inventories 43.9 34.2 21.0 99.1 Other current assets 2.1 2.9 6.2 11.2 Property, plant and equipment 18.4 42.0 5.0 65.4 Goodwill 279.9 105.6 126.7 512.2 Other intangible assets 238.6 116.9 25.4 380.9 Other noncurrent assets 7.6 3.1 0.4 11.1 Total current liabilities (35.9) (26.9) (19.5) (82.3) Deferred tax liabilities (54.8) — (3.9) (58.7) Other noncurrent liabilities (6.9) (2.3) (4.5) (13.7) Total consideration $ 519.0 $ 290.0 $ 168.5 $ 977.5 The following table summarizes the allocation of consideration for all businesses acquired in 2022 to the fair values of identifiable assets acquired and liabilities assumed at the acquisition dates. Initial accounting for all 2022 acquisitions is complete. Dosatron International All others Total Consideration Accounts receivable $ 1.8 $ 16.2 $ 18.0 Inventories 6.2 20.4 26.6 Other current assets 0.1 1.3 1.4 Property, plant and equipment 0.3 8.9 9.2 Goodwill 57.4 151.9 209.3 Other intangible assets 41.9 43.0 84.9 Other noncurrent assets 13.8 0.9 14.7 Total current liabilities (3.5) (30.7) (34.2) Deferred tax liabilities (13.8) (9.7) (23.5) Other noncurrent liabilities — (1.9) (1.9) Total consideration $ 104.2 $ 200.3 $ 304.5

Restructuring (Tables)

Restructuring (Tables)	12 Months Ended
	Dec. 31, 2024
Restructuring and Related Activities [Abstract]
Schedule of Restructuring Activity	For the years ended December 31, 2024, 2023 and 2022, “Restructuring charges, net” were recognized within “Other operating expense, net” in the Consolidated Statements of Operations and consisted of the following. 2024 2023 2022 Industrial Technologies and Services $ 20.6 $ 15.1 $ 20.1 Precision and Science Technologies 7.9 4.1 8.7 Corporate 2.7 0.7 0.5 Restructuring charges, net $ 31.2 $ 19.9 $ 29.3 The following table summarizes the activity associated with the Company’s restructuring programs (included in “Accrued liabilities” in the Consolidated Balance Sheets) for the years ended December 31, 2024 and 2023. 2024 2023 Balance at beginning of period $ 15.5 $ 14.9 Charged to expense - termination benefits 27.1 13.0 Charged to expense - other (1) 2.5 4.2 Payments (21.6) (17.1) Foreign currency translation and other (1.2) 0.5 Balance at end of period $ 22.3 $ 15.5 (1) Excludes $1.6 million and $2.7 million of non-cash charges that impacted restructuring expense but not the restructuring liabilities during the years ended December 31, 2024 and 2023, respectively.

Allowance for Credit Losses (Ta

Allowance for Credit Losses (Tables)	12 Months Ended
	Dec. 31, 2024
Receivables [Abstract]
Schedule of Allowance for Credit Losses	The following table summarized the activity associated with allowance for credit losses for the years ended December 31, 2024, 2023 and 2022. 2024 2023 2022 Balance at beginning of period $ 53.8 $ 47.2 $ 42.3 Provision charged to expense 7.5 9.4 10.1 Write-offs, net of recoveries (3.3) (3.3) (3.2) Foreign currency translation and other (0.7) 0.5 (2.0) Balance at end of period $ 57.3 $ 53.8 $ 47.2

Inventories (Tables)

Inventories (Tables)	12 Months Ended
	Dec. 31, 2024
Inventory Disclosure [Abstract]
Schedule of Inventories	Inventories as of December 31, 2024 and 2023 consisted of the following. 2024 2023 Raw materials, including parts and subassemblies $ 675.1 $ 590.7 Work-in-process 116.3 145.1 Finished goods 342.8 337.8 1,134.2 1,073.6 LIFO reserve (79.2) (72.5) Inventories $ 1,055.0 $ 1,001.1

Property, Plant, and Equipment

Property, Plant, and Equipment (Tables)	12 Months Ended
	Dec. 31, 2024
Property, Plant and Equipment [Abstract]
Schedule of Property, Plant and Equipment	Property, plant and equipment, net as of December 31, 2024 and 2023 consisted of the following. 2024 2023 Land and land improvements $ 62.3 $ 67.7 Buildings 385.6 337.1 Machinery and equipment 792.6 655.8 Office furniture and equipment 76.8 71.0 Construction in progress 92.3 80.6 1,409.6 1,212.2 Accumulated depreciation (567.5) (500.8) Property, plant and equipment, net $ 842.1 $ 711.4

Goodwill and Other Intangible_2

Goodwill and Other Intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The changes in the carrying amount of goodwill attributable to each reportable segment for the years ended December 31, 2024 and 2023 are as follows. Industrial Technologies and Services Precision and Science Technologies Total Balance as of December 31, 2022 $ 4,222.5 $ 1,841.7 $ 6,064.2 Acquisitions 509.1 2.4 511.5 Foreign currency translation and other (1) 21.9 12.1 34.0 Balance as of December 31, 2023 4,753.5 1,856.2 6,609.7 Acquisitions 263.9 1,404.3 1,668.2 Foreign currency translation and other (1) (86.7) (43.1) (129.8) Balance as of December 31, 2024 $ 4,930.7 $ 3,217.4 $ 8,148.1 (1) Includes measurement period adjustments.
Schedule of Goodwill by Acquisition	The goodwill attributable to these businesses is as follows. 2024 Acquisitions Industrial Technologies and Services Precision and Science Technologies Total ILC Dover $ — $ 1,309.8 $ 1,309.8 Friulair 69.2 — 69.2 APSCO 51.6 — 51.6 Other acquisitions 143.1 94.5 237.6 $ 263.9 $ 1,404.3 $ 1,668.2 The Company acquired several businesses during the year ended December 31, 2023. The excess of the purchase price over the estimated fair values of intangible assets, identifiable assets and assumed liabilities was recorded as goodwill. The goodwill attributable to these businesses is as follows. 2023 Acquisitions Industrial Technologies and Services Precision and Science Technologies Total Air Treatment $ 279.9 $ — $ 279.9 Roots 106.6 — 106.6 Other acquisitions 122.6 2.4 125.0 $ 509.1 $ 2.4 $ 511.5
Schedule of Other Intangible Assets	Other intangible assets as of December 31, 2024 and 2023 consisted of the following. December 31, 2024 December 31, 2023 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount Amortized intangible assets: Customer lists and relationships $ 4,010.1 $ (1,830.1) $ 2,180.0 $ 3,279.3 $ (1,585.4) $ 1,693.9 Technology 549.1 (243.3) 305.8 413.8 (178.9) 234.9 Tradenames 63.6 (32.4) 31.2 52.2 (27.9) 24.3 Backlog 4.3 (4.2) 0.1 3.0 (1.3) 1.7 Other 128.5 (112.1) 16.4 117.1 (104.1) 13.0 Unamortized intangible assets: Tradenames 1,839.3 — 1,839.3 1,643.3 — 1,643.3 Total other intangible assets $ 6,594.9 $ (2,222.1) $ 4,372.8 $ 5,508.7 $ (1,897.6) $ 3,611.1

Supply Chain Finance Program (T

Supply Chain Finance Program (Tables)	12 Months Ended
	Dec. 31, 2024
Payables and Accruals [Abstract]
Schedule of Supplier Finance Obligations	The following table summarizes the activity associated with the Company’s SCF Program for the years ended December 31, 2024 and 2023. 2024 2023 Confirmed obligations outstanding at beginning of period $ 24.3 $ 9.7 Invoices confirmed 117.0 112.9 Confirmed invoices paid (116.8) (98.3) Confirmed obligations outstanding at end of period $ 24.5 $ 24.3

Accrued Liabilities (Tables)

Accrued Liabilities (Tables)	12 Months Ended
	Dec. 31, 2024
Payables and Accruals [Abstract]
Schedule of Accrued Liabilities	Accrued liabilities as of December 31, 2024 and 2023 consisted of the following: 2024 2023 Salaries, wages and related fringe benefits $ 229.5 $ 262.4 Contract liabilities 318.6 331.2 Product warranty 67.9 61.9 Operating lease liabilities 56.3 41.6 Restructuring 22.3 15.5 Taxes 72.5 78.4 Accrued interest 33.2 33.1 Other 171.9 171.4 Total accrued liabilities $ 972.2 $ 995.5
Schedule of Product Warranty Liability	A reconciliation of the changes in the accrued product warranty liability for the years ended December 31, 2024 and 2023 is as follows. 2024 2023 Balance at beginning of period $ 61.9 $ 46.2 Product warranty accruals 37.5 44.4 Acquired warranty 0.7 2.2 Settlements (30.7) (31.2) Foreign currency translation and other (1.5) 0.3 Balance at end of period $ 67.9 $ 61.9

Debt (Tables)

Debt (Tables)	12 Months Ended
	Dec. 31, 2024
Debt Disclosure [Abstract]
Schedule of Debt	Debt as of December 31, 2024 and 2023 consisted of the following. 2024 2023 Short-term borrowings $ 1.7 $ 1.0 Long-term debt Dollar Term Loan B, due February 2027 (1)(2) $ — $ 347.7 Dollar Term Loan, due February 2027 (1)(2) — 892.3 5.197% Senior Notes due June 2027 (1) 699.9 — 5.400% Senior Notes due August 2028 (1) 498.6 498.2 5.176% Senior Notes due June 2029 (1) 750.0 — 5.314% Senior Notes due June 2031 (1) 500.0 — 5.700% Senior Notes due August 2033 (1) 993.4 992.6 5.450% Senior Notes due June 2034 (1) 749.5 — 5.700% Senior Notes due June 2054 (1) 597.6 — Finance leases and other long-term debt 14.1 15.2 Swap valuation adjustments (0.3) — Unamortized debt issuance costs (47.0) (23.4) Total long-term debt, net, including current maturities 4,755.8 2,722.6 Current maturities of long-term debt 1.4 29.6 Total long-term debt, net $ 4,754.4 $ 2,693.0 (1) This amount is net of unamortized discounts. Total unamortized discounts were $11.0 million and $9.9 million as of December 31, 2024 and 2023 , respectively. (2) The weighted-average interest rate was 7.18% for the five month period prior to the loan repayment in May 2024, as discussed below.

Benefit Plans (Tables)

Benefit Plans (Tables)	12 Months Ended
	Dec. 31, 2024
Retirement Benefits [Abstract]
Schedule of Reconciliation of Benefit Obligations	The following table provides a reconciliation of the changes in the benefit obligations and in the fair value of the plan assets for the periods described below. Pension Benefits Other Postretirement Benefits U.S. Plans Non-U.S. Plans 2024 2023 2024 2023 2024 2023 Reconciliation of Benefit Obligations: Beginning balance $ 294.0 $ 319.8 $ 263.2 $ 247.5 $ 18.3 $ 21.0 Service cost 0.1 0.1 2.9 2.6 — — Interest cost 13.4 15.7 10.7 11.1 0.8 0.9 Participant contributions — — 0.2 — — — Plan amendments — — — 0.3 (10.9) — Actuarial losses (gains) (1) (18.1) 6.0 (11.3) 3.3 0.2 (1.0) Benefit payments (22.2) (16.1) (14.5) (13.6) (2.4) (2.7) Acquisitions — — 10.2 — — — Plan settlements (2.5) (31.5) — — — — Other — — 0.6 — — — Effect of foreign currency exchange rate changes — — (10.6) 12.0 (0.1) 0.1 Benefit obligations ending balance $ 264.7 $ 294.0 $ 251.4 $ 263.2 $ 5.9 $ 18.3 Reconciliation of Fair Value of Plan Assets: Beginning balance $ 237.5 $ 263.6 $ 206.0 $ 196.4 Actual return on plan assets (6.0) 18.7 (7.1) 6.7 Employer contributions 0.1 2.8 6.5 6.6 Participant contributions — — 0.2 — Acquisitions — — 8.5 — Benefit payments (22.2) (16.1) (14.5) (13.6) Plan settlements (2.5) (31.5) — — Other — — 0.6 — Effect of foreign currency exchange rate changes — — (5.6) 9.9 Fair value of plan assets ending balance $ 206.9 $ 237.5 $ 194.6 $ 206.0 Funded Status as of Period End $ (57.8) $ (56.5) $ (56.8) $ (57.2) $ (5.9) $ (18.3) (1) Actuarial losses (gains) primarily resulted from changes in discount rates.
Schedule of Component of Accumulated Other Comprehensive (Loss) Income	Amounts recognized as a component of accumulated other comprehensive income (loss) as of December 31, 2024 and 2023 that have not been recognized as a component of net periodic benefit cost are presented in the following table. Pension Benefits Other Postretirement Benefits U.S. Plans Non-U.S. Plans 2024 2023 2024 2023 2024 2023 Net actuarial losses (gains) $ (10.8) $ (11.0) $ 7.6 $ (1.1) $ (3.2) $ (4.3) Prior service cost — — 2.7 2.9 (10.9) 0.1 Amounts included in accumulated other comprehensive income (loss) $ (10.8) $ (11.0) $ 10.3 $ 1.8 $ (14.1) $ (4.2)
Schedule of Pension and Other Postretirement Benefit Liabilities included in Balance Sheets	Pension and other postretirement benefit liabilities and assets are included in the following captions in the Consolidated Balance Sheets as of December 31, 2024 and 2023. 2024 2023 Other assets $ 18.5 $ 18.8 Accrued liabilities (6.4) (6.2) Pension and other postretirement benefits (132.6) (144.6)
Schedule of Pension plans with an Accumulated Benefit Obligation in Excess of Plan Assets	The following table provides information for pension plans with an accumulated benefit obligation in excess of plan assets as of December 31, 2024 and 2023. U.S. Pension Plans Non-U.S. Pension Plans 2024 2023 2024 2023 Projected benefit obligations $ 264.7 $ 294.0 $ 119.7 $ 105.4 Accumulated benefit obligation 264.7 294.0 112.7 86.4 Fair value of plan assets 206.9 237.5 42.8 17.0
Schedule of Components of Net Periodic Benefit Cost (Income) and Other Amounts Recognized in Other Comprehensive (Loss) Income, Before Income Tax Effects	The following tables provide the components of net periodic benefit cost (income) and other amounts recognized in other comprehensive income (loss), before income tax effects, for the years ended December 31, 2024, 2023 and 2022. U.S. Pension Plans 2024 2023 2022 Net Periodic Benefit Cost: Service cost $ 0.1 $ 0.1 $ 4.4 Interest cost 13.4 15.7 11.3 Expected return on plan assets (12.7) (13.2) (13.0) Amortization of net actuarial loss — 0.1 — Net periodic benefit cost 0.8 2.7 2.7 Loss (gain) due to settlement 0.4 (0.4) (0.5) Total net periodic benefit cost recognized $ 1.2 $ 2.3 $ 2.2 Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss): Net actuarial loss $ 0.6 $ 0.5 $ 0.4 Amortization of net actuarial gain (loss) (0.4) 0.3 0.5 Total recognized in other comprehensive income (loss) $ 0.2 $ 0.8 $ 0.9 Total recognized in net periodic benefit cost and other comprehensive income (loss) $ 1.4 $ 3.1 $ 3.1 Non-U.S. Pension Plans 2024 2023 2022 Net Periodic Benefit Cost (Income): Service cost $ 2.9 $ 2.6 $ 3.3 Interest cost 10.7 11.1 5.9 Expected return on plan assets (11.2) (11.0) (11.8) Amortization of prior service cost 0.2 0.1 0.1 Amortization of net actuarial loss (1.3) (1.7) 0.3 Total net periodic benefit cost (income) recognized $ 1.3 $ 1.1 $ (2.2) Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss): Net actuarial loss (gain) $ 7.0 $ 7.5 $ (33.3) Amortization of net actuarial gain (loss) 1.3 1.7 (0.3) Prior service cost — 0.3 — Amortization of prior service cost (0.2) (0.1) (0.1) Effect of foreign currency exchange rate changes 0.4 0.3 (3.2) Total recognized in other comprehensive income (loss) $ 8.5 $ 9.7 $ (36.9) Total recognized in net periodic benefit cost (income) and other comprehensive income (loss) $ 9.8 $ 10.8 $ (39.1) Other Postretirement Benefits 2024 2023 2022 Net Periodic Benefit Cost (Income): Interest cost $ 0.8 $ 0.9 $ 0.7 Amortization of prior service cost 0.1 0.1 — Amortization of net actuarial loss (0.8) (1.1) — Total net periodic benefit cost (income) recognized $ 0.1 $ (0.1) $ 0.7 Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss): Net actuarial loss (gain) $ 0.2 $ (1.0) $ (5.0) Amortization of net actuarial loss 0.8 1.1 — Prior service cost (10.9) — — Amortization of prior service cost (0.1) (0.1) — Total recognized in other comprehensive income (loss) $ (10.0) $ — $ (5.0) Total recognized in net periodic benefit cost (income) and other comprehensive income (loss) $ (9.9) $ (0.1) $ (4.3)
Schedule of Assumptions Used	The following actuarial assumptions were used to determine net periodic benefit cost (income) and benefit obligations for the years ended December 31, 2024, 2023 and 2022. U.S. Pension Plans Non-U.S. Pension Plans 2024 2023 2022 2024 2023 2022 Weighted-average actuarial assumptions used to determine net periodic benefit cost: Discount rate 5.0 % 5.2 % 2.7 % 4.2 % 4.5 % 1.6 % Expected long-term rate of return on plan assets 5.8 % 5.4 % 3.5 % 5.5 % 5.5 % 4.4 % Rate of compensation increases N/A N/A 3.0 % 5.0 % 4.3 % 4.3 % Weighted-average actuarial assumptions used to determine benefit obligations: Discount rate 5.5 % 5.0 % 5.2 % 4.5 % 4.2 % 4.5 % Rate of compensation increases N/A N/A N/A 5.0 % 5.0 % 4.3 % The following actuarial assumptions were used to determine other postretirement benefit plans costs and obligations for the years ended December 31, 2024, 2023 and 2022. Other Postretirement Benefits 2024 2023 2022 Discount rate used to determine net periodic benefit cost 4.9% - 5.1% 4.9% - 5.2% 2.4% - 3.0% Discount rate used to determine benefit obligations 4.4% - 5.4% 4.9% - 5.1% 4.9% - 5.2% Weighted-average actuarial assumptions used to determine other postretirement benefit plans costs and obligations: Healthcare cost trend rate assumed for next year 5.1 % 6.8 % 6.8 % Rate to which the cost trend rate is assumed to decline (the ultimate trend rate) 4.0 % 4.4 % 4.5 % Year that the date reaches the ultimate trend rate 2040 2035 2034
Schedule of Expected Benefit Payments	The following table reflects the estimated benefit payments for the next five years and for the years 2030 through 2034. The estimated benefit payments for the non-U.S. pension plans were calculated using foreign exchange rates as of December 31, 2024. Pension Benefits Other Postretirement Benefits U.S. Plans Non-U.S. Plans 2025 $ 26.4 $ 14.7 $ 2.4 2026 25.1 14.9 0.4 2027 24.9 14.5 0.4 2028 23.9 15.1 0.3 2029 23.4 17.1 0.3 Aggregate 2030-2034 98.3 86.0 1.3
Schedule of Allocation of Plan Assets	The following table presents the long-term target allocations for these plans as of December 31, 2024. U.S. Plans UK Plan Asset category: Equity 16 % 12 % Fixed income 83 % 56 % Real estate and other 1 % 32 % Total 100 % 100 %
Schedule of Changes in Fair Value of Plan Assets	The following tables present the fair values of the Company’s pension plan assets as of December 31, 2024 and 2023 by asset category within the ASC 820 hierarchy (as defined in Note 21 “Fair Value Measurements”). December 31, 2024 Quoted Prices in Active Markets for Identical Assets Significant Observable Inputs Significant Unobservable Inputs Investments Measured at NAV (5) Total Asset Category Cash and cash equivalents (1) $ 5.1 $ — $ — $ — $ 5.1 Equity funds: U.S. small-cap — — — 0.9 0.9 U.S. mid-cap — — — 2.6 2.6 U.S. large-cap — 2.5 — 11.6 14.1 International equity (2) — 23.2 — 26.5 49.7 Total equity funds — 25.7 — 41.6 67.3 Fixed income funds: Corporate bonds - international — 23.8 — 15.8 39.6 UK index-linked gilts — 66.0 — — 66.0 U.S. fixed income - government securities — — — 20.5 20.5 U.S. fixed income - short duration — — — 1.8 1.8 U.S. fixed income - intermediate duration — — — 25.2 25.2 U.S. fixed income - long duration — — — 122.7 122.7 Global fixed income — — — 1.8 1.8 Total fixed income funds — 89.8 — 187.8 277.6 Other types of investments: International real estate (3) — 11.6 — — 11.6 Other (4) — 38.1 1.8 39.9 Total $ 5.1 $ 127.1 $ 38.1 $ 231.2 $ 401.5 December 31, 2023 Quoted Prices in Active Markets for Identical Assets Significant Observable Inputs Significant Unobservable Inputs Investments Measured at NAV (5) Total Asset Category Cash and cash equivalents (1) $ 7.1 $ — $ — $ — $ 7.1 Equity funds: U.S. small-cap — — — 3.7 3.7 U.S. large-cap — 2.0 — 17.5 19.5 International equity (2) 14.2 10.5 — 17.2 41.9 Total equity funds 14.2 12.5 — 38.4 65.1 Fixed income funds: Corporate bonds - international — 26.9 — 15.8 42.7 UK index-linked gilts — 78.7 — — 78.7 U.S. fixed income - government securities — — — 43.2 43.2 U.S. fixed income - short duration — — — 1.3 1.3 U.S. fixed income - intermediate duration — — — 30.9 30.9 U.S. fixed income - long corporate — — — 122.3 122.3 Global fixed income — — — 7.2 7.2 Total fixed income funds — 105.6 — 220.7 326.3 Other types of investments: International real estate (3) — 15.4 — — 15.4 Other (4) — 29.6 — 29.6 Total $ 21.3 $ 133.5 $ 29.6 $ 259.1 $ 443.5 (1) Cash and cash equivalents consist of traditional domestic and foreign highly liquid short-term securities with the goal of providing liquidity and preservation of capital while maximizing return on assets. (2) The International category consists of investment funds focused on companies operating in developed and emerging markets outside of the U.S. These investments target broad diversification across large and mid/small-cap companies and economic sectors. (3) International real estate consists primarily of equity and debt investments made, directly or indirectly, in various interests in unimproved and improved real properties. (4) Other investments consist of insurance and reinsurance contracts securing the retirement benefits. The fair value of these contracts was calculated at the discount value of premiums paid by the Company, less expenses charged by the insurance providers. The insurance providers with which the Company has placed these contracts are well-known financial institutions with an established history of providing insurance services. (5) Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy.

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Income (Loss) (Tables)	12 Months Ended
	Dec. 31, 2024
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Schedule of Other Comprehensive Income (Loss)	The before tax income (loss) and related income tax effect are as follows. Foreign Currency Translation Adjustments, Net Cash Flow Hedges Pension and Other Postretirement Benefit Plans Total Balance as of December 31, 2021 $ (29.9) $ — $ (11.7) $ (41.6) Before tax income (loss) (237.1) 21.3 41.0 (174.8) Income tax effect (15.8) (5.3) (14.2) (35.3) Other comprehensive income (loss) (252.9) 16.0 26.8 (210.1) Balance as of December 31, 2022 $ (282.8) $ 16.0 $ 15.1 $ (251.7) Before tax income (loss) 23.0 (5.1) (10.5) 7.4 Income tax effect 11.8 1.3 3.6 16.7 Other comprehensive income (loss) 34.8 (3.8) (6.9) 24.1 Balance as of December 31, 2023 $ (248.0) $ 12.2 $ 8.2 $ (227.6) Before tax income (loss) (218.6) (14.1) 1.3 (231.4) Income tax effect (13.0) 5.0 (1.5) (9.5) Other comprehensive loss (231.6) (9.1) (0.2) (240.9) Balance as of December 31, 2024 $ (479.6) $ 3.1 $ 8.0 $ (468.5)
Schedule of Changes in Accumulated Other Comprehensive Income (Loss)	Changes in accumulated other comprehensive income (loss) by component for the periods described below are presented in the following table (1) . Foreign Currency Translation Adjustments, Net Cash Flow Hedges Pension and Other Postretirement Benefit Plans Total Balance as of December 31, 2021 $ (29.9) $ — $ (11.7) $ (41.6) Other comprehensive income (loss) before reclassifications (244.3) 13.9 26.9 (203.5) Amounts reclassified from accumulated other comprehensive income (loss) (8.6) 2.1 (0.1) (6.6) Other comprehensive income (loss) (252.9) 16.0 26.8 (210.1) Balance as of December 31, 2022 $ (282.8) $ 16.0 $ 15.1 $ (251.7) Other comprehensive income (loss) before reclassifications 49.0 7.9 (4.7) 52.2 Amounts reclassified from accumulated other comprehensive income (loss) (14.2) (11.7) (2.2) (28.1) Other comprehensive income (loss) 34.8 (3.8) (6.9) 24.1 Balance as of December 31, 2023 $ (248.0) $ 12.2 $ 8.2 $ (227.6) Other comprehensive income (loss) before reclassifications (218.3) 2.7 0.8 (214.8) Amounts reclassified from accumulated other comprehensive income (loss) (13.3) (11.8) (1.0) (26.1) Other comprehensive loss (231.6) (9.1) (0.2) (240.9) Balance as of December 31, 2024 $ (479.6) $ 3.1 $ 8.0 $ (468.5) (1) All amounts are net of tax. Amounts in parentheses indicate debits.
Schedule of Reclassification out of Accumulated Other Comprehensive Income (Loss)	Reclassifications out of accumulated other comprehensive income (loss) for the years ended December 31, 2024, 2023 and 2022 are presented in the following table. Amount Reclassified from Accumulated Other Comprehensive Income (Loss) Details about Accumulated Other Comprehensive Income (Loss) Components 2024 2023 2022 Affected Line(s) in the Statement Where Net Income is Presented Cash flow hedges (interest rate swaps and caps) $ (15.7) $ (15.6) $ 2.8 Interest expense Provision (benefit) for income taxes 3.9 3.9 (0.7) Provision for income taxes Cash flow hedges (interest rate swaps and caps), net of tax $ (11.8) $ (11.7) $ 2.1 Net investment hedges $ (17.7) $ (19.0) $ (11.5) Interest expense Provision for income taxes 4.4 4.8 2.9 Provision for income taxes Net investment hedges, net of tax $ (13.3) $ (14.2) $ (8.6) Amortization of defined benefit pension and other postretirement benefit items (1) $ (1.4) $ (2.9) $ (0.1) Cost of sales and Selling and administrative expenses Provision for income taxes 0.4 0.7 — Provision for income taxes Amortization of defined benefit pension and other postretirement benefit items, net of tax $ (1.0) $ (2.2) $ (0.1) Total reclassifications for the period $ (26.1) $ (28.1) $ (6.6) (1) These components are included in the computation of net periodic benefit cost. See Note 13 “Benefit Plans” for additional details.

Revenue from Contracts with C_2

Revenue from Contracts with Customers (Tables)	12 Months Ended
	Dec. 31, 2024
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregation of Revenue	The following table provides disaggregated revenue by reportable segment for the years ended December 31, 2024 and 2023. Industrial Technologies and Services Precision and Science Technologies Total 2024 2023 2024 2023 2024 2023 Primary Geographic Markets United States $ 2,461.2 $ 2,328.0 $ 651.1 $ 567.2 $ 3,112.3 $ 2,895.2 Other Americas 452.9 373.1 88.3 29.0 541.2 402.1 Total Americas 2,914.1 2,701.1 739.4 596.2 3,653.5 3,297.3 EMEIA 1,854.9 1,800.8 520.0 466.7 2,374.9 2,267.5 China 680.8 785.7 113.8 138.9 794.6 924.6 Other Asia Pacific 368.3 345.2 43.7 41.5 412.0 386.7 Total Asia Pacific 1,049.1 1,130.9 157.5 180.4 1,206.6 1,311.3 Total $ 5,818.1 $ 5,632.8 $ 1,416.9 $ 1,243.3 $ 7,235.0 $ 6,876.1 Product Categories Original equipment (1) $ 3,494.0 $ 3,425.9 $ 1,110.2 $ 990.9 $ 4,604.2 $ 4,416.8 Aftermarket (2) 2,324.1 2,206.9 306.7 252.4 2,630.8 2,459.3 Total $ 5,818.1 $ 5,632.8 $ 1,416.9 $ 1,243.3 $ 7,235.0 $ 6,876.1 Pattern of Revenue Recognition Revenue recognized at point in time (3) $ 5,295.6 $ 5,147.2 $ 1,376.4 $ 1,236.2 $ 6,672.0 $ 6,383.4 Revenue recognized over time (4) 522.5 485.6 40.5 7.1 563.0 492.7 Total $ 5,818.1 $ 5,632.8 $ 1,416.9 $ 1,243.3 $ 7,235.0 $ 6,876.1 (1) Revenues from sales of capital equipment within the Industrial Technologies and Services segment and sales of components to original equipment manufacturers in the Precision and Science Technologies segment. (2) Revenues from sales of spare parts, accessories, other components and services in support of maintaining customer owned, installed base of the Company’s original equipment. (3) Revenues from short and long duration product and service contracts recognized at a point in time when control is transferred to the customer generally when product delivery has occurred and services have been rendered. (4) Revenues primarily from long duration ETO product contracts, certain multi-year service contracts, and certain contracts for the delivery of a significant volume of substantially similar products recognized over time as contractual performance obligations are completed.
Schedule of Contract Balances	The following table provides the contract balances as of December 31, 2024 and 2023 presented in the Consolidated Balance Sheets. December 31, 2024 December 31, 2023 Accounts receivable, net $ 1,335.4 $ 1,234.2 Contract assets 111.2 85.6 Contract liabilities - current 318.6 331.2 Contract liabilities - noncurrent 0.9 1.0

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2024
Income Tax Disclosure [Abstract]
Schedule of Income (Loss) Before Income Taxes	Income before income taxes for the years ended December 31, 2024, 2023 and 2022 consisted of the following. 2024 2023 2022 U.S. $ 383.7 $ 356.0 $ 267.5 Non-U.S. 749.1 675.1 474.7 Income before income taxes $ 1,132.8 $ 1,031.1 $ 742.2
Schedule of Components of Provision (Benefit) for Income Taxes	The following table details the components of the Provision for income taxes for the years ended December 31, 2024, 2023 and 2022. 2024 2023 2022 Current: U.S. federal $ 87.5 $ 111.5 $ 66.5 U.S. state and local 22.8 23.7 21.5 Non-U.S. 185.3 181.7 147.4 Deferred: U.S. federal (9.7) (44.0) (37.3) U.S. state and local (5.7) (6.9) (5.5) Non-U.S. (17.7) (26.0) (43.0) Provision for income taxes $ 262.5 $ 240.0 $ 149.6
Schedule of Effective Income Tax Rate Reconciliation	The U.S. federal corporate statutory rate is reconciled to the Company’s effective income tax rate for the years ended December 31, 2024, 2023 and 2022 as follows. 2024 2023 2022 U.S. federal corporate statutory rate 21.0 % 21.0 % 21.0 % State and local taxes, less federal tax benefit 1.4 1.3 2.0 Net effects of foreign tax rate differential 2.5 1.8 1.5 Withholding tax 1.3 1.5 2.1 Repatriation cost (1.5) (2.0) (3.2) Global Intangible Low-Tax Income (“GILTI”) 0.4 0.7 0.3 ASC 740-30 (formerly APB 23) 1.5 1.7 1.9 Valuation allowance changes 0.4 1.7 0.5 Uncertain tax positions 0.9 0.9 0.2 Equity compensation (1.3) (0.6) (0.6) Nondeductible acquisition costs 0.3 0.4 0.4 Foreign Derived Intangible Income (“FDII”) deduction (1.1) (1.4) (1.6) Tax credits (0.6) (0.7) (1.1) Income not subject to tax (0.3) (1.6) (3.5) Amortization of goodwill and other intangible assets (1.3) (0.8) — Interest on equity (1.8) (0.7) (0.4) Return to provision adjustment (0.2) 0.1 — Loss on sale 1.1 — — Other, net 0.5 — 0.7 Effective income tax rate 23.2 % 23.3 % 20.2 %
Schedule of Deferred Tax Assets and Liabilities	The principal items that gave rise to deferred income tax assets and liabilities as of December 31, 2024 and 2023 are as follows. 2024 2023 Deferred Tax Assets: Reserves and accruals $ 83.4 $ 80.1 Allowance for credit losses 7.4 7.8 Inventory reserve 9.0 5.9 Pension and postretirement benefit plans 20.0 25.3 Tax loss carryforwards 112.4 81.3 Deferred taxes recorded in other comprehensive income 1.4 13.4 Foreign tax credit carryforwards 50.7 57.9 Other 22.4 32.2 Total deferred tax assets 306.7 303.9 Valuation allowance (125.6) (115.7) Deferred Tax Liabilities: LIFO inventory (20.3) (20.2) Investment in partnership (30.2) (35.7) Property, plant and equipment (50.0) (42.5) Intangible assets (770.4) (635.4) Unremitted foreign earnings (41.8) (35.5) Total deferred tax liabilities (912.7) (769.3) Net deferred income tax liability $ (731.6) $ (581.1)
Schedule of Tax Attributes and Related Valuation Allowance	The Company believes that it is more likely than not that it will realize its deferred tax assets through the reduction of future taxable income, other than for the deferred tax assets reflected below. Tax attributes and related valuation allowances as of December 31, 2024 were as follows. Tax Benefit Valuation Allowance Carryforward Period Ends Tax Attributes to be Carried Forward U.S. federal net operating loss $ 13.3 $ (0.1) 2032-2038 U.S. federal capital loss 0.6 (0.6) 2029 U.S. federal tax credit 50.8 (50.8) 2025-2034 Alternative minimum tax credit 0.5 (0.1) Unlimited U.S. state and local net operating losses 4.9 (2.1) 2026-2041 U.S. state capital loss 0.3 (0.1) 2028 Non U.S. net operating losses 62.6 (36.5) Unlimited Non U.S. capital losses 0.6 (0.6) Unlimited Excess interest 30.0 (29.7) Unlimited Other deferred tax assets 5.0 (5.0) Unlimited Total tax carryforwards $ 168.6 $ (125.6)
Schedule of Valuation Allowance	A reconciliation of the changes in the valuation allowance for deferred tax assets for the years ended December 31, 2024, 2023 and 2022 are as follows. 2024 2023 2022 Beginning balance $ 115.7 $ 107.3 $ 106.4 Revaluation or additions due to acquisitions or mergers (1) 22.9 — — Charged to tax expense (10.8) 6.4 3.1 Charged to other accounts (2.2) 2.0 (2.2) Ending balance $ 125.6 $ 115.7 $ 107.3 (1) Revaluation for the tax year ended December 31, 2024 relates to the inclusion of ILC Dover’s opening balance sheet beginning valuation allowance.
Schedule of Unrecognized Tax Benefits Roll Forward	Below is a tabular reconciliation of the changes in total unrecognized tax benefits during the years ended December 31, 2024, 2023 and 2022. 2024 2023 2022 Beginning balance $ 19.1 $ 10.8 $ 21.1 Gross increases for tax positions of prior years 0.8 0.4 0.4 Gross decreases for tax positions of prior years (0.3) — (3.7) Gross increases for tax positions of current year 8.1 7.9 4.1 Settlements — — (9.9) Lapse of statute of limitations (0.6) (0.2) (0.1) Changes due to currency fluctuations (0.7) 0.2 (1.1) Ending balance $ 26.4 $ 19.1 $ 10.8

Leases (Tables)

Leases (Tables)	12 Months Ended
	Dec. 31, 2024
Leases [Abstract]
Schedule of Components of Lease Expense	The components of lease expense for the years ended December 31, 2024 and 2023 are as follows. 2024 2023 Operating lease cost $ 64.5 $ 53.7 Finance lease cost Amortization of right-of-use assets $ 1.5 $ 1.5 Interest on lease liabilities 0.9 0.9 Total finance lease cost $ 2.4 $ 2.4 Short-term lease cost $ 2.2 $ 1.9
Schedule of Supplemental Cash Flow Information Related to Leases	Supplemental cash flow information related to leases for the years ended December 31, 2024 and 2023 is as follows. 2024 2023 Supplemental Cash Flows Information Cash Paid for Amounts Included in the Measurement of Lease Liabilities Operating cash flows from operating leases $ 63.8 $ 53.7 Operating cash flows from finance leases 0.9 1.0 Financing cash flows from finance leases 1.3 1.2 Leased Assets Obtained in Exchange for New Operating Lease Liabilities 96.2 62.5
Schedule of Supplemental Balance Sheet Information Related to Leases	Supplemental balance sheet information related to leases is as follows. December 31, 2024 December 31, 2023 Operating leases Other assets $ 226.6 $ 164.4 Accrued liabilities $ 56.3 $ 41.6 Other liabilities 165.5 116.9 Total operating lease liabilities $ 221.8 $ 158.5 Finance Leases Property, plant and equipment $ 11.1 $ 12.3 Short-term borrowings and current maturities of long-term debt $ 1.3 $ 1.3 Long-term debt, less current maturities 12.6 13.6 Total finance lease liabilities $ 13.9 $ 14.9 Weighted Average Remaining Lease Term (in years) Operating leases 5.2 5.1 Finance leases 9.4 10.3 Weighted Average Discount Rate Operating leases 4.1 % 3.6 % Finance leases 6.5 % 6.4 %
Schedule of Maturities of Operating Lease Liabilities	Maturities of lease liabilities as of December 31, 2024 are as follows. Operating Leases Finance Leases 2025 $ 63.6 $ 2.2 2026 55.1 2.1 2027 41.3 2.1 2028 29.4 2.1 2029 17.7 2.1 Thereafter 39.2 8.5 Total lease payments $ 246.3 $ 19.1 Less imputed interest (24.5) (5.2) Total $ 221.8 $ 13.9
Schedule of Maturities of Finance Lease Liabilities	Maturities of lease liabilities as of December 31, 2024 are as follows. Operating Leases Finance Leases 2025 $ 63.6 $ 2.2 2026 55.1 2.1 2027 41.3 2.1 2028 29.4 2.1 2029 17.7 2.1 Thereafter 39.2 8.5 Total lease payments $ 246.3 $ 19.1 Less imputed interest (24.5) (5.2) Total $ 221.8 $ 13.9

Stock-Based Compensation Plans

Stock-Based Compensation Plans (Tables)	12 Months Ended
	Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]
Schedule of Stock-based Compensation Expense	Stock-based compensation expense for the years ended December 31, 2024, 2023 and 2022 is included in “Cost of sales” and “Selling and administrative expenses” in the Consolidated Statements of Operations and is only related to continuing operations. 2024 2023 2022 Equity awards granted under the 2013 Plan and 2017 Plan (1) $ 58.8 $ 51.1 $ 80.0 Increase (decrease) in the liability for stock appreciation rights (“SAR”) — 0.8 (1.1) Total stock-based compensation expense $ 58.8 $ 51.9 $ 78.9 (1) In 2022, of the $80.0 million of expense for equity awards granted under the 2013 Plan and 2017 Plan, $39.5 million related to the $150 million equity grant to nearly 16,000 employees worldwide announced in the third quarter of 2020.
Schedule of Stock Option Awards	A summary of the Company’s stock option activity for the year ended December 31, 2024 is presented in the following table (underlying shares in thousands). Shares Weighted-Average Exercise Price Wtd. Avg. Remaining Contractual Term (years) Aggregate Intrinsic Value of In-The-Money Options Outstanding at December 31, 2023 5,282 $ 31.09 Granted 610 90.55 Exercised or Settled (1,615) 19.96 Forfeited (88) 65.08 Expired (4) 40.22 Outstanding at December 31, 2024 4,185 43.33 5.5 $ 197.4 Vested at December 31, 2024 2,708 29.34 4.1 $ 165.5
Schedule of Fair Value Assumptions	The following assumptions were used to estimate the fair value of options granted during the years ended December 31, 2024, 2023 and 2022. 2024 2023 2022 Expected life of options (in years) 6.3 - 7.5 6.3 - 7.5 6.3 Risk-free interest rate 3.7% - 4.3% 3.8% - 4.6% 1.9% - 3.9% Assumed volatility 34.9% - 35.2% 35.6% - 36.6% 37.1% - 38.3% Expected dividend rate 0.1% 0.0% - 0.1% 0.1% - 0.2% The following assumptions were used to estimate the fair value of performance share units granted during the year ended December 31, 2024, 2023 and 2022 using the Monte Carlo simulation pricing model. 2024 2023 2022 Expected term (in years) 2.8 2.9 2.9 - 5.0 Risk-free interest rate 4.5% 4.4% 1.7% - 3.4% Assumed volatility 28.9% 31.8% 35.0% - 36.4% Expected dividend rate 0.1 % 0.1 % 0.2 %
Schedule of Restricted Stock Unit Activity	A summary of the Company’s restricted stock unit activity for the year ended December 31, 2024 is presented in the following table (underlying shares in thousands). Shares Weighted-Average Grant-Date Fair Value Non-vested as of December 31, 2023 957 $ 52.18 Granted 433 90.94 Vested (469) 47.96 Forfeited (87) 68.20 Non-vested as of December 31, 2024 834 73.00
Schedule of Performance Stock Unit Activity	A summary of the Company’s performance stock unit activity for the year ended December 31, 2024 is presented in the following table (underlying shares in thousands). Shares Weighted-Average Grant-Date Fair Value Non-vested as of December 31, 2023 1,380 $ 49.53 Granted 87 132.98 Change in units based on performance 122 55.84 Vested (244) 55.84 Forfeited (6) 71.81 Non-vested as of December 31, 2024 1,339 54.28

Hedging Activities, Derivativ_2

Hedging Activities, Derivative Instruments and Credit Risk (Tables)	12 Months Ended
	Dec. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Derivative Instruments	The following table summarizes the notional amounts, fair values and classification of the Company’s outstanding derivatives by risk category and instrument type within the Consolidated Balance Sheets as of December 31, 2024 and 2023. December 31, 2024 Derivative Classification Notional Amount (1) Fair Value (1) Other Current Assets Fair Value (1) Other Assets Fair Value (1) Accrued Liabilities Fair Value (1) Other Liabilities Derivatives Designated as Hedging Instruments Interest rate swap contracts Fair value $ 750.0 $ — $ 1.4 $ 0.9 $ 0.9 Cross-currency interest rate swap contracts Net investment 1,074.3 11.5 15.8 — — Derivatives Not Designated as Hedging Instruments Foreign currency forwards Fair value $ 124.3 $ 1.8 $ — $ — $ — Foreign currency forwards Fair value 69.0 — — 1.2 — December 31, 2023 Derivative Classification Notional Amount (1) Fair Value (1) Other Current Assets Fair Value (1) Other Assets Fair Value (1) Accrued Liabilities Fair Value (1) Other Liabilities Derivatives Designated as Hedging Instruments Interest rate swap contracts Cash flow $ 528.5 $ 8.2 $ 1.2 $ — $ — Cross-currency interest rate swap contracts Net investment 1,054.2 15.7 — — 63.1 (1) Notional amounts represent the gross contract amounts of the outstanding derivatives excluding the total notional amount of positions that have been effectively closed through offsetting positions. The net gains and net losses associated with positions that have been effectively closed through offsetting positions but not yet settled are included in the asset and liability derivatives fair value columns, respectively.
Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location	December 31, 2024 December 31, 2023 Long-term debt: Carrying amount of hedged debt $ 749.7 $ — Cumulative hedging adjustments, included in carrying amount (0.3) —
Schedule of Cash Flow Hedges Included in Comprehensive (Loss) Income	Gains on derivatives designated as cash flow hedges included in the Consolidated Statements of Comprehensive Income (Loss) for the years ended December 31, 2024, 2023 and 2022 are presented in the table below. 2024 2023 2022 Gain recognized in OCI on derivatives $ 1.6 $ 10.5 $ 18.3 Gain (loss) reclassified from AOCI into income (effective portion) (1) 15.7 15.6 (2.8) (1) Gains (losses) on derivatives reclassified from AOCI into income were included in “Interest expense” in the Consolidated Statements of Operations.
Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss)	Gains (losses) on derivatives designated as net investment hedges included in the Condensed Consolidated Statements of Comprehensive Income (Loss) for the years ended December 31, 2024, 2023 and 2022 are presented in the table below. 2024 2023 2022 Gain (loss) recognized in OCI on derivatives $ 72.5 $ (17.5) $ 0.6 Gain reclassified from AOCI into income (effective portion) (1) 17.7 19.0 11.5 (1) Gains (losses) on derivatives reclassified from AOCI into income were included in “Interest expense” in the Consolidated Statements of Operations.
Schedule of Gains (Losses) on Derivative Instruments Not Designated as Accounting Hedges and Total Net Foreign Currency (Losses) Gains	The Company’s gains (losses) on derivative instruments not designated as accounting hedges and total net foreign currency transaction gains (losses) for the years ended December 31, 2024, 2023 and 2022 were as follows. 2024 2023 2022 Foreign currency forward contracts gains 0.1 0.3 3.4 Total foreign currency transaction gains (losses), net (3.2) (5.1) 5.9

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
	Dec. 31, 2024
Fair Value Disclosures [Abstract]
Schedule of Assets and Liabilities Measured at Fair Value	The following table summarizes the Company’s financial assets and liabilities measured at fair value on a recurring basis. December 31, 2024 Level 1 Level 2 Level 3 Total Financial Assets Trading securities held in deferred compensation plan (1) $ 21.0 $ — $ — $ 21.0 Interest rate swaps (2) — 1.4 — 1.4 Cross-currency interest rate swaps (3) — 27.3 — 27.3 Foreign currency forwards (4) — 1.8 — 1.8 Total $ 21.0 $ 30.5 $ — $ 51.5 Financial Liabilities Deferred compensation plan (1) $ 28.7 $ — $ — $ 28.7 Interest rate swaps (2) — 1.8 — 1.8 Contingent consideration (5) — — 22.2 22.2 Foreign currency forwards (4) — 1.2 — 1.2 Total $ 28.7 $ 3.0 $ 22.2 $ 53.9 December 31, 2023 Level 1 Level 2 Level 3 Total Financial Assets Trading securities held in deferred compensation plan (1) $ 16.8 $ — $ — $ 16.8 Interest rate swaps (5) — 9.4 — 9.4 Cross-currency interest rate swaps (3) — 15.7 — 15.7 Total $ 16.8 $ 25.1 $ — $ 41.9 Financial Liabilities Deferred compensation plan (1) $ 24.7 $ — $ — $ 24.7 Cross-currency interest rate swaps (3) — 63.1 — 63.1 Contingent consideration (5) — — 42.2 42.2 Total $ 24.7 $ 63.1 $ 42.2 $ 130.0 (1) Based on the quoted price of publicly traded mutual funds and other equity securities which are classified as trading securities and accounted for using the mark-to-market method. (2) Measured as the present value of all expected future cash flows based on the SOFR-based swap yield curves. The present value calculation uses discount rates that have been adjusted to reflect the credit quality of the Company and its counterparties. (3) Measured as the present value of all expected future cash flows on each leg of the contracts. The model utilizes inputs of observable market data including interest yield curves and foreign currency exchange rates. The present value calculation uses cross-currency basis-adjusted discount factors that have been adjusted to reflect the credit quality of the Company and its counterparties. (4) Based on calculations that use readily observable market parameters as their basis, such as spot and forward rates. (5) Measured as the present value of expected consideration payable for completed acquisitions, generally derived using probability-weighted analysis of achieving projected revenue or EBITDA targets.
Schedule of Activity for Contingent Consideration	The following table provides a reconciliation of the activity for contingent consideration for the years ended December 31, 2024 and 2023. 2024 2023 Balance at beginning of period $ 42.2 $ 43.9 Acquisitions 6.7 13.5 Changes in fair value (15.3) 7.3 Payments (10.0) (23.2) Foreign currency translation and other (1.4) 0.7 Balance at end of period $ 22.2 $ 42.2

Contingencies (Tables)

Contingencies (Tables)	12 Months Ended
	Dec. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Schedule of Discontinued Operations	The results of operations of SVT and HPS are presented as discontinued operations for the year ended December 31, 2022 as summarized below: Specialty Vehicle Technologies High Pressure Solutions Total Revenues $ 6.6 $ — $ 6.6 Cost of sales 6.5 — 6.5 Gross Profit 0.1 — 0.1 Selling and administrative expenses 0.1 — 0.1 Gain on sale (2.8) — (2.8) Other operating expense, net 0.7 1.6 2.3 Income from Discontinued Operations Before Income Taxes 2.1 (1.6) 0.5 Provision for income taxes (13.2) (1.5) (14.7) Income from Discontinued Operations, Net of Tax $ 15.3 $ (0.1) $ 15.2 The following table summarizes the impacts of the divestiture. Assets divested: Cash and cash equivalents $ 153.5 Insurance recovery receivable 13.9 Liabilities divested: Asbestos indemnity liability - current (12.3) Asbestos indemnity liability - noncurrent (111.4) Loss on Asbestos Sale, before transaction costs 43.7 Transaction costs 15.1 Loss on Asbestos Sale 58.8 Income tax benefit (7.6) Loss on Asbestos Sale, net of tax $ 51.2

Other Operating Expense, Net (T

Other Operating Expense, Net (Tables)	12 Months Ended
	Dec. 31, 2024
Other Income and Expenses [Abstract]
Schedule of Other Operating Expense, Net	The components of “Other operating expense, net” for the years ended December 31, 2024, 2023 and 2022 were as follows. 2024 2023 2022 Other Operating Expense, Net Foreign currency transaction losses (gains), net $ 3.2 $ 5.1 $ (5.9) Restructuring charges, net (1) 31.2 19.9 29.3 Acquisition and other transaction related expenses (2) 47.1 52.2 38.7 Loss on asbestos sale (3) 58.8 — — Other, net (1.7) 0.5 2.8 Total other operating expense, net $ 138.6 $ 77.7 $ 64.9 (1) See Note 5 “Restructuring.” (2) Represents costs associated with successful and abandoned acquisitions, including third-party expenses, post-closure integration costs and non-cash charges and credits arising from fair value purchase accounting adjustments. (3) See Note 22 “Contingencies.”

Segment Reporting (Tables)

Segment Reporting (Tables)	12 Months Ended
	Dec. 31, 2024
Segment Reporting [Abstract]
Schedule of Segment Results	The following table provides summarized information about the Company’s operations by reportable segment and reconciles Segment Adjusted EBITDA to Income from Continuing Operations Before Income Taxes for the years ended December 31, 2024, 2023 and 2022. Industrial Technologies and Services Precision and Science Technologies Total 2024 2023 2022 2024 2023 2022 2024 2023 2022 Revenue $ 5,818.1 $ 5,632.8 $ 4,705.1 1,416.9 1,243.3 1,211.2 $ 7,235.0 $ 6,876.1 $ 5,916.3 Segment cost of sales (1) 3,193.3 3,225.0 2,785.5 736.2 648.8 652.4 3,929.5 3,873.8 3,437.9 Segment selling and administrative expenses (2) 868.5 818.5 702.5 264.6 222.5 212.6 1,133.1 1,041.0 915.1 Other segment items (3) 1.5 2.0 3.1 (2.7) (0.8) (1.3) (1.2) 1.2 1.8 Segment Adjusted EBITDA $ 1,754.8 $ 1,587.3 $ 1,214.0 418.8 372.8 347.5 2,173.6 1,960.1 1,561.5 (1) Segment cost of sales excludes adjustments to LIFO inventories, depreciation and amortization expense, restructuring and related business transformation costs, acquisition and other transaction related expenses and non-cash charges. (2) Segment selling and administrative expenses excludes depreciation and amortization expense, restructuring and related business transformation costs, acquisition and other transaction related expenses and non-cash charges. (3) Other miscellaneous segment expenses. 2024 2023 2022 Total Segment Adjusted EBITDA 2,173.6 1,960.1 1,561.5 Less items to reconcile Segment Adjusted EBITDA to Income from Continuing Operations Before Income Taxes: Corporate expenses not allocated to segments 155.5 173.3 126.7 Interest expense 213.2 156.7 103.2 Depreciation and amortization expense (1) 478.0 455.4 429.4 Impairment of other intangible assets 13.9 — — Restructuring and related business transformation costs (2) 32.3 22.9 32.3 Acquisition and other transaction related expenses and non-cash charges (3) 59.8 63.9 40.7 Stock-based compensation (4) 58.8 51.9 85.6 Foreign currency transaction losses (gains), net 3.2 5.1 (5.9) Loss on extinguishment of debt 3.0 13.5 1.1 Adjustments to LIFO inventories 6.7 12.0 36.1 Cybersecurity incident costs 0.5 2.3 — Loss on asbestos sale 58.8 — — Gain on settlement of post-acquisition contingencies (5) — — (6.2) Interest income on cash and cash equivalents (43.3) (28.8) (8.0) Other adjustments (6) 0.4 0.8 (15.7) Income from Continuing Operations Before Income Taxes $ 1,132.8 $ 1,031.1 $ 742.2 (1) Depreciation and amortization expense excludes $4.0 million, $3.7 million and $3.4 million of depreciation of rental equipment for the years ended December 31, 2024, 2023 and 2022, respectively. (2) Restructuring and related business transformation costs consist of the following. 2024 2023 2022 Restructuring charges $ 31.2 $ 19.9 $ 29.3 Facility reorganization, relocation and other costs 1.1 3.0 3.0 Total restructuring and related business transformation costs $ 32.3 $ 22.9 $ 32.3 (3) Represents costs associated with successful and abandoned acquisitions, including third-party expenses, post-closure integration costs and non-cash charges and credits arising from fair value purchase accounting adjustments. (4) Represents stock-based compensation expense recognized for the year ended December 31, 2022 of $78.9 million and associated employer taxes of $6.7 million. (5) Represents gains from settling post-acquisition contingencies related to the Merger outside of the measurement period. (6) Includes (i) pension and other postretirement benefits (“OPEB”) plan costs other than service cost and (ii) other miscellaneous adjustments. The following tables provide summarized information about the Company’s reportable segments. Depreciation and Amortization Expense 2024 2023 2022 Industrial Technologies and Services $ 296.0 $ 313.8 $ 294.7 Precision and Science Technologies 177.1 135.4 133.6 Corporate and other 8.9 9.9 4.5 Total depreciation and amortization expense $ 482.0 $ 459.1 $ 432.8 Capital Expenditures 2024 2023 2022 Industrial Technologies and Services $ 83.0 $ 83.9 $ 66.3 Precision and Science Technologies 21.3 18.5 17.7 Corporate and other 44.8 3.0 10.6 Total capital expenditures $ 149.1 $ 105.4 $ 94.6 Identifiable Assets 2024 2023 Industrial Technologies and Services $ 10,369.6 $ 10,138.8 Precision and Science Technologies 5,884.1 3,464.7 Corporate and other 1,756.1 1,960.0 Total identifiable assets $ 18,009.8 $ 15,563.5
Scheduled of Property, Plant and Equipment by Geographic Region	The following table presents property, plant and equipment, net by geographic region for the years ended December 31, 2024, and 2023. 2024 2023 United States $ 381.8 $ 286.0 Other Americas 38.1 12.8 Total Americas 419.9 298.8 EMEIA (1) 256.5 245.7 China 152.3 160.9 Other Asia Pacific 13.4 6.0 Total Asia Pacific 165.7 166.9 Total $ 842.1 $ 711.4 (1) Europe, Middle East, India and Africa (“EMEIA”)

Earnings Per Share (Tables)

Earnings Per Share (Tables)	12 Months Ended
	Dec. 31, 2024
Earnings Per Share [Abstract]
Schedule of Basic and Diluted Earnings Per Share	The number of weighted-average shares outstanding used in the computations of basic and diluted earnings per share for the years ended December 31, 2024, 2023 and 2022 were as follows. 2024 2023 2022 Weighted-average shares outstanding - Basic 403.4 404.8 405.3 Dilutive effect of outstanding share-based compensation awards 3.8 4.2 4.9 Weighted-average shares outstanding - Diluted 407.2 409.0 410.2

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Cash and Cash Equivalents [Abstract]
Restricted cash and cash equivalents	$ 10.5	$ 1.2
Goodwill and Indefinite-Lived Intangible Assets [Abstract]
Fair value percentage of reporting units using income approach	75%
Fair value percentage of reporting units using market approach	25%
Guarantees and Product Warranties [Abstract]
Warranty period after time of sale (in months)	12 months
Income Taxes [Abstract]
Income tax expense under the Tax Act	$ 4.6
Research and Development [Abstract]
Research and development expense	$ 116.6	$ 108.2	$ 91.3
Buildings | Minimum
Cash and Cash Equivalents [Abstract]
Estimated useful lives of property, plant and equipment (in years)	10 years
Buildings | Maximum
Cash and Cash Equivalents [Abstract]
Estimated useful lives of property, plant and equipment (in years)	30 years
Machinery and Equipment | Minimum
Cash and Cash Equivalents [Abstract]
Estimated useful lives of property, plant and equipment (in years)	7 years
Machinery and Equipment | Maximum
Cash and Cash Equivalents [Abstract]
Estimated useful lives of property, plant and equipment (in years)	10 years
Office Equipment | Minimum
Cash and Cash Equivalents [Abstract]
Estimated useful lives of property, plant and equipment (in years)	3 years
Office Equipment | Maximum
Cash and Cash Equivalents [Abstract]
Estimated useful lives of property, plant and equipment (in years)	10 years

Discontinued Operations - Narra

Discontinued Operations - Narrative (Details) $ in Millions		12 Months Ended
	Feb. 14, 2021 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2024 business	Apr. 09, 2021 USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Number of businesses that comprise discontinued operations | business			2
Discontinued Operations, Disposed of by Sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Gain on sale		$ 2.8
Discontinued Operations, Disposed of by Sale | Specialty Vehicle Technologies
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cash consideration for sale of business				$ 1,680
Gain on sale		2.8
Discontinued Operations, Disposed of by Sale | High Pressure Solutions
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cash consideration for sale of business	$ 278.3
Majority interest sold (as percent)	55%
Common equity interest retained after disposal (as percent)	45%
Gain on sale		$ 0

Discontinued Operations - Resul

Discontinued Operations - Results of Operations (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Income from Discontinued Operations, Net of Tax	$ 0	$ 0	$ 15.2
Discontinued Operations, Disposed of by Sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Revenues			6.6
Cost of sales			6.5
Gross Profit			0.1
Selling and administrative expenses			0.1
Gain on sale			(2.8)
Other operating expense, net			2.3
Income from Discontinued Operations Before Income Taxes			0.5
Provision for income taxes			(14.7)
Income from Discontinued Operations, Net of Tax			15.2
Discontinued Operations, Disposed of by Sale | Specialty Vehicle Technologies
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Revenues			6.6
Cost of sales			6.5
Gross Profit			0.1
Selling and administrative expenses			0.1
Gain on sale			(2.8)
Other operating expense, net			0.7
Income from Discontinued Operations Before Income Taxes			2.1
Provision for income taxes			(13.2)
Income from Discontinued Operations, Net of Tax			15.3
Discontinued Operations, Disposed of by Sale | High Pressure Solutions
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Revenues			0
Cost of sales			0
Gross Profit			0
Selling and administrative expenses			0
Gain on sale			0
Other operating expense, net			1.6
Income from Discontinued Operations Before Income Taxes			(1.6)
Provision for income taxes			(1.5)
Income from Discontinued Operations, Net of Tax			$ (0.1)

Acquisitions - Narrative (Detai

Acquisitions - Narrative (Details) $ in Millions

12 Months Ended

Oct. 31, 2024 USD ($)

Oct. 01, 2024 USD ($)

Jun. 03, 2024 USD ($)

Jun. 01, 2024 USD ($)

May 31, 2024 USD ($)

May 01, 2024 USD ($)

Apr. 02, 2024 USD ($)

Apr. 01, 2024 USD ($)

Feb. 01, 2024 USD ($)

Aug. 18, 2023 USD ($)

Apr. 01, 2023 USD ($)

Feb. 01, 2023 USD ($)

Jan. 03, 2023 USD ($)

Dec. 01, 2022 USD ($)

Nov. 01, 2022 USD ($)

Oct. 01, 2022 USD ($)

Sep. 01, 2022 USD ($)

Feb. 01, 2022 USD ($)

Dec. 31, 2024 USD ($)

Dec. 31, 2023 USD ($) business

Dec. 31, 2022 USD ($)

Business Acquisition [Line Items]

Goodwill

$ 8,148.1

$ 6,609.7

$ 6,064.2

Industrial Technologies and Services

Business Acquisition [Line Items]

Goodwill

4,930.7

4,753.5

4,222.5

Friulair

Business Acquisition [Line Items]

Cash consideration

$ 143.3

Contingent consideration

11

Amount of goodwill deductible

$ 0

Goodwill

69.2

Controlled Fluidics

Business Acquisition [Line Items]

Cash consideration

$ 49.9

Contingent consideration

$ 2

Ethafilter s.r.l.

Business Acquisition [Line Items]

Cash consideration

$ 15.5

Air Systems, LLC

Business Acquisition [Line Items]

Cash consideration

$ 34.9

Complete Air And Power Solutions

Business Acquisition [Line Items]

Cash consideration

$ 99.3

Fruvac Ltd.

Business Acquisition [Line Items]

Cash consideration

$ 28

Del PD Pumps & Gear Pvt Ltd.

Business Acquisition [Line Items]

Cash consideration

$ 25.2

ILC Dover

Business Acquisition [Line Items]

Cash consideration

$ 2,349.7

Contingent consideration

75

Amount of goodwill deductible

0

Goodwill

1,309.8

1,309.8

ILC Dover | Customer Relationships

Business Acquisition [Line Items]

Business combination, recognized identifiable assets acquired and liabilities assumed, finite-lived intangibles

$ 621

Acquired finite-lived intangible assets, weighted average useful life

14 years

ILC Dover | Acquired Technology

Business Acquisition [Line Items]

Business combination, recognized identifiable assets acquired and liabilities assumed, finite-lived intangibles

$ 142

Acquired finite-lived intangible assets, weighted average useful life

8 years

ILC Dover | Tradenames

Business Acquisition [Line Items]

Business combination, recognized identifiable assets acquired and liabilities assumed, indefinite-lived intangibles

$ 207.5

APSCO

Business Acquisition [Line Items]

Cash consideration

$ 113.2

Goodwill

51.6

Blutek

Business Acquisition [Line Items]

Cash consideration

9.6

UT Pumps & Systems Private Ltd

Business Acquisition [Line Items]

Cash consideration

$ 11.7

Penn Valley Pump Co LLC

Business Acquisition [Line Items]

Cash consideration

$ 33.2

All others

Business Acquisition [Line Items]

Amount of goodwill deductible

159.9

Goodwill

237.6

126.7

151.9

Aggregate consideration

55.6

$ 83.3

19.9

Number of businesses acquired | business

10

Acquisitions In 2024

Business Acquisition [Line Items]

Goodwill

1,668.2

Revenue from acquisition date

349.6

Net loss from acquisition date

5.6

Air Treatment

Business Acquisition [Line Items]

Cash consideration

$ 519

Amount of goodwill deductible

$ 0

Goodwill

$ 279.9

Paragon Tank Truck Equipment

Business Acquisition [Line Items]

Cash consideration

$ 42.2

EcoPlant Technological Innovation Ltd

Business Acquisition [Line Items]

Cash consideration

$ 29.5

Contingent consideration

$ 17

Roots

Business Acquisition [Line Items]

Cash consideration

$ 292.5

Goodwill

105.6

Total

Business Acquisition [Line Items]

Goodwill

512.2

Revenue from acquisition date

408

293.7

Net loss from acquisition date

58.8

16.1

Houdstermaatschappij Jorc B.V. | Industrial Technologies and Services

Business Acquisition [Line Items]

Cash consideration

$ 30.2

Westwood Technical Limited

Business Acquisition [Line Items]

Cash consideration

$ 8.1

Contingent consideration

9.3

Holtec Gas Systems LLC

Business Acquisition [Line Items]

Cash consideration

13

Hydro Prokav Pumps (India) Private Limited

Business Acquisition [Line Items]

Cash consideration

$ 14

Dosatron International L.L.C

Business Acquisition [Line Items]

Cash consideration

$ 89.5

Contingent consideration

$ 14.7

Pedro Gil Construcciones Mecanicas, S.L.

Business Acquisition [Line Items]

Cash consideration

$ 18.4

Everest Blower Systems Private Limited

Business Acquisition [Line Items]

Cash consideration

$ 75.3

Contingent consideration

$ 12.1

Total Consideration

Business Acquisition [Line Items]

Goodwill

209.3

Revenue from acquisition date

132.3

124.4

38.4

Net loss from acquisition date

$ 17

$ 19.5

$ 3.4

Acquisitions - Schedule of Busi

Acquisitions - Schedule of Business Acquisitions by Acquisition, Consideration (Details) - USD ($) $ in Millions	Dec. 31, 2024	Jun. 03, 2024	Dec. 31, 2023	Dec. 31, 2022
Business Acquisition [Line Items]
Goodwill	$ 8,148.1		$ 6,609.7	$ 6,064.2
Acquisitions In 2024
Business Acquisition [Line Items]
Accounts receivable	99.8
Inventories	151
Other current assets	40.8
Property, plant and equipment	118.8
Goodwill	1,668.2
Other intangible assets	1,186.2
Other noncurrent assets	25.3
Total current liabilities	(101)
Deferred tax liabilities	(184.1)
Other noncurrent liabilities	(29.1)
Total consideration	2,975.9
ILC Dover
Business Acquisition [Line Items]
Accounts receivable	41.4
Inventories	84
Other current assets	35.1
Property, plant and equipment	90.8
Goodwill	1,309.8	$ 1,309.8
Other intangible assets	973.1
Other noncurrent assets	15.8
Total current liabilities	(31.3)
Deferred tax liabilities	(151.5)
Other noncurrent liabilities	(17.5)
Total consideration	2,349.7
Friulair
Business Acquisition [Line Items]
Accounts receivable	14.2
Inventories	13.2
Other current assets	0.5
Property, plant and equipment	7.2
Goodwill	69.2
Other intangible assets	84.5
Other noncurrent assets	0
Total current liabilities	(11.6)
Deferred tax liabilities	(24.6)
Other noncurrent liabilities	(2.8)
Total consideration	149.8
APSCO
Business Acquisition [Line Items]
Accounts receivable	6.4
Inventories	7.5
Other current assets	0.5
Property, plant and equipment	2.3
Goodwill	51.6
Other intangible assets	48.1
Other noncurrent assets	3.5
Total current liabilities	(3.7)
Deferred tax liabilities	0
Other noncurrent liabilities	(3)
Total consideration	113.2
All others
Business Acquisition [Line Items]
Accounts receivable	37.8		11.7	16.2
Inventories	46.3		21	20.4
Other current assets	4.7		6.2	1.3
Property, plant and equipment	18.5		5	8.9
Goodwill	237.6		126.7	151.9
Other intangible assets	80.5		25.4	43
Other noncurrent assets	6		0.4	0.9
Total current liabilities	(54.4)		(19.5)	(30.7)
Deferred tax liabilities	(8)		(3.9)	(9.7)
Other noncurrent liabilities	(5.8)		(4.5)	(1.9)
Total consideration	$ 363.2		168.5	200.3
Total
Business Acquisition [Line Items]
Accounts receivable			52.3
Inventories			99.1
Other current assets			11.2
Property, plant and equipment			65.4
Goodwill			512.2
Other intangible assets			380.9
Other noncurrent assets			11.1
Total current liabilities			(82.3)
Deferred tax liabilities			(58.7)
Other noncurrent liabilities			(13.7)
Total consideration			977.5
Air Treatment
Business Acquisition [Line Items]
Accounts receivable			26.1
Inventories			43.9
Other current assets			2.1
Property, plant and equipment			18.4
Goodwill			279.9
Other intangible assets			238.6
Other noncurrent assets			7.6
Total current liabilities			(35.9)
Deferred tax liabilities			(54.8)
Other noncurrent liabilities			(6.9)
Total consideration			519
Roots
Business Acquisition [Line Items]
Accounts receivable			14.5
Inventories			34.2
Other current assets			2.9
Property, plant and equipment			42
Goodwill			105.6
Other intangible assets			116.9
Other noncurrent assets			3.1
Total current liabilities			(26.9)
Deferred tax liabilities			0
Other noncurrent liabilities			(2.3)
Total consideration			$ 290
Total Consideration
Business Acquisition [Line Items]
Accounts receivable				18
Inventories				26.6
Other current assets				1.4
Property, plant and equipment				9.2
Goodwill				209.3
Other intangible assets				84.9
Other noncurrent assets				14.7
Total current liabilities				(34.2)
Deferred tax liabilities				(23.5)
Other noncurrent liabilities				(1.9)
Total consideration				304.5
Dosatron International
Business Acquisition [Line Items]
Accounts receivable				1.8
Inventories				6.2
Other current assets				0.1
Property, plant and equipment				0.3
Goodwill				57.4
Other intangible assets				41.9
Other noncurrent assets				13.8
Total current liabilities				(3.5)
Deferred tax liabilities				(13.8)
Other noncurrent liabilities				0
Total consideration				$ 104.2

Restructuring (Details)

Restructuring (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 31.2	$ 19.9	$ 29.3
2020 Plan
Restructuring Cost and Reserve [Line Items]
Restructuring charges	31.2	19.9	29.3
2020 Plan | Corporate
Restructuring Cost and Reserve [Line Items]
Restructuring charges	2.7	0.7	0.5
2020 Plan | Industrial Technologies and Services
Restructuring Cost and Reserve [Line Items]
Restructuring charges	20.6	15.1	20.1
2020 Plan | Precision and Science Technologies
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 7.9	$ 4.1	$ 8.7

Restructuring - Activity in Res

Restructuring - Activity in Restructuring Programs (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Restructuring Reserve [Roll Forward]
Balance at beginning of period	$ 15.5	$ 14.9
Charged to expense - termination benefits	27.1	13
Charged to expense - other	2.5	4.2
Payments	(21.6)	(17.1)
Foreign currency translation and other	(1.2)	0.5
Balance at end of period	22.3	15.5
Other operating income (expense) | 2020 Plan
Restructuring Reserve [Roll Forward]
Non-cash charges	$ 1.6	$ 2.7

Allowance for Credit Losses (De

Allowance for Credit Losses (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Balance at beginning of the period	$ 53.8	$ 47.2	$ 42.3
Provision charged to expense	7.5	9.4	10.1
Write-offs, net of recoveries	(3.3)	(3.3)	(3.2)
Foreign currency translation and other	(0.7)	0.5	(2)
Balance at end of the period	$ 57.3	$ 53.8	$ 47.2

Inventories - Schedule of Inven

Inventories - Schedule of Inventories (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Inventories [Abstract]
Raw materials, including parts and subassemblies	$ 675.1	$ 590.7
Work-in-process	116.3	145.1
Finished goods	342.8	337.8
Inventories, gross	1,134.2	1,073.6
LIFO reserve	(79.2)	(72.5)
Inventories	$ 1,055	$ 1,001.1

Inventories - Narrative (Detail

Inventories - Narrative (Details)	Dec. 31, 2024	Dec. 31, 2023
Inventory Disclosure [Abstract]
Percentage of inventory	34%	37%

Property, Plant, and Equipmen_2

Property, Plant, and Equipment (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Property, Plant and Equipment [Abstract]
Land and land improvements	$ 62.3	$ 67.7
Buildings	385.6	337.1
Machinery and equipment	792.6	655.8
Office furniture and equipment	76.8	71
Construction in progress	92.3	80.6
Property, plant and equipment, gross	1,409.6	1,212.2
Accumulated depreciation	(567.5)	(500.8)
Property, plant and equipment, net	$ 842.1	$ 711.4

Goodwill and Other Intangible_3

Goodwill and Other Intangible Assets - Goodwill by Segment (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Goodwill [Roll Forward]
Balance at beginning of period	$ 6,609.7	$ 6,064.2
Acquisitions	1,668.2	511.5
Foreign currency translation and other	(129.8)	34
Balance at end of period	8,148.1	6,609.7
Industrial Technologies and Services
Goodwill [Roll Forward]
Balance at beginning of period	4,753.5	4,222.5
Acquisitions	263.9	509.1
Foreign currency translation and other	(86.7)	21.9
Balance at end of period	4,930.7	4,753.5
Precision and Science Technologies
Goodwill [Roll Forward]
Balance at beginning of period	1,856.2	1,841.7
Acquisitions	1,404.3	2.4
Foreign currency translation and other	(43.1)	12.1
Balance at end of period	$ 3,217.4	$ 1,856.2

Goodwill and Other Intangible_4

Goodwill and Other Intangible Assets - Goodwill by Acquisition (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Business Combination, Goodwill [Abstract]
Goodwill acquired	$ 1,668.2	$ 511.5
ILC Dover
Business Combination, Goodwill [Abstract]
Goodwill acquired	1,309.8
Friulair
Business Combination, Goodwill [Abstract]
Goodwill acquired	69.2
APSCO
Business Combination, Goodwill [Abstract]
Goodwill acquired	51.6
Air Treatment
Business Combination, Goodwill [Abstract]
Goodwill acquired		279.9
Roots
Business Combination, Goodwill [Abstract]
Goodwill acquired		106.6
Other acquisitions
Business Combination, Goodwill [Abstract]
Goodwill acquired	237.6	125
Industrial Technologies and Services
Business Combination, Goodwill [Abstract]
Goodwill acquired	263.9	509.1
Industrial Technologies and Services | ILC Dover
Business Combination, Goodwill [Abstract]
Goodwill acquired	0
Industrial Technologies and Services | Friulair
Business Combination, Goodwill [Abstract]
Goodwill acquired	69.2
Industrial Technologies and Services | APSCO
Business Combination, Goodwill [Abstract]
Goodwill acquired	51.6
Industrial Technologies and Services | Air Treatment
Business Combination, Goodwill [Abstract]
Goodwill acquired		279.9
Industrial Technologies and Services | Roots
Business Combination, Goodwill [Abstract]
Goodwill acquired		106.6
Industrial Technologies and Services | Other acquisitions
Business Combination, Goodwill [Abstract]
Goodwill acquired	143.1	122.6
Precision and Science Technologies
Business Combination, Goodwill [Abstract]
Goodwill acquired	1,404.3	2.4
Precision and Science Technologies | ILC Dover
Business Combination, Goodwill [Abstract]
Goodwill acquired	1,309.8
Precision and Science Technologies | Friulair
Business Combination, Goodwill [Abstract]
Goodwill acquired	0
Precision and Science Technologies | APSCO
Business Combination, Goodwill [Abstract]
Goodwill acquired	0
Precision and Science Technologies | Air Treatment
Business Combination, Goodwill [Abstract]
Goodwill acquired		0
Precision and Science Technologies | Roots
Business Combination, Goodwill [Abstract]
Goodwill acquired		0
Precision and Science Technologies | Other acquisitions
Business Combination, Goodwill [Abstract]
Goodwill acquired	$ 94.5	$ 2.4

Goodwill and Other Intangible_5

Goodwill and Other Intangible Assets - Narrative (Details) - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Goodwill [Line Items]
Goodwill impairment	$ 0	$ 0	$ 0
Amortization of intangible assets	373,000,000	367,500,000	347,600,000
Anticipated amortization of intangible assets in 2025	375,000,000
Anticipated amortization of intangible assets in 2026	315,000,000
Anticipated amortization of intangible assets in 2027	275,000,000
Anticipated amortization of intangible assets in 2028	275,000,000
Anticipated amortization of intangible assets in 2029	$ 220,000,000
Impairment Of Intangible Asset Indefinite Lived Excluding Goodwill Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag	impairment
Tradenames
Goodwill [Line Items]
Impairment of indefinite-lived intangible assets	$ 0	0	0
Precision and Science Technologies
Goodwill [Line Items]
Impairment of indefinite-lived intangible assets			$ 13,900,000
Industrial Technologies and Services
Goodwill [Line Items]
Accumulated impairment loss of goodwill	$ 220,600,000	$ 220,600,000

Goodwill and Other Intangible_6

Goodwill and Other Intangible Assets - Other Intangible Assets (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Amortized intangible assets:
Accumulated Amortization	$ (2,222.1)	$ (1,897.6)
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Gross Carrying Amount	6,594.9	5,508.7
Accumulated Amortization	(2,222.1)	(1,897.6)
Net Carrying Amount	4,372.8	3,611.1
Tradenames
Unamortized intangible assets:
Carrying amount	1,839.3	1,643.3
Customer lists and relationships
Amortized intangible assets:
Gross Carrying Amount	4,010.1	3,279.3
Accumulated Amortization	(1,830.1)	(1,585.4)
Net Carrying Amount	2,180	1,693.9
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	(1,830.1)	(1,585.4)
Technology
Amortized intangible assets:
Gross Carrying Amount	549.1	413.8
Accumulated Amortization	(243.3)	(178.9)
Net Carrying Amount	305.8	234.9
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	(243.3)	(178.9)
Tradenames
Amortized intangible assets:
Gross Carrying Amount	63.6	52.2
Accumulated Amortization	(32.4)	(27.9)
Net Carrying Amount	31.2	24.3
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	(32.4)	(27.9)
Backlog
Amortized intangible assets:
Gross Carrying Amount	4.3	3
Accumulated Amortization	(4.2)	(1.3)
Net Carrying Amount	0.1	1.7
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	(4.2)	(1.3)
Other
Amortized intangible assets:
Gross Carrying Amount	128.5	117.1
Accumulated Amortization	(112.1)	(104.1)
Net Carrying Amount	16.4	13
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	$ (112.1)	$ (104.1)

Supply Chain Finance Program (D

Supply Chain Finance Program (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Supplier Finance Program, Obligation [Roll Forward]
Confirmed obligations outstanding at beginning of period	$ 24.3	$ 9.7
Invoices confirmed	117	112.9
Confirmed invoices paid	$ (116.8)	$ (98.3)
Supplier finance program, obligation, statement of financial position	Accounts payable	Accounts payable
Confirmed obligations outstanding at end of period	$ 24.5	$ 24.3

Accrued Liabilities - Accrued L

Accrued Liabilities - Accrued Liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Accrued Liabilities [Abstract]
Salaries, wages and related fringe benefits	$ 229.5	$ 262.4
Contract liabilities	318.6	331.2
Product warranty	67.9	61.9	$ 46.2
Operating lease liabilities	56.3	41.6
Restructuring	22.3	15.5
Taxes	72.5	78.4
Accrued interest	33.2	33.1
Other	171.9	171.4
Total accrued liabilities	$ 972.2	$ 995.5
Operating lease, liability, current, statement of financial position	Total accrued liabilities	Total accrued liabilities

Accrued Liabilities - Accrued P

Accrued Liabilities - Accrued Product Warranty Liability (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Movement in Standard Product Warranty Accrual [Roll Forward]
Balance at the beginning of period	$ 61.9	$ 46.2
Product warranty accruals	37.5	44.4
Acquired warranty	0.7	2.2
Settlements	(30.7)	(31.2)
Foreign currency translation and other	(1.5)	0.3
Balance at the end of period	$ 67.9	$ 61.9

Debt - Schedule of Debt (Detail

Debt - Schedule of Debt (Details) - USD ($) $ in Millions	Dec. 31, 2024	May 31, 2024	May 10, 2024	Dec. 31, 2023	Aug. 14, 2023
Debt [Abstract]
Short-term borrowings	$ 1.7			$ 1
Long-term debt:
Finance leases and other long-term debt	14.1			15.2
Swap valuation adjustments	(0.3)			0
Unamortized debt issuance costs	(47)			(23.4)
Total long-term debt, net, including current maturities	4,755.8			2,722.6
Current maturities of long-term debt	1.4			29.6
Total long-term debt, net	4,754.4			2,693
Original issue discounts	11			9.9
Dollar Term Loan B, due 2027
Long-term debt:
Long-term debt	0			347.7
Weighted-average interest rate of debt instrument (as a percent)		7.18%
Dollar Term Loan, due 2027
Long-term debt:
Long-term debt	0			892.3
Weighted-average interest rate of debt instrument (as a percent)		7.18%
5.197% Senior Notes Due 2027 | Senior Notes
Long-term debt:
Long-term debt	$ 699.9			$ 0
Stated interest rate of debt instrument (as a percent)	5.197%		5.197%	5.197%
5.400% Senior Notes Due 2028 | Senior Notes
Long-term debt:
Long-term debt	$ 498.6			$ 498.2
Stated interest rate of debt instrument (as a percent)	5.40%			5.40%
5.176% Senior Notes Due 2029 | Senior Notes
Long-term debt:
Long-term debt	$ 750			$ 0
Stated interest rate of debt instrument (as a percent)	5.176%		5.176%	5.176%
5.314% Senior Notes Due 2031 | Senior Notes
Long-term debt:
Long-term debt	$ 500			$ 0
Stated interest rate of debt instrument (as a percent)	5.314%		5.314%	5.314%
5.700% Senior Notes Due 2033 | Senior Notes
Long-term debt:
Long-term debt	$ 993.4			$ 992.6
Stated interest rate of debt instrument (as a percent)	5.70%				5.70%
5.450% Senior Notes Due 2034 | Senior Notes
Long-term debt:
Long-term debt	$ 749.5			$ 0
Stated interest rate of debt instrument (as a percent)	5.45%		5.45%	5.45%
5.700% Senior Notes Due 2054 | Senior Notes
Long-term debt:
Long-term debt	$ 597.6			$ 0
Stated interest rate of debt instrument (as a percent)	5.70%		5.70%	5.70%

Debt - New Senior Notes (Detail

Debt - New Senior Notes (Details) - Senior Notes - USD ($)	May 10, 2024	Aug. 14, 2023	Dec. 31, 2024	Dec. 31, 2023
Debt Instrument [Line Items]
Aggregate principal amount	$ 3,300,000,000	$ 1,500,000,000
Debt Instrument, Redemption, Period One
Debt Instrument [Line Items]
Redemption price, percentage	100%	100%
5.197% Senior Notes Due 2027
Debt Instrument [Line Items]
Aggregate principal amount	$ 700,000,000
Stated interest rate of debt instrument (as a percent)	5.197%		5.197%	5.197%
5.176% Senior Notes Due 2029
Debt Instrument [Line Items]
Aggregate principal amount	$ 750,000,000
Stated interest rate of debt instrument (as a percent)	5.176%		5.176%	5.176%
5.314% Senior Notes Due 2031
Debt Instrument [Line Items]
Aggregate principal amount	$ 500,000,000
Stated interest rate of debt instrument (as a percent)	5.314%		5.314%	5.314%
5.450% Senior Notes Due 2034
Debt Instrument [Line Items]
Aggregate principal amount	$ 750,000,000
Stated interest rate of debt instrument (as a percent)	5.45%		5.45%	5.45%
5.700% Senior Notes Due 2054
Debt Instrument [Line Items]
Aggregate principal amount	$ 600,000,000
Stated interest rate of debt instrument (as a percent)	5.70%		5.70%	5.70%

Debt - Existing Senior Notes (D

Debt - Existing Senior Notes (Details) - Senior Notes - USD ($)	May 10, 2024	Aug. 14, 2023	Dec. 31, 2024	Dec. 31, 2023
Debt Instrument [Line Items]
Aggregate principal amount	$ 3,300,000,000	$ 1,500,000,000
Debt Instrument, Redemption, Period One
Debt Instrument [Line Items]
Redemption price, percentage	100%	100%
Debt Instrument, Redemption, Period Two
Debt Instrument [Line Items]
Redemption price, percentage		101%
5.400% Senior Notes Due 2028
Debt Instrument [Line Items]
Aggregate principal amount		$ 500,000,000
Stated interest rate of debt instrument (as a percent)			5.40%	5.40%
5.700% Senior Notes Due 2033
Debt Instrument [Line Items]
Aggregate principal amount		$ 1,000,000,000
Stated interest rate of debt instrument (as a percent)		5.70%	5.70%

Debt - Senior Secured Credit Fa

Debt - Senior Secured Credit Facilities (Details) - USD ($) $ in Millions		12 Months Ended
	Apr. 21, 2023	Dec. 31, 2024	Dec. 31, 2023	Apr. 20, 2023
Revolving Credit Facility
Debt Instrument [Line Items]
Unused borrowing capacity	$ 2,000			$ 1,100
Write-off of unamortized debt issuance costs	$ 0.9
Dollar Term Loan B, due 2027
Debt Instrument [Line Items]
Write-off of unamortized debt issuance costs		$ 3	$ 12.6

Debt - New Revolving Credit Fac

Debt - New Revolving Credit Facility (Details)	May 10, 2024 USD ($) extensionOption	Dec. 31, 2024 USD ($)
Revolving credit facility, due 2020 | Ingersoll Rand
Debt Instrument [Line Items]
Aggregate principal amount		$ 2,600,000,000
Letters of credit outstanding		200,000,000
Revolving credit facility, due 2024
Debt Instrument [Line Items]
Letters of credit outstanding		0
Long-term debt obligations		0
Unused borrowing capacity		$ 2,600,000,000
Revolving Credit Facility | New Revolving Credit Facility
Debt Instrument [Line Items]
Maximum borrowing capacity	$ 2,600,000,000
Debt instrument, extension options | extensionOption	2
Debt instrument, extension term	1 year
Basis spread on variable rate (as a percent)	0.10%
Debt instrument, covenant, adjusted consolidated total net debt to consolidated adjusted ebitda ratio, maximum	3.50
Debt instrument, covenant, following a qualified acquisition, adjusted consolidated total net debt to consolidated adjusted ebitda ratio, maximum	4

Debt - Commercial Paper Program

Debt - Commercial Paper Program (Details) - USD ($) $ in Millions	Aug. 13, 2024	Dec. 31, 2024
Debt Instrument [Line Items]
Line of credit facility, fair value of amount outstanding		$ 0
Commercial Paper | Commercial Paper Notes
Debt Instrument [Line Items]
Maximum borrowing capacity	$ 2,600
Line of credit facility, expiration period	397 days

Debt - Fair Value of Debt and T

Debt - Fair Value of Debt and Total Debt Maturities (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Debt Disclosure [Abstract]
Fair value of debt	$ 4,900	$ 2,800
Debt maturities, next twelve months	3.1
Debt maturities, year two	1.7
Debt maturities, year three	701.5
Debt maturities, year four	501.5
Debt maturities, year five	751.5
Debt maturities, after year five	$ 2,856.5

Benefit Plans - Reconciliation

Benefit Plans - Reconciliation of Changes in Benefit Obligations and Fair Value of Plan Assets (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Reconciliation of Fair Value of Plan Assets:
Beginning balance	$ 443.5
Fair value of plan assets ending balance	401.5	$ 443.5
Pension Benefits | U.S. Plans
Reconciliation of Benefit Obligations:
Beginning balance	294	319.8
Service cost	0.1	0.1	$ 4.4
Interest cost	13.4	15.7	11.3
Participant contributions	0	0
Plan amendments	0	0
Actuarial losses (gains)	(18.1)	6
Benefit payments	(22.2)	(16.1)
Acquisitions	0	0
Plan settlements	(2.5)	(31.5)
Other	0	0
Effect of foreign currency exchange rate changes	0	0
Benefit obligations ending balance	264.7	294	319.8
Reconciliation of Fair Value of Plan Assets:
Beginning balance	237.5	263.6
Actual return on plan assets	(6)	18.7
Employer contributions	0.1	2.8
Participant contributions	0	0
Acquisitions	0	0
Benefit payments	(22.2)	(16.1)
Plan settlements	(2.5)	(31.5)
Other	0	0
Effect of foreign currency exchange rate changes	0	0
Fair value of plan assets ending balance	206.9	237.5	263.6
Funded Status as of Period End	(57.8)	(56.5)
Pension Benefits | Non-U.S. Plans
Reconciliation of Benefit Obligations:
Beginning balance	263.2	247.5
Service cost	2.9	2.6	3.3
Interest cost	10.7	11.1	5.9
Participant contributions	0.2	0
Plan amendments	0	0.3
Actuarial losses (gains)	(11.3)	3.3
Benefit payments	(14.5)	(13.6)
Acquisitions	10.2	0
Plan settlements	0	0
Other	0.6	0
Effect of foreign currency exchange rate changes	(10.6)	12
Benefit obligations ending balance	251.4	263.2	247.5
Reconciliation of Fair Value of Plan Assets:
Beginning balance	206	196.4
Actual return on plan assets	(7.1)	6.7
Employer contributions	6.5	6.6
Participant contributions	0.2	0
Acquisitions	8.5	0
Benefit payments	(14.5)	(13.6)
Plan settlements	0	0
Other	0.6	0
Effect of foreign currency exchange rate changes	(5.6)	9.9
Fair value of plan assets ending balance	194.6	206	196.4
Funded Status as of Period End	(56.8)	(57.2)
Other Postretirement Benefits
Reconciliation of Benefit Obligations:
Beginning balance	18.3	21
Service cost	0	0
Interest cost	0.8	0.9	0.7
Participant contributions	0	0
Plan amendments	(10.9)	0
Actuarial losses (gains)	0.2	(1)
Benefit payments	(2.4)	(2.7)
Acquisitions	0	0
Plan settlements	0	0
Other	0	0
Effect of foreign currency exchange rate changes	(0.1)	0.1
Benefit obligations ending balance	5.9	18.3	$ 21
Reconciliation of Fair Value of Plan Assets:
Funded Status as of Period End	$ (5.9)	$ (18.3)

Benefit Plans - Recognized as C

Benefit Plans - Recognized as Component of Accumulated Other Comprehensive (Loss) Income (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Pension Benefits | U.S. Plans
Amounts Recognized as a Component of Accumulated Other Comprehensive (Loss) Income [Abstract]
Net actuarial losses (gains)	$ (10.8)	$ (11)
Prior service cost	0	0
Amounts included in accumulated other comprehensive income (loss)	(10.8)	(11)
Pension Benefits | Non-U.S. Plans
Amounts Recognized as a Component of Accumulated Other Comprehensive (Loss) Income [Abstract]
Net actuarial losses (gains)	7.6	(1.1)
Prior service cost	2.7	2.9
Amounts included in accumulated other comprehensive income (loss)	10.3	1.8
Other Postretirement Benefits
Amounts Recognized as a Component of Accumulated Other Comprehensive (Loss) Income [Abstract]
Net actuarial losses (gains)	(3.2)	(4.3)
Prior service cost	(10.9)	0.1
Amounts included in accumulated other comprehensive income (loss)	$ (14.1)	$ (4.2)

Benefit Plans - Pension and Oth

Benefit Plans - Pension and Other Postretirement Benefit Liabilities in Consolidated Balance Sheets (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Total Pension and Other Postretirement Benefit Liabilities Included in Balance Sheets [Abstract]
Other assets	$ 18.5	$ 18.8
Accrued liabilities	(6.4)	(6.2)
Pension and other postretirement benefits	$ (132.6)	$ (144.6)

Benefit Plans - Accumulated Ben

Benefit Plans - Accumulated Benefit Obligation in Excess of Plan Assets (Details) - Pension Benefits - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
U.S. Plans
Accumulated Benefit Obligation in Excess of Plan Assets [Abstract]
Projected benefit obligations	$ 264.7	$ 294
Accumulated benefit obligation	264.7	294
Fair value of plan assets	206.9	237.5
Accumulated benefit obligation	264.7	294
Non-U.S. Plans
Accumulated Benefit Obligation in Excess of Plan Assets [Abstract]
Projected benefit obligations	119.7	105.4
Accumulated benefit obligation	112.7	86.4
Fair value of plan assets	42.8	17
Accumulated benefit obligation	$ 243.3	$ 254.8

Benefit Plans - Net Periodic Be

Benefit Plans - Net Periodic Benefit Cost and Other Comprehensive (Loss) Income, Before Income Tax Effects (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Pension Benefits | U.S. Plans
Net Periodic Benefit Cost:
Service cost	$ 0.1	$ 0.1	$ 4.4
Interest cost	13.4	15.7	11.3
Expected return on plan assets	(12.7)	(13.2)	(13)
Amortization of net actuarial loss	0	0.1	0
Net periodic benefit cost	0.8	2.7	2.7
Loss (gain) due to settlement	0.4	(0.4)	(0.5)
Total net periodic benefit cost recognized	1.2	2.3	2.2
Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss):
Net actuarial loss (gain)	0.6	0.5	0.4
Amortization of net actuarial gain (loss)	(0.4)	0.3	0.5
Total recognized in other comprehensive income (loss)	0.2	0.8	0.9
Total recognized in net periodic benefit cost and other comprehensive income (loss)	1.4	3.1	3.1
Pension Benefits | Non-U.S. Plans
Net Periodic Benefit Cost:
Service cost	2.9	2.6	3.3
Interest cost	10.7	11.1	5.9
Expected return on plan assets	(11.2)	(11)	(11.8)
Amortization of prior-service cost	0.2	0.1	0.1
Amortization of net actuarial loss	(1.3)	(1.7)	0.3
Net periodic benefit cost	1.3	1.1	(2.2)
Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss):
Net actuarial loss (gain)	7	7.5	(33.3)
Amortization of net actuarial gain (loss)	1.3	1.7	(0.3)
Prior service cost	0	0.3	0
Amortization of prior service cost	(0.2)	(0.1)	(0.1)
Effect of foreign currency exchange rate changes	0.4	0.3	(3.2)
Total recognized in other comprehensive income (loss)	8.5	9.7	(36.9)
Total recognized in net periodic benefit cost and other comprehensive income (loss)	9.8	10.8	(39.1)
Other Postretirement Benefits
Net Periodic Benefit Cost:
Service cost	0	0
Interest cost	0.8	0.9	0.7
Amortization of prior-service cost	0.1	0.1	0
Amortization of net actuarial loss	(0.8)	(1.1)	0
Total net periodic benefit cost recognized	0.1	(0.1)	0.7
Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss):
Net actuarial loss (gain)	0.2	(1)	(5)
Amortization of net actuarial gain (loss)	0.8	1.1	0
Prior service cost	(10.9)	0	0
Amortization of prior service cost	(0.1)	(0.1)	0
Total recognized in other comprehensive income (loss)	(10)	0	(5)
Total recognized in net periodic benefit cost and other comprehensive income (loss)	$ (9.9)	$ (0.1)	$ (4.3)

Benefit Plans - Weighted Averag

Benefit Plans - Weighted Average Actuarial Assumptions (Details)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Pension Benefits | U.S. Plans
Weighted-average actuarial assumptions used to determine net periodic benefit cost:
Discount rate (as a percent)	5%	5.20%	2.70%
Expected long-term rate of return on plan assets (as a percent)	5.80%	5.40%	3.50%
Rate of compensation increases (as a percent)			3%
Weighted-average actuarial assumptions used to determine benefit obligations:
Discount rate (as a percent)	5.50%	5%	5.20%
Pension Benefits | Non-U.S. Plans
Weighted-average actuarial assumptions used to determine net periodic benefit cost:
Discount rate (as a percent)	4.20%	4.50%	1.60%
Expected long-term rate of return on plan assets (as a percent)	5.50%	5.50%	4.40%
Rate of compensation increases (as a percent)	5%	4.30%	4.30%
Weighted-average actuarial assumptions used to determine benefit obligations:
Discount rate (as a percent)	4.50%	4.20%	4.50%
Rate of compensation increases (as a percent)	5%	5%	4.30%
Other Postretirement Benefits | Minimum
Weighted-average actuarial assumptions used to determine net periodic benefit cost:
Discount rate (as a percent)	4.90%	4.90%	2.40%
Weighted-average actuarial assumptions used to determine benefit obligations:
Discount rate (as a percent)	4.40%	4.90%	4.90%
Other Postretirement Benefits | Maximum
Weighted-average actuarial assumptions used to determine net periodic benefit cost:
Discount rate (as a percent)	5.10%	5.20%	3%
Weighted-average actuarial assumptions used to determine benefit obligations:
Discount rate (as a percent)	5.40%	5.10%	5.20%

Benefit Plans - Assumed Health

Benefit Plans - Assumed Health Care Cost Trend Rate (Details) - Other Postretirement Benefits	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Weighted-average actuarial assumptions used to determine other postretirement benefit plans costs and obligations:
Healthcare cost trend rate assumed for next year (as a percent)	5.10%	6.80%	6.80%
Rate to which the cost trend rate is assumed to decline (the ultimate trend rate) (as a percent)	4%	4.40%	4.50%

Benefit Plans - Estimated Benef

Benefit Plans - Estimated Benefit Payments for the Next Five Years (Details) $ in Millions	Dec. 31, 2024 USD ($)
Pension Benefits | U.S. Plans
Defined Benefit Plan, Expected Future Benefit Payment [Abstract]
2025	$ 26.4
2026	25.1
2027	24.9
2028	23.9
2029	23.4
Aggregate 2030-2034	98.3
Expected future employer contributions in the next year	5.2
Pension Benefits | Non-U.S. Plans
Defined Benefit Plan, Expected Future Benefit Payment [Abstract]
2025	14.7
2026	14.9
2027	14.5
2028	15.1
2029	17.1
Aggregate 2030-2034	86
Expected future employer contributions in the next year	7.3
Other Postretirement Benefits
Defined Benefit Plan, Expected Future Benefit Payment [Abstract]
2025	2.4
2026	0.4
2027	0.4
2028	0.3
2029	0.3
Aggregate 2030-2034	1.3
Expected future employer contributions in the next year	$ 2.4

Benefit Plans - Long-Term Targe

Benefit Plans - Long-Term Target Allocations (Details)	12 Months Ended
	Dec. 31, 2024
Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets [Abstract]
Proportion of U.S. and U.K pension plans in total benefit obligation (as a percent)	76%
Proportion of U.S. and U.K pension plans in total plan assets (as a percent)	87%
U.S. Plans
Defined Benefit Plan, Plan Assets, Allocations [Abstract]
Long-term target allocations (as a percent)	100%
U.S. Plans | Equity
Defined Benefit Plan, Plan Assets, Allocations [Abstract]
Long-term target allocations (as a percent)	16%
U.S. Plans | Fixed income
Defined Benefit Plan, Plan Assets, Allocations [Abstract]
Long-term target allocations (as a percent)	83%
U.S. Plans | Real estate and other
Defined Benefit Plan, Plan Assets, Allocations [Abstract]
Long-term target allocations (as a percent)	1%
UK Plan
Defined Benefit Plan, Plan Assets, Allocations [Abstract]
Long-term target allocations (as a percent)	100%
UK Plan | Equity
Defined Benefit Plan, Plan Assets, Allocations [Abstract]
Long-term target allocations (as a percent)	12%
UK Plan | Fixed income
Defined Benefit Plan, Plan Assets, Allocations [Abstract]
Long-term target allocations (as a percent)	56%
UK Plan | Real estate and other
Defined Benefit Plan, Plan Assets, Allocations [Abstract]
Long-term target allocations (as a percent)	32%

Benefit Plans - Fair Values of

Benefit Plans - Fair Values of Pension Plan Assets by Asset Category (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	$ 401.5	$ 443.5
Total contribution to defined contribution plans	49.1	47	$ 46.6
Cash and cash equivalents
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	5.1	7.1
Total equity funds
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	67.3	65.1
U.S. small-cap
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0.9	3.7
U.S. mid-cap
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	2.6
U.S. large-cap
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	14.1	19.5
International equity
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	49.7	41.9
Fixed income
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	277.6	326.3
Corporate bonds - international
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	39.6	42.7
UK index-linked gilts
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	66	78.7
U.S. fixed income - government securities
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	20.5	43.2
U.S. fixed income - short duration
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	1.8	1.3
U.S. fixed income - intermediate duration
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	25.2	30.9
U.S. fixed income - long duration
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	122.7	122.3
Global fixed income
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	1.8	7.2
International real estate
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	11.6	15.4
Other
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	39.9	29.6
Investments Measured at NAV
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	231.2	259.1
Investments Measured at NAV | Cash and cash equivalents
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Investments Measured at NAV | Total equity funds
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	41.6	38.4
Investments Measured at NAV | U.S. small-cap
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0.9	3.7
Investments Measured at NAV | U.S. mid-cap
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	2.6
Investments Measured at NAV | U.S. large-cap
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	11.6	17.5
Investments Measured at NAV | International equity
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	26.5	17.2
Investments Measured at NAV | Fixed income
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	187.8	220.7
Investments Measured at NAV | Corporate bonds - international
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	15.8	15.8
Investments Measured at NAV | UK index-linked gilts
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Investments Measured at NAV | U.S. fixed income - government securities
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	20.5	43.2
Investments Measured at NAV | U.S. fixed income - short duration
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	1.8	1.3
Investments Measured at NAV | U.S. fixed income - intermediate duration
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	25.2	30.9
Investments Measured at NAV | U.S. fixed income - long duration
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	122.7	122.3
Investments Measured at NAV | Global fixed income
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	1.8	7.2
Investments Measured at NAV | International real estate
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Investments Measured at NAV | Other
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	1.8	0
Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	5.1	21.3
Quoted Prices in Active Markets for Identical Assets (Level 1) | Cash and cash equivalents
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	5.1	7.1
Quoted Prices in Active Markets for Identical Assets (Level 1) | Total equity funds
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	14.2
Quoted Prices in Active Markets for Identical Assets (Level 1) | U.S. small-cap
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | U.S. mid-cap
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | U.S. large-cap
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | International equity
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	14.2
Quoted Prices in Active Markets for Identical Assets (Level 1) | Fixed income
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Corporate bonds - international
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | UK index-linked gilts
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | U.S. fixed income - government securities
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | U.S. fixed income - short duration
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | U.S. fixed income - intermediate duration
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | U.S. fixed income - long duration
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Global fixed income
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | International real estate
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Other
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets
Significant Observable Inputs (Level 2)
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	127.1	133.5
Significant Observable Inputs (Level 2) | Cash and cash equivalents
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Significant Observable Inputs (Level 2) | Total equity funds
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	25.7	12.5
Significant Observable Inputs (Level 2) | U.S. small-cap
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Significant Observable Inputs (Level 2) | U.S. mid-cap
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0
Significant Observable Inputs (Level 2) | U.S. large-cap
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	2.5	2
Significant Observable Inputs (Level 2) | International equity
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	23.2	10.5
Significant Observable Inputs (Level 2) | Fixed income
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	89.8	105.6
Significant Observable Inputs (Level 2) | Corporate bonds - international
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	23.8	26.9
Significant Observable Inputs (Level 2) | UK index-linked gilts
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	66	78.7
Significant Observable Inputs (Level 2) | U.S. fixed income - government securities
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Significant Observable Inputs (Level 2) | U.S. fixed income - short duration
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Significant Observable Inputs (Level 2) | U.S. fixed income - intermediate duration
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Significant Observable Inputs (Level 2) | U.S. fixed income - long duration
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Significant Observable Inputs (Level 2) | Global fixed income
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Significant Observable Inputs (Level 2) | International real estate
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	11.6	15.4
Significant Observable Inputs (Level 2) | Other
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Significant Unobservable Inputs (Level 3)
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	38.1	29.6
Significant Unobservable Inputs (Level 3) | Cash and cash equivalents
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Significant Unobservable Inputs (Level 3) | Total equity funds
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Significant Unobservable Inputs (Level 3) | U.S. small-cap
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Significant Unobservable Inputs (Level 3) | U.S. mid-cap
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0
Significant Unobservable Inputs (Level 3) | U.S. large-cap
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Significant Unobservable Inputs (Level 3) | International equity
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Significant Unobservable Inputs (Level 3) | Fixed income
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Significant Unobservable Inputs (Level 3) | Corporate bonds - international
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Significant Unobservable Inputs (Level 3) | UK index-linked gilts
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Significant Unobservable Inputs (Level 3) | U.S. fixed income - government securities
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Significant Unobservable Inputs (Level 3) | U.S. fixed income - short duration
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Significant Unobservable Inputs (Level 3) | U.S. fixed income - intermediate duration
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Significant Unobservable Inputs (Level 3) | U.S. fixed income - long duration
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Significant Unobservable Inputs (Level 3) | Global fixed income
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Significant Unobservable Inputs (Level 3) | International real estate
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Significant Unobservable Inputs (Level 3) | Other
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	$ 38.1	$ 29.6

Stockholders' Equity and Nonc_2

Stockholders' Equity and Noncontrolling Interests (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Apr. 25, 2024	Aug. 24, 2021
Noncontrolling Interest [Line Items]
Voting common stock authorized (in shares)	1,000,000,000	1,000,000,000
Voting common stock outstanding (in shares)	402,880,079	403,347,394
Voting common stock, par value (in USD per share)	$ 0.01	$ 0.01
2021 Repurchase Program
Noncontrolling Interest [Line Items]
Amount authorized for repurchase					$ 750
Stock repurchased (in shares)	2,665,262	3,963,243	5,673,937
Weighted average exercise price (in shares)	$ 93.80	$ 62.98	$ 45.36
Stock repurchased	$ 250	$ 249.6	$ 257.3
Repurchase Program 2024
Noncontrolling Interest [Line Items]
Amount authorized for repurchase				$ 1,000
IR India Limited
Noncontrolling Interest [Line Items]
Ownership interest by parent (as a percent)	75%

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Income (Loss) - Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Balance at beginning of period	$ 9,846.7	$ 9,257.2	$ 9,071.2
Other comprehensive income (loss)	(238.2)	25.8	(217.3)
Balance at end of period	10,245.3	9,846.7	9,257.2
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Balance at beginning of period	(227.6)	(251.7)	(41.6)
Before tax income (loss)	(231.4)	7.4	(174.8)
Income tax effect	(9.5)	16.7	(35.3)
Other comprehensive income (loss)	(240.9)	24.1	(210.1)
Balance at end of period	(468.5)	(227.6)	(251.7)
Foreign Currency Translation Adjustments, Net
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Balance at beginning of period	(248)	(282.8)	(29.9)
Before tax income (loss)	(218.6)	23	(237.1)
Income tax effect	(13)	11.8	(15.8)
Other comprehensive income (loss)	(231.6)	34.8	(252.9)
Balance at end of period	(479.6)	(248)	(282.8)
Cash Flow Hedges
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Balance at beginning of period	12.2	16	0
Before tax income (loss)	(14.1)	(5.1)	21.3
Income tax effect	5	1.3	(5.3)
Other comprehensive income (loss)	(9.1)	(3.8)	16
Balance at end of period	3.1	12.2	16
Pension and Other Postretirement Benefit Plans
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Balance at beginning of period	8.2	15.1	(11.7)
Before tax income (loss)	1.3	(10.5)	41
Income tax effect	(1.5)	3.6	(14.2)
Other comprehensive income (loss)	(0.2)	(6.9)	26.8
Balance at end of period	$ 8	$ 8.2	$ 15.1

Accumulated Other Comprehensi_4

Accumulated Other Comprehensive Income (Loss) - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Foreign currency translation adjustments, net	$ 2.7	$ 1.7	$ (7.2)

Accumulated Other Comprehensi_5

Accumulated Other Comprehensive Income (Loss) - Changes in Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Balance at beginning of period	$ 9,846.7	$ 9,257.2	$ 9,071.2
Other comprehensive income (loss)	(238.2)	25.8	(217.3)
Balance at end of period	10,245.3	9,846.7	9,257.2
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Balance at beginning of period	(227.6)	(251.7)	(41.6)
Other comprehensive income (loss) before reclassifications	(214.8)	52.2	(203.5)
Amounts reclassified from accumulated other comprehensive income (loss)	(26.1)	(28.1)	(6.6)
Other comprehensive income (loss)	(240.9)	24.1	(210.1)
Balance at end of period	(468.5)	(227.6)	(251.7)
Foreign Currency Translation Adjustments, Net
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Balance at beginning of period	(248)	(282.8)	(29.9)
Other comprehensive income (loss) before reclassifications	(218.3)	49	(244.3)
Amounts reclassified from accumulated other comprehensive income (loss)	(13.3)	(14.2)	(8.6)
Other comprehensive income (loss)	(231.6)	34.8	(252.9)
Balance at end of period	(479.6)	(248)	(282.8)
Cash Flow Hedges
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Balance at beginning of period	12.2	16	0
Other comprehensive income (loss) before reclassifications	2.7	7.9	13.9
Amounts reclassified from accumulated other comprehensive income (loss)	(11.8)	(11.7)	2.1
Other comprehensive income (loss)	(9.1)	(3.8)	16
Balance at end of period	3.1	12.2	16
Pension and Other Postretirement Benefit Plans
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Balance at beginning of period	8.2	15.1	(11.7)
Other comprehensive income (loss) before reclassifications	0.8	(4.7)	26.9
Amounts reclassified from accumulated other comprehensive income (loss)	(1)	(2.2)	(0.1)
Other comprehensive income (loss)	(0.2)	(6.9)	26.8
Balance at end of period	$ 8	$ 8.2	$ 15.1

Accumulated Other Comprehensi_6

Accumulated Other Comprehensive Income (Loss) - Reclassifications out of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Interest expense	$ 213.2	$ 156.7	$ 103.2
Provision for income taxes	(262.5)	(240)	(149.6)
Net Income Attributable to Ingersoll Rand Inc.	838.6	778.7	604.7
Reclassification out of Accumulated Other Comprehensive (Loss) Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net Income Attributable to Ingersoll Rand Inc.	(26.1)	(28.1)	(6.6)
Cash Flow Hedges | Reclassification out of Accumulated Other Comprehensive (Loss) Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Interest expense	(15.7)	(15.6)	2.8
Provision for income taxes	3.9	3.9	(0.7)
Net Income Attributable to Ingersoll Rand Inc.	(11.8)	(11.7)	2.1
Accumulated Gain (Loss), Net Investment Hedge, Including Noncontrolling Interest | Reclassification out of Accumulated Other Comprehensive (Loss) Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Interest expense	(17.7)	(19)	(11.5)
Provision for income taxes	4.4	4.8	2.9
Net Income Attributable to Ingersoll Rand Inc.	(13.3)	(14.2)	(8.6)
Pension and Other Postretirement Benefit Plans | Reclassification out of Accumulated Other Comprehensive (Loss) Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Provision for income taxes	0.4	0.7	0
Cost of sales and Selling and administrative expenses	(1.4)	(2.9)	(0.1)
Net Income Attributable to Ingersoll Rand Inc.	$ (1)	$ (2.2)	$ (0.1)

Revenue from Contracts with C_3

Revenue from Contracts with Customers - Disaggregation of Revenue (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Disaggregation of Revenue [Abstract]
Revenues	$ 7,235	$ 6,876.1	$ 5,916.3
Revenue recognized at point in time
Disaggregation of Revenue [Abstract]
Revenues	6,672	6,383.4
Revenue recognized at point over time
Disaggregation of Revenue [Abstract]
Revenues	563	492.7
Original equipment
Disaggregation of Revenue [Abstract]
Revenues	4,604.2	4,416.8
Aftermarket
Disaggregation of Revenue [Abstract]
Revenues	2,630.8	2,459.3
Americas
Disaggregation of Revenue [Abstract]
Revenues	3,653.5	3,297.3
U.S. Plans
Disaggregation of Revenue [Abstract]
Revenues	3,112.3	2,895.2
Other Americas
Disaggregation of Revenue [Abstract]
Revenues	541.2	402.1
EMEIA
Disaggregation of Revenue [Abstract]
Revenues	2,374.9	2,267.5
Total Asia Pacific
Disaggregation of Revenue [Abstract]
Revenues	1,206.6	1,311.3
China
Disaggregation of Revenue [Abstract]
Revenues	794.6	924.6
Other Asia Pacific
Disaggregation of Revenue [Abstract]
Revenues	412	386.7
Industrial Technologies and Services
Disaggregation of Revenue [Abstract]
Revenues	5,818.1	5,632.8
Industrial Technologies and Services | Revenue recognized at point in time
Disaggregation of Revenue [Abstract]
Revenues	5,295.6	5,147.2
Industrial Technologies and Services | Revenue recognized at point over time
Disaggregation of Revenue [Abstract]
Revenues	522.5	485.6
Industrial Technologies and Services | Original equipment
Disaggregation of Revenue [Abstract]
Revenues	3,494	3,425.9
Industrial Technologies and Services | Aftermarket
Disaggregation of Revenue [Abstract]
Revenues	2,324.1	2,206.9
Industrial Technologies and Services | Americas
Disaggregation of Revenue [Abstract]
Revenues	2,914.1	2,701.1
Industrial Technologies and Services | U.S. Plans
Disaggregation of Revenue [Abstract]
Revenues	2,461.2	2,328
Industrial Technologies and Services | Other Americas
Disaggregation of Revenue [Abstract]
Revenues	452.9	373.1
Industrial Technologies and Services | EMEIA
Disaggregation of Revenue [Abstract]
Revenues	1,854.9	1,800.8
Industrial Technologies and Services | Total Asia Pacific
Disaggregation of Revenue [Abstract]
Revenues	1,049.1	1,130.9
Industrial Technologies and Services | China
Disaggregation of Revenue [Abstract]
Revenues	680.8	785.7
Industrial Technologies and Services | Other Asia Pacific
Disaggregation of Revenue [Abstract]
Revenues	368.3	345.2
Precision and Science Technologies
Disaggregation of Revenue [Abstract]
Revenues	1,416.9	1,243.3
Precision and Science Technologies | Revenue recognized at point in time
Disaggregation of Revenue [Abstract]
Revenues	1,376.4	1,236.2
Precision and Science Technologies | Revenue recognized at point over time
Disaggregation of Revenue [Abstract]
Revenues	40.5	7.1
Precision and Science Technologies | Original equipment
Disaggregation of Revenue [Abstract]
Revenues	1,110.2	990.9
Precision and Science Technologies | Aftermarket
Disaggregation of Revenue [Abstract]
Revenues	306.7	252.4
Precision and Science Technologies | Americas
Disaggregation of Revenue [Abstract]
Revenues	739.4	596.2
Precision and Science Technologies | U.S. Plans
Disaggregation of Revenue [Abstract]
Revenues	651.1	567.2
Precision and Science Technologies | Other Americas
Disaggregation of Revenue [Abstract]
Revenues	88.3	29
Precision and Science Technologies | EMEIA
Disaggregation of Revenue [Abstract]
Revenues	520	466.7
Precision and Science Technologies | Total Asia Pacific
Disaggregation of Revenue [Abstract]
Revenues	157.5	180.4
Precision and Science Technologies | China
Disaggregation of Revenue [Abstract]
Revenues	113.8	138.9
Precision and Science Technologies | Other Asia Pacific
Disaggregation of Revenue [Abstract]
Revenues	$ 43.7	$ 41.5

Revenue from Contracts with C_4

Revenue from Contracts with Customers - Performance Obligations (Details) $ in Millions	Dec. 31, 2024 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01
Revenue, Performance Obligation [Abstract]
Remaining performance obligation	$ 742.6
Remaining performance obligation, expected timing of satisfaction	12 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01
Revenue, Performance Obligation [Abstract]
Remaining performance obligation	$ 788.6
Remaining performance obligation, expected timing of satisfaction

Revenue from Contracts with C_5

Revenue from Contracts with Customers - Contract Balances (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Contract with Customer, Asset and Liability [Abstract]
Accounts receivable, net	$ 1,335.4	$ 1,234.2
Contract assets	111.2	85.6
Contract liabilities - current	318.6	331.2
Contract liabilities - noncurrent	$ 0.9	$ 1

Revenue from Contracts with C_6

Revenue from Contracts with Customers - Narrative (Details) $ in Millions	Dec. 31, 2023 USD ($)
Revenue from Contract with Customer [Abstract]
Contract liabilities	$ 332.2

Income Taxes - Income (Loss) Be

Income Taxes - Income (Loss) Before Income Taxes (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]
U.S.	$ 383.7	$ 356	$ 267.5
Non-U.S.	749.1	675.1	474.7
Income Before Income Taxes	$ 1,132.8	$ 1,031.1	$ 742.2

Income Taxes - Provision (Benef

Income Taxes - Provision (Benefit) for Income Taxes (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Current:
U.S. federal	$ 87.5	$ 111.5	$ 66.5
U.S. state and local	22.8	23.7	21.5
Non-U.S.	185.3	181.7	147.4
Deferred:
U.S. federal	(9.7)	(44)	(37.3)
U.S. state and local	(5.7)	(6.9)	(5.5)
Non-U.S.	(17.7)	(26)	(43)
Provision for income taxes	$ 262.5	$ 240	$ 149.6

Income Taxes - Effective Income

Income Taxes - Effective Income Tax Rate Reconciliation (Details)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Effective Income Tax Rate Reconciliation, Percent [Abstract]
U.S. federal corporate statutory rate	21%	21%	21%
State and local taxes, less federal tax benefit	1.40%	1.30%	2%
Net effects of foreign tax rate differential	2.50%	1.80%	1.50%
Withholding tax	1.30%	1.50%	2.10%
Repatriation cost	(1.50%)	(2.00%)	(3.20%)
Global Intangible Low-Tax Income (“GILTI”)	0.40%	0.70%	0.30%
ASC 740-30 (formerly APB 23)	1.50%	1.70%	1.90%
Valuation allowance changes	0.40%	1.70%	0.50%
Uncertain tax positions	0.90%	0.90%	0.20%
Equity compensation	(1.30%)	(0.60%)	(0.60%)
Nondeductible acquisition costs	0.30%	0.40%	0.40%
Foreign Derived Intangible Income (“FDII”) deduction	(1.10%)	(1.40%)	(1.60%)
Tax credits	(0.60%)	(0.70%)	(1.10%)
Income not subject to tax	(0.30%)	(1.60%)	(3.50%)
Amortization of goodwill and other intangible assets	(1.30%)	(0.80%)	0%
Interest on equity	(1.80%)	(0.70%)	(0.40%)
Return to provision adjustment	(0.20%)	0.10%	0%
Loss on sale	1.10%	0%	0%
Other, net	0.50%	0%	0.70%
Effective income tax rate	23.20%	23.30%	20.20%

Income Taxes - Deferred Tax Ass

Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Deferred Tax Assets:
Reserves and accruals	$ 83.4	$ 80.1
Allowance for credit losses	7.4	7.8
Inventory reserve	9	5.9
Pension and postretirement benefit plans	20	25.3
Tax loss carryforwards	112.4	81.3
Deferred taxes recorded in other comprehensive income	1.4	13.4
Foreign tax credit carryforwards	50.7	57.9
Other	22.4	32.2
Total deferred tax assets	306.7	303.9
Valuation allowance	(125.6)	(115.7)
Deferred Tax Liabilities:
LIFO inventory	(20.3)	(20.2)
Investment in partnership	(30.2)	(35.7)
Property, plant and equipment	(50)	(42.5)
Intangible assets	(770.4)	(635.4)
Unremitted foreign earnings	(41.8)	(35.5)
Total deferred tax liabilities	(912.7)	(769.3)
Net deferred income tax liability	$ (731.6)	$ (581.1)

Income Taxes - Net Operating Lo

Income Taxes - Net Operating Loss and Tax Credit Carryforwards (Details) $ in Millions	Dec. 31, 2024 USD ($)
Tax Credit Carryforward [Line Items]
Excess interest	$ 30
Other deferred tax assets	5
Total tax carryforwards	168.6
Valuation Allowance
Excess interest	(29.7)
Other deferred tax assets	(5)
Total tax carryforwards	(125.6)
Domestic Tax Jurisdiction
Tax Credit Carryforward [Line Items]
Net operating loss subject to expiration	13.3
Tax credit carryforward	50.8
Alternative minimum tax credit	0.5
Valuation Allowance
Net operating loss subject to expiration	(0.1)
Tax credit carryforward	(50.8)
Alternative minimum tax credit	(0.1)
Domestic Tax Jurisdiction | Capital Loss Carryforward
Tax Credit Carryforward [Line Items]
Capital loss	0.6
Valuation Allowance
Capital loss	(0.6)
State and Local Jurisdiction
Tax Credit Carryforward [Line Items]
Net operating loss subject to expiration	4.9
Valuation Allowance
Net operating loss subject to expiration	(2.1)
State and Local Jurisdiction | Capital Loss Carryforward
Tax Credit Carryforward [Line Items]
Tax credit carryforward	0.3
Valuation Allowance
Tax credit carryforward	(0.1)
Non U.S. Tax Authority
Tax Credit Carryforward [Line Items]
Net operating loss not subject to expiration	62.6
Valuation Allowance
Net operating loss not subject to expiration	(36.5)
Non U.S. Tax Authority | Capital Loss Carryforward
Tax Credit Carryforward [Line Items]
Tax credit carryforward	0.6
Valuation Allowance
Tax credit carryforward	$ (0.6)

Income Taxes - Valuation Allowa

Income Taxes - Valuation Allowance for Deferred Tax Assets (Details) - Valuation allowance for deferred tax assets - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Beginning balance	$ 115.7	$ 107.3	$ 106.4
Revaluation or additions due to acquisitions or mergers	22.9	0	0
Charged to tax expense	(10.8)	6.4	3.1
Charged to other accounts	(2.2)	2	(2.2)
Ending balance	$ 125.6	$ 115.7	$ 107.3

Income Taxes - Narrative (Detai

Income Taxes - Narrative (Details) $ in Millions	12 Months Ended
	Dec. 31, 2024 USD ($) Jurisdiction	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)
Income Tax Disclosure [Abstract]
Unrecognized tax benefits	$ 26.4	$ 19.1	$ 10.8	$ 21.1
Unrecognized tax benefits, that would effect effective tax rate if recognized	26.4
Interest and penalties accrued	$ 3.2	$ 2
Number of jurisdictions outside U.S. | Jurisdiction	48
Income tax reconciliation withholding tax	$ 41.8

Income Taxes - Unrecognized Tax

Income Taxes - Unrecognized Tax Benefits and Other Disclosures (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Unrecognized Tax Benefits [Roll Forward]
Beginning balance	$ 19.1	$ 10.8	$ 21.1
Gross increases for tax positions of prior years	0.8	0.4	0.4
Gross decreases for tax positions of prior years	(0.3)	0	(3.7)
Gross increases for tax positions of current year	8.1	7.9	4.1
Settlements	0	0	(9.9)
Lapse of statute of limitations	(0.6)	(0.2)	(0.1)
Changes due to currency fluctuations	(0.7)		(1.1)
Changes due to currency fluctuations		0.2
Ending balance	$ 26.4	$ 19.1	$ 10.8

Leases - Components of Lease Ex

Leases - Components of Lease Expense (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Lease, Cost [Abstract]
Operating lease cost	$ 64.5	$ 53.7
Finance lease cost
Amortization of right-of-use assets	1.5	1.5
Interest on lease liabilities	0.9	0.9
Total finance lease cost	2.4	2.4
Short-term lease cost	$ 2.2	$ 1.9

Leases - Supplemental Cash Flow

Leases - Supplemental Cash Flows Information (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Cash Paid for Amounts Included in the Measurement of Lease Liabilities
Operating cash flows from operating leases	$ 63.8	$ 53.7
Operating cash flows from finance leases	0.9	1
Financing cash flows from finance leases	1.3	1.2
Leased Assets Obtained in Exchange for New Operating Lease Liabilities	$ 96.2	$ 62.5

Leases - Supplemental Balance S

Leases - Supplemental Balance Sheet Information Related to Leases (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Operating leases
Operating lease, right-of-use asset, statement of financial position	Other assets	Other assets
Other assets	$ 226.6	$ 164.4
Operating Lease Liabilities, Gross Difference, Amount [Abstract]
Operating lease, liability, current, statement of financial position	Accrued liabilities	Accrued liabilities
Accrued liabilities	$ 56.3	$ 41.6
Operating lease, liability, noncurrent, statement of financial position	Other liabilities	Other liabilities
Other liabilities	$ 165.5	$ 116.9
Total operating lease liabilities	$ 221.8	$ 158.5
Finance Leases
Finance lease, right-of-use asset, statement of financial position	Property, plant and equipment, net of accumulated depreciation of $567.5 and $500.8, respectively	Property, plant and equipment, net of accumulated depreciation of $567.5 and $500.8, respectively
Property, plant and equipment	$ 11.1	$ 12.3
Finance Lease Liabilities, Gross Difference, Amount [Abstract]
Finance lease, liability, current, statement of financial position	Short-term borrowings and current maturities of long-term debt	Short-term borrowings and current maturities of long-term debt
Short-term borrowings and current maturities of long-term debt	$ 1.3	$ 1.3
Finance lease, liability, noncurrent, statement of financial position	Long-term debt, less current maturities	Long-term debt, less current maturities
Long-term debt, less current maturities	$ 12.6	$ 13.6
Total finance lease liabilities	$ 13.9	$ 14.9
Weighted Average Remaining Lease Term (in years)
Operating leases	5 years 2 months 12 days	5 years 1 month 6 days
Finance leases	9 years 4 months 24 days	10 years 3 months 18 days
Weighted Average Discount Rate
Operating leases (as a percent)	4.10%	3.60%
Finance leases (as a percent)	6.50%	6.40%

Leases - Maturities of Lease Li

Leases - Maturities of Lease Liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Operating Leases
2025	$ 63.6
2026	55.1
2027	41.3
2028	29.4
2029	17.7
Thereafter	39.2
Total lease payments	246.3
Less imputed interest	(24.5)
Total operating lease liabilities	221.8	$ 158.5
Finance Leases
2025	2.2
2026	2.1
2027	2.1
2028	2.1
2029	2.1
Thereafter	8.5
Total lease payments	19.1
Less imputed interest	(5.2)
Total finance lease liabilities	$ 13.9	$ 14.9

Compensation Related Costs, Sha

Compensation Related Costs, Share Based Payments (Details) - Continuing Operations	3 Months Ended	12 Months Ended
	Sep. 30, 2020 USD ($) employee	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense		$ 58,800,000	$ 51,900,000	$ 78,900,000
Share-based payment arrangement, total equity grant to employees	$ 150,000,000
Share-based payment arrangement, total equity grant to employees, number of employees | employee	16,000
Equity Awards | 2013 Stock Incentive Plan and 2017 Omnibus Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense		58,800,000	51,100,000	80,000,000
Stock Appreciation Rights (SARs) | 2013 Stock Incentive Plan and 2017 Omnibus Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense		$ 0	$ 800,000	$ (1,100,000)
Equity Awards - Founders Grant | 2013 Stock Incentive Plan and 2017 Omnibus Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 39,500,000

Stock-Based Compensation Plan_2

Stock-Based Compensation Plans - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended			12 Months Ended
	Mar. 31, 2024	Sep. 30, 2022	Sep. 30, 2020	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	May 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation expense				$ 110.6
Weighted average grant date fair value of stock options granted (in USD per share)				$ 38.97	$ 25.28	$ 21.24
Grant date and recognized in compensation expense over		4 years 3 months 18 days
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Issuance of common stock for stock-based compensation plans (in shares)		300,000		300,000
Total intrinsic value of stock options exercised				$ 114.8	$ 75	$ 27.7
Performance Share Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)	3 years	5 years
Volume-weighted average closing		60 days
Closing price per share (in USD per share)		$ 81.85
Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)			2 years
Omnibus Incentive Plan 2017 | Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award expiration period (in years)				10 years
2013 Stock Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Capital stock reserved for future issuance (in shares)				20,900,000
2013 Stock Incentive Plan | Tranche One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting rate (as a percent)				50%
2013 Stock Incentive Plan | Tranche Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting rate (as a percent)				50%
2013 Stock Incentive Plan | Tranche Three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting rate (as a percent)				50%
2013 Stock Incentive Plan | Performance Share Units | Tranche One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting rate (as a percent)				50%
2013 Stock Incentive Plan | Performance Share Units | Tranche Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting rate (as a percent)				50%
2013 Stock Incentive Plan | Performance Share Units | Tranche Three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting rate (as a percent)				50%
2013 Stock Incentive Plan | Stock Appreciation Rights (SARs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares outstanding (in shares)				0	0
Share-Based Payment Arrangement, Option, Five Year Vesting
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)				5 years
Share-Based Payment Arrangement, Option, Four Year Vesting
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)				4 years
Share-Based Payment Arrangement, Option, Three Year Vesting
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)				3 years
Minimum | Omnibus Incentive Plan 2017 | Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)				4 years
Maximum | Omnibus Incentive Plan 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Capital stock reserved for future issuance (in shares)							19,600,000
Maximum | Omnibus Incentive Plan 2017 | Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)				5 years

Stock-Based Compensation Plan_3

Stock-Based Compensation Plans - Stock Option Awards (Details) - Stock Options $ / shares in Units, shares in Thousands, $ in Millions	12 Months Ended
	Dec. 31, 2024 USD ($) $ / shares shares
Shares
Balance at beginning of period (in shares) | shares	5,282
Granted (in shares) | shares	610
Exercised or settled (in shares) | shares	(1,615)
Forfeited (in shares) | shares	(88)
Expired (in shares) | shares	(4)
Balance at end of period (in shares) | shares	4,185
Vested (in shares) | shares	2,708
Weighted-Average Exercise Price (per share)
Balance at beginning of period (in USD per share) | $ / shares	$ 31.09
Granted (in USD per share) | $ / shares	90.55
Exercised or settled (in USD per share) | $ / shares	19.96
Forfeited (in USD per share) | $ / shares	65.08
Expired (in USD per share) | $ / shares	40.22
Balance at end of period (in USD per share) | $ / shares	43.33
Vested (in USD per share) | $ / shares	$ 29.34
Weighted average remaining contractual term of options outstanding (in years)	5 years 6 months
Weighted average remaining contractual term of options vested (in years)	4 years 1 month 6 days
Aggregate intrinsic value of in-the-money options outstanding | $	$ 197.4
Aggregate intrinsic value of in-the-money options vested | $	$ 165.5

Stock-Based Compensation Plan_4

Stock-Based Compensation Plans - Assumptions Used to Estimate Fair Value (Details)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Expected life of options (in years)			6 years 3 months 18 days
Risk-free interest rate, minimum	3.70%	3.80%	1.90%
Risk-free interest rate, maximum	4.30%	4.60%	3.90%
Assumed volatility, minimum	34.90%	35.60%	37.10%
Assumed volatility, maximum	35.20%	36.60%	38.30%
Expected dividend rate	0.10%
Stock Options | Minimum
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Expected life of options (in years)	6 years 3 months 18 days	6 years 3 months 18 days
Expected dividend rate		0%	0.10%
Stock Options | Maximum
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Expected life of options (in years)	7 years 6 months	7 years 6 months
Expected dividend rate		0.10%	0.20%
Performance Share Units
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Expected life of options (in years)	2 years 9 months 18 days	2 years 10 months 24 days
Risk-free interest rate, minimum			1.70%
Risk-free interest rate, maximum			3.40%
Risk-free interest rate	4.50%	4.40%
Assumed volatility, minimum			35%
Assumed volatility, maximum			36.40%
Assumed volatility	28.90%	31.80%
Expected dividend rate	0.10%	0.10%	0.20%
Performance Share Units | Minimum
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Expected life of options (in years)			2 years 10 months 24 days
Performance Share Units | Maximum
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Expected life of options (in years)			5 years

Stock-Based Compensation Plan_5

Stock-Based Compensation Plans - Restricted Stock Unit Awards (Details) - Restricted Stock Units shares in Thousands	12 Months Ended
	Dec. 31, 2024 $ / shares shares
Shares
Balance at beginning of period (in shares) | shares	957
Granted (in shares) | shares	433
Vested (in shares) | shares	(469)
Forfeited (in shares) | shares	(87)
Balance at end of period (in shares) | shares	834
Weighted-Average Grant-Date Fair Value
Balance at beginning of period (in USD per share) | $ / shares	$ 52.18
Granted (in USD per share) | $ / shares	90.94
Vested (in USD per share) | $ / shares	47.96
Forfeited (in USD per share) | $ / shares	68.20
Balance at end of period (in USD per share) | $ / shares	$ 73

Stock-Based Compensation Plan_6

Stock-Based Compensation Plans - Performance Share Unit Awards (Details) - Performance Share Units shares in Thousands	12 Months Ended
	Dec. 31, 2024 $ / shares shares
Shares
Balance at beginning of period (in shares) | shares	1,380
Granted (in shares) | shares	87
Change in units based on performance (in shares) | shares	122
Vested (in shares) | shares	(244)
Forfeited (in shares) | shares	(6)
Balance at end of period (in shares) | shares	1,339
Weighted-Average Grant-Date Fair Value
Balance at beginning of period (in USD per share) | $ / shares	$ 49.53
Granted (in USD per share) | $ / shares	132.98
Change in units based on performance (in USD per share) | $ / shares	55.84
Vested (in USD per share) | $ / shares	55.84
Forfeited (in USD per share) | $ / shares	71.81
Balance at end of period (in USD per share) | $ / shares	$ 54.28

Hedging Activities, Derivativ_3

Hedging Activities, Derivative Instruments and Credit Risk - Narrative (Details) € in Millions		12 Months Ended
	May 10, 2024 USD ($)	Dec. 31, 2024 USD ($) contract	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2024 EUR (€) contract	May 07, 2024 USD ($)	Dec. 30, 2022 USD ($)	Feb. 29, 2020 EUR (€)
Derivatives, Fair Value [Line Items]
Off-balance sheet derivative instruments		$ 0	$ 0
Unrecognized gain (loss) on cash flow hedges		(9,100,000)	(3,800,000)	$ 16,000,000
Payments of interest rate cap premiums		$ 0	0	13,400,000
Euro Term Loan due in 2020
Derivatives, Fair Value [Line Items]
Amount of hedged item | €								€ 601.2
Foreign currency forwards
Derivatives, Fair Value [Line Items]
Number of instruments held | contract		9			9
Foreign currency forwards | Minimum
Derivatives, Fair Value [Line Items]
Notional amount		$ 7,700,000
Foreign currency forwards | Maximum
Derivatives, Fair Value [Line Items]
Term of derivative contract (in years)		1 year
Notional amount		$ 68,200,000
Interest rate swap contracts
Derivatives, Fair Value [Line Items]
Number of instruments held | contract		2			2
Gains, net of income tax				$ 36,400,000
Interest rate swap contracts | Fair value | 5.176% Senior Notes Due 2029
Derivatives, Fair Value [Line Items]
Number of instruments held | contract		4			4
Interest rate swap contracts | Fair value | 5.314% Senior Notes Due 2031
Derivatives, Fair Value [Line Items]
Number of instruments held | contract		2			2
Interest rate swap contracts | Fair value | 5.450% Senior Notes Due 2034
Derivatives, Fair Value [Line Items]
Number of instruments held | contract		1			1
Interest rate swap contracts | Fair value | Derivatives Designated as Hedging Instruments
Derivatives, Fair Value [Line Items]
Notional amount		$ 750,000,000
Interest rate swap contracts | Fair value | Derivatives Designated as Hedging Instruments | 5.176% Senior Notes Due 2029
Derivatives, Fair Value [Line Items]
Notional amount		400,000,000
Interest rate swap contracts | Fair value | Derivatives Designated as Hedging Instruments | 5.314% Senior Notes Due 2031
Derivatives, Fair Value [Line Items]
Notional amount		250,000,000
Interest rate swap contracts | Fair value | Derivatives Designated as Hedging Instruments | 5.450% Senior Notes Due 2034
Derivatives, Fair Value [Line Items]
Notional amount		100,000,000
Interest rate swap contracts | Fair value | Derivatives Designated as Hedging Instruments
Derivatives, Fair Value [Line Items]
Notional amount		528,500,000	528,500,000
Amount expected to be reclassified into earnings		$ 4,800,000
Fixed interest rate (as a percent)		3.20%			3.20%
Unrecognized gain (loss) on cash flow hedges		$ 4,800,000
Interest rate swap contracts | Fair value | Derivatives Designated as Hedging Instruments | 5.450% Senior Notes Due 2034
Derivatives, Fair Value [Line Items]
Notional amount		750,000,000
Amount expected to be reclassified into earnings						$ (2,100,000)
Interest rate swap contracts | Fair value | Derivatives Designated as Hedging Instruments | 5.700% Senior Notes Due 2054
Derivatives, Fair Value [Line Items]
Notional amount		$ 500,000,000
Amount expected to be reclassified into earnings						$ (2,300,000)
Interest rate cap contracts | Fair value | Derivatives Designated as Hedging Instruments
Derivatives, Fair Value [Line Items]
Derivative, cap interest rate		4%			4%
Gain recognized in OCI on derivatives		$ 1,300,000
Cross-currency interest rate swap contracts
Derivatives, Fair Value [Line Items]
Number of instruments held | contract		3			3
Cross-currency interest rate swap contracts | SOFR
Derivatives, Fair Value [Line Items]
Number of instruments held | contract		3			3
Cross-currency interest rate swap contracts | Net investment | Derivatives Designated as Hedging Instruments
Derivatives, Fair Value [Line Items]
Notional amount		$ 1,074,300,000	$ 1,054,200,000		€ 500
Fixed interest rate (as a percent)		1.60%			1.60%
Payments of interest rate cap premiums	$ 10,000,000
Cross-currency interest rate swap contracts | Net investment | Derivatives Designated as Hedging Instruments | SOFR
Derivatives, Fair Value [Line Items]
Notional amount		$ 525,700,000			€ 500
Payments of interest rate cap premiums	$ 9,900,000
Cross Currency Interest Rate Contract, 5.4% Fixed Rate | Net investment | Derivatives Designated as Hedging Instruments
Derivatives, Fair Value [Line Items]
Notional amount		$ 428,900,000
Fixed interest rate (as a percent)		5.40%			5.40%
Cross Currency Interest Rate Contract, Expiring May 2027 | Net investment | Derivatives Designated as Hedging Instruments
Derivatives, Fair Value [Line Items]
Notional amount | €					€ 400
Fixed interest rate (as a percent)		3.70%			3.70%
Cross Currency Interest Rate Contract, Expiring May 2029
Derivatives, Fair Value [Line Items]
Number of instruments held | contract		3			3
Cross Currency Interest Rate Contract, Expiring May 2029 | Net investment | Derivatives Designated as Hedging Instruments
Derivatives, Fair Value [Line Items]
Notional amount | €					€ 300
Fixed interest rate (as a percent)		4.10%			4.10%
Cross Currency Interest Rate Contract, 5.7% Fixed Rate One | Net investment | Derivatives Designated as Hedging Instruments
Derivatives, Fair Value [Line Items]
Notional amount		$ 322,700,000
Fixed interest rate (as a percent)		5.70%			5.70%
Cross Currency Interest Rate Contract, Expiring May 2031
Derivatives, Fair Value [Line Items]
Number of instruments held | contract		3			3
Cross Currency Interest Rate Contract, Expiring May 2031 | Net investment | Derivatives Designated as Hedging Instruments
Derivatives, Fair Value [Line Items]
Notional amount | €					€ 300
Fixed interest rate (as a percent)		4.10%			4.10%
Cross Currency Interest Rate Contract, 5.7% Fixed Rate Two | Net investment | Derivatives Designated as Hedging Instruments
Derivatives, Fair Value [Line Items]
Notional amount		$ 322,700,000
Fixed interest rate (as a percent)		5.70%			5.70%
Cross Currency Interest Rate Contract, 3.2% Fixed Rate
Derivatives, Fair Value [Line Items]
Number of instruments held | contract		2			2
Cross Currency Interest Rate Contract, 3.2% Fixed Rate | Net investment | Derivatives Designated as Hedging Instruments
Derivatives, Fair Value [Line Items]
Notional amount							$ 528,500,000
Fixed interest rate (as a percent)							3.20%

Hedging Activities, Derivativ_4

Hedging Activities, Derivative Instruments and Credit Risk - Balance Sheets (Details) € in Millions, $ in Millions	Dec. 31, 2024 USD ($)	Dec. 31, 2024 EUR (€)	Dec. 31, 2023 USD ($)
Interest rate swap contracts | Derivatives Designated as Hedging Instruments | Fair value
Derivatives, Fair Value [Line Items]
Notional Amount	$ 750
Interest rate swap contracts | Derivatives Designated as Hedging Instruments | Cash flow
Derivatives, Fair Value [Line Items]
Notional Amount	528.5		$ 528.5
Interest rate swap contracts | Fair Value Other Current Assets | Derivatives Designated as Hedging Instruments | Fair value
Derivatives, Fair Value [Line Items]
Assets fair value	0
Interest rate swap contracts | Fair Value Other Current Assets | Derivatives Designated as Hedging Instruments | Cash flow
Derivatives, Fair Value [Line Items]
Assets fair value			8.2
Interest rate swap contracts | Fair Value Other Assets | Derivatives Designated as Hedging Instruments | Fair value
Derivatives, Fair Value [Line Items]
Assets fair value	1.4
Interest rate swap contracts | Fair Value Other Assets | Derivatives Designated as Hedging Instruments | Cash flow
Derivatives, Fair Value [Line Items]
Assets fair value			1.2
Interest rate swap contracts | Fair Value Accrued Liabilities | Derivatives Designated as Hedging Instruments | Fair value
Derivatives, Fair Value [Line Items]
Liabilities fair value	0.9
Interest rate swap contracts | Fair Value Accrued Liabilities | Derivatives Designated as Hedging Instruments | Cash flow
Derivatives, Fair Value [Line Items]
Liabilities fair value			0
Interest rate swap contracts | Fair Value Other Liabilities | Derivatives Designated as Hedging Instruments | Fair value
Derivatives, Fair Value [Line Items]
Liabilities fair value	0.9
Interest rate swap contracts | Fair Value Other Liabilities | Derivatives Designated as Hedging Instruments | Cash flow
Derivatives, Fair Value [Line Items]
Liabilities fair value			0
Cross-currency interest rate swap contracts | Derivatives Designated as Hedging Instruments | Net investment
Derivatives, Fair Value [Line Items]
Notional Amount	1,074.3	€ 500	1,054.2
Cross-currency interest rate swap contracts | Fair Value Other Current Assets | Derivatives Designated as Hedging Instruments | Net investment
Derivatives, Fair Value [Line Items]
Assets fair value	11.5		15.7
Cross-currency interest rate swap contracts | Fair Value Other Assets | Derivatives Designated as Hedging Instruments | Net investment
Derivatives, Fair Value [Line Items]
Assets fair value	15.8		0
Cross-currency interest rate swap contracts | Fair Value Accrued Liabilities | Derivatives Designated as Hedging Instruments | Net investment
Derivatives, Fair Value [Line Items]
Liabilities fair value	0		0
Cross-currency interest rate swap contracts | Fair Value Other Liabilities | Derivatives Designated as Hedging Instruments | Net investment
Derivatives, Fair Value [Line Items]
Liabilities fair value	0		$ 63.1
Foreign currency forwards | Derivatives Not Designated as Hedging Instruments | Fair value
Derivatives, Fair Value [Line Items]
Notional Amount	124.3
Foreign currency forwards | Fair Value Other Current Assets | Derivatives Not Designated as Hedging Instruments | Fair value
Derivatives, Fair Value [Line Items]
Assets fair value	1.8
Foreign currency forwards | Fair Value Other Assets | Derivatives Not Designated as Hedging Instruments | Fair value
Derivatives, Fair Value [Line Items]
Assets fair value	0
Foreign currency forwards | Fair Value Accrued Liabilities | Derivatives Not Designated as Hedging Instruments | Fair value
Derivatives, Fair Value [Line Items]
Liabilities fair value	0
Foreign currency forwards | Fair Value Other Liabilities | Derivatives Not Designated as Hedging Instruments | Fair value
Derivatives, Fair Value [Line Items]
Liabilities fair value	0
Foreign currency forwards | Derivatives Not Designated as Hedging Instruments | Fair value
Derivatives, Fair Value [Line Items]
Notional Amount	69
Foreign currency forwards | Fair Value Other Current Assets | Derivatives Not Designated as Hedging Instruments | Fair value
Derivatives, Fair Value [Line Items]
Assets fair value	0
Foreign currency forwards | Fair Value Other Assets | Derivatives Not Designated as Hedging Instruments | Fair value
Derivatives, Fair Value [Line Items]
Assets fair value	0
Foreign currency forwards | Fair Value Accrued Liabilities | Derivatives Not Designated as Hedging Instruments | Fair value
Derivatives, Fair Value [Line Items]
Liabilities fair value	1.2
Foreign currency forwards | Fair Value Other Liabilities | Derivatives Not Designated as Hedging Instruments | Fair value
Derivatives, Fair Value [Line Items]
Liabilities fair value	$ 0

Hedging Activities and Derivati

Hedging Activities and Derivative Instruments - Schedule of Long Term Hedge (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Hedged Liability, Statement of Financial Position [Extensible Enumeration]	Long-term debt, less current maturities
Carrying amount of hedged debt	$ 749.7	$ 0
Cumulative hedging adjustments, included in carrying amount	$ (0.3)	$ 0

Hedging Activities, Derivativ_5

Hedging Activities, Derivative Instruments and Credit Risk - Cash Flow Hedges included in Accumulated Other Comprehensive Income (Loss) (Details) - Interest rate swap contracts - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Gains and Losses on Derivatives Designated as Cash Flow Hedges [Abstract]
Gain recognized in OCI on derivatives	$ 1.6	$ 10.5	$ 18.3
Gain (loss) reclassified from AOCI into income (effective portion)	$ 15.7	$ 15.6	$ (2.8)

Hedging Activities, Derivativ_6

Hedging Activities, Derivative Instruments and Credit Risk -Schedule of Net Investment Hedges included in Accumulated Other Comprehensive Income (Loss) (Details) - Cross-currency interest rate swap contracts - Net investment - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain (loss) recognized in OCI on derivatives	$ 72.5	$ (17.5)	$ 0.6
Gain (loss) reclassified from AOCI into income (effective portion)	$ 17.7	$ 19	$ 11.5

Hedging Activities, Derivativ_7

Hedging Activities, Derivative Instruments and Credit Risk - Derivative Instruments not Designated as Accounting Hedges (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Foreign Currency Derivative Instruments Not Designated as Hedging Instruments at Fair Value, Net [Abstract]
Total foreign currency transaction gains (losses), net	$ (3.2)	$ (5.1)	$ 5.9
Foreign currency forward contracts gains
Foreign Currency Derivative Instruments Not Designated as Hedging Instruments at Fair Value, Net [Abstract]
Total foreign currency transaction gains (losses), net	$ 0.1	$ 0.3	$ 3.4

Fair Value Measurements - Fair

Fair Value Measurements - Fair Value Measurements (Details) - Recurring - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Financial Assets
Trading securities held in deferred compensation plan	$ 21	$ 16.8
Interest rate swaps	1.4	9.4
Cross-currency interest rate swaps	27.3	15.7
Foreign currency forwards	1.8
Total	51.5	41.9
Financial Liabilities
Deferred compensation plan	28.7	24.7
Interest rate swaps	1.8
Cross-currency interest rate swaps		63.1
Contingent consideration	22.2	42.2
Foreign currency forwards	1.2
Total	53.9	130
Level 1
Financial Assets
Trading securities held in deferred compensation plan	21	16.8
Interest rate swaps	0	0
Cross-currency interest rate swaps	0	0
Foreign currency forwards	0
Total	21	16.8
Financial Liabilities
Deferred compensation plan	28.7	24.7
Interest rate swaps	0
Cross-currency interest rate swaps		0
Contingent consideration	0	0
Foreign currency forwards	0
Total	28.7	24.7
Level 2
Financial Assets
Trading securities held in deferred compensation plan	0	0
Interest rate swaps	1.4	9.4
Cross-currency interest rate swaps	27.3	15.7
Foreign currency forwards	1.8
Total	30.5	25.1
Financial Liabilities
Deferred compensation plan	0	0
Interest rate swaps	1.8
Cross-currency interest rate swaps		63.1
Contingent consideration	0	0
Foreign currency forwards	1.2
Total	3	63.1
Level 3
Financial Assets
Trading securities held in deferred compensation plan	0	0
Interest rate swaps	0	0
Cross-currency interest rate swaps	0	0
Foreign currency forwards	0
Total	0	0
Financial Liabilities
Deferred compensation plan	0	0
Interest rate swaps	0
Cross-currency interest rate swaps		0
Contingent consideration	22.2	42.2
Foreign currency forwards	0
Total	$ 22.2	$ 42.2

Fair Value Measurements - Conti

Fair Value Measurements - Contingent Consideration (Details) - Contingent Consideration - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at beginning of period	$ 42.2	$ 43.9
Acquisitions	6.7	13.5
Changes in fair value	(15.3)	7.3
Payments	(10)	(23.2)
Foreign currency translation and other	(1.4)	0.7
Balance at end of period	$ 22.2	$ 42.2

Contingencies - Narrative (Deta

Contingencies - Narrative (Details) $ in Millions		3 Months Ended	12 Months Ended
	Jun. 05, 2024 USD ($) subsidiary	Jun. 30, 2024 USD ($)	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)
Loss Contingencies [Line Items]
Number of subsidiaries that hold asbestos liabilities and assets | subsidiary	3
Discontinued Operation Gain Loss On Disposal Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag			after-tax loss
Undiscounted accrual liabilities for environmental loss contingencies			$ 13.6	$ 16.7
Discontinued Operations, Disposed of by Sale | Asbestos Portfolio Sale
Loss Contingencies [Line Items]
Proceeds from divestiture of businesses	$ 188.5
Pre tax loss		$ 58.8	58.8
Income tax benefit		7.6	7.6
Loss after tax		$ 51.2	$ 51.2
Discontinued Operations, Disposed of by Sale | Asbestos Portfolio Sale | Insurance Settlement
Loss Contingencies [Line Items]
Proceeds from divestiture of businesses	143.5
Delticus Holdings LLC | Discontinued Operations, Disposed of by Sale | Asbestos Portfolio Sale
Loss Contingencies [Line Items]
Proceeds from divestiture of businesses	35
Ingersoll Rand | Discontinued Operations, Disposed of by Sale | Asbestos Portfolio Sale
Loss Contingencies [Line Items]
Proceeds from divestiture of businesses	$ 10
InTelCo | Onyx TopCo LLC
Loss Contingencies [Line Items]
Ownership interest	100%
Asbestos and Silica Related Litigation
Loss Contingencies [Line Items]
Estimated litigation liability				126.9
Insurance recovery receivable				$ 157.7

Contingencies - Schedule of Dis

Contingencies - Schedule of Discontinued Operations (Details) - Discontinued Operations, Disposed of by Sale - Asbestos Portfolio Sale - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2024
Assets divested:
Cash and cash equivalents		$ 153.5
Insurance recovery receivable		13.9
Liabilities divested:
Asbestos indemnity liability - current		(12.3)
Asbestos indemnity liability - noncurrent		(111.4)
Loss on Asbestos Sale, before transaction costs		43.7
Transaction costs		15.1
Loss on Asbestos Sale	$ 58.8	58.8
Income tax benefit	(7.6)	(7.6)
Loss on Asbestos Sale, net of tax	$ 51.2	$ 51.2

Other Operating Expense, Net (D

Other Operating Expense, Net (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Other Operating Expense, Net
Foreign currency transaction losses (gains), net	$ 3.2	$ 5.1	$ (5.9)
Restructuring charges, net	31.2	19.9	29.3
Acquisition and other transaction related expenses	47.1	52.2	38.7
Loss on asbestos sale	58.8	0	0
Other, net	(1.7)	0.5	2.8
Total other operating expense, net	$ 138.6	$ 77.7	$ 64.9

Segment Reporting - Narrative (

Segment Reporting - Narrative (Details)	12 Months Ended
	Dec. 31, 2024 segment
Segment Reporting [Abstract]
Number of reportable segments	2

Segment Reporting - Segment Res

Segment Reporting - Segment Results (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Segment Reporting [Abstract]
Revenues	$ 7,235	$ 6,876.1	$ 5,916.3
Segment cost of sales	4,065	3,993.9	3,590.7
Segment selling and administrative expenses	1,344.4	1,272.7	1,095.8
Other operating expense, net	(138.6)	(77.7)	(64.9)
Adjusted EBITDA	2,173.6	1,960.1	1,561.5
Less items to reconcile Segment Adjusted EBITDA to Income from Continuing Operations Before Income Taxes:
Interest expense	213.2	156.7	103.2
Impairment of other intangible assets	13.9	0	0
Restructuring and related business transformation costs	32.3	22.9	32.3
Stock-based compensation	58.8	51.9	78.9
Foreign currency transaction losses (gains), net	3.2	5.1	(5.9)
Loss on extinguishment of debt	3	13.5	1.1
Adjustments to LIFO inventories	6.7	12	36.1
Loss on asbestos sale	58.8	0	0
Income Before Income Taxes	1,132.8	1,031.1	742.2
Depreciation of rental equipment	4	3.7	3.4
Restructuring Costs [Abstract]
Restructuring charges	31.2	19.9	29.3
Facility reorganization, relocation and other costs	1.1	3	3
Total restructuring and related business transformation costs	32.3	22.9	32.3
Stock-based compensation expense recognized in continuing operations			78.9
Increase (decrease) in stock-based compensation expense due to costs associated with employer taxes			6.7
Total depreciation and amortization expense	482	459.1	432.8
Total capital expenditures	149.1	105.4	94.6
Total identifiable assets	18,009.8	15,563.5
Industrial Technologies and Services
Segment Reporting [Abstract]
Revenues	5,818.1	5,632.8
Precision and Science Technologies
Segment Reporting [Abstract]
Revenues	1,416.9	1,243.3
Operating segments
Segment Reporting [Abstract]
Segment cost of sales	3,929.5	3,873.8	3,437.9
Segment selling and administrative expenses	1,133.1	1,041	915.1
Other operating expense, net	(1.2)	1.2	1.8
Operating segments | Industrial Technologies and Services
Segment Reporting [Abstract]
Revenues	5,818.1	5,632.8	4,705.1
Segment cost of sales	3,193.3	3,225	2,785.5
Segment selling and administrative expenses	868.5	818.5	702.5
Other operating expense, net	1.5	2	3.1
Adjusted EBITDA	1,754.8	1,587.3	1,214
Restructuring Costs [Abstract]
Total depreciation and amortization expense	296	313.8	294.7
Total capital expenditures	83	83.9	66.3
Total identifiable assets	10,369.6	10,138.8
Operating segments | Precision and Science Technologies
Segment Reporting [Abstract]
Revenues	1,416.9	1,243.3	1,211.2
Segment cost of sales	736.2	648.8	652.4
Segment selling and administrative expenses	264.6	222.5	212.6
Other operating expense, net	(2.7)	(0.8)	(1.3)
Adjusted EBITDA	418.8	372.8	347.5
Restructuring Costs [Abstract]
Total depreciation and amortization expense	177.1	135.4	133.6
Total capital expenditures	21.3	18.5	17.7
Total identifiable assets	5,884.1	3,464.7
Corporate and other
Less items to reconcile Segment Adjusted EBITDA to Income from Continuing Operations Before Income Taxes:
Corporate expenses not allocated to segments	155.5	173.3	126.7
Restructuring Costs [Abstract]
Total depreciation and amortization expense	8.9	9.9	4.5
Total capital expenditures	44.8	3	10.6
Total identifiable assets	1,756.1	1,960
Assets of discontinued operations
Less items to reconcile Segment Adjusted EBITDA to Income from Continuing Operations Before Income Taxes:
Interest expense	213.2	156.7	103.2
Depreciation and amortization expense	478	455.4	429.4
Impairment of other intangible assets	13.9	0	0
Restructuring and related business transformation costs	32.3	22.9	32.3
Acquisition and other transaction related expenses and non-cash charges	59.8	63.9	40.7
Stock-based compensation	58.8	51.9	85.6
Foreign currency transaction losses (gains), net	3.2	5.1	(5.9)
Loss on extinguishment of debt	3	13.5	1.1
Adjustments to LIFO inventories	6.7	12	36.1
Cybersecurity incident costs	0.5	2.3	0
Loss on asbestos sale	58.8	0	0
Gain on settlement of post-acquisition contingencies	0	0	(6.2)
Interest income on cash and cash equivalents	(43.3)	(28.8)	(8)
Other adjustments	0.4	0.8	(15.7)
Restructuring Costs [Abstract]
Total restructuring and related business transformation costs	$ 32.3	$ 22.9	$ 32.3

Segment Reporting - Property, P

Segment Reporting - Property, Plant and Equipment by Geographic Region (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	$ 842.1	$ 711.4
Reportable geographical components | Americas
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	419.9	298.8
Reportable geographical components | United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	381.8	286
Reportable geographical components | Other Americas
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	38.1	12.8
Reportable geographical components | EMEIA
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	256.5	245.7
Reportable geographical components | Total Asia Pacific
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	165.7	166.9
Reportable geographical components | China
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	152.3	160.9
Reportable geographical components | Other Asia Pacific
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	$ 13.4	$ 6

Earnings Per Share - Basic and

Earnings Per Share - Basic and Diluted Earnings Per Share (Details) - shares shares in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Average shares outstanding:
Weighted-average shares outstanding - Basic (in shares)	403.4	404.8	405.3
Dilutive effect of outstanding share-based compensation awards (in shares)	3.8	4.2	4.9
Weighted-average shares outstanding - Diluted (in shares)	407.2	409	410.2

Earnings Per Share - Narrative

Earnings Per Share - Narrative (Details) - shares shares in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Earnings Per Share [Abstract]
Antidilutive securities excluded from computation of earnings (loss) per share (in shares)	0.5	1.3	1.8

Subsequent Events (Details)

Subsequent Events (Details) € in Millions, $ in Millions		12 Months Ended
	Feb. 03, 2025 USD ($) Trademark	Dec. 31, 2024 USD ($) contract	Dec. 31, 2023 USD ($) business	Dec. 31, 2022 USD ($)	Feb. 11, 2025 EUR (€) contract	Dec. 31, 2024 EUR (€) contract
Cross-currency interest rate swap contracts
Subsequent Event [Line Items]
Number of instruments held | contract		3				3
Cross-currency interest rate swap contracts | Net investment | Derivatives Designated as Hedging Instruments
Subsequent Event [Line Items]
Notional amount		$ 1,074.3	$ 1,054.2			€ 500
Subsequent Event | Cross-currency interest rate swap contracts | Net investment | Derivatives Designated as Hedging Instruments
Subsequent Event [Line Items]
Number of instruments held | contract					2
Notional amount | €					€ 250
All others
Subsequent Event [Line Items]
Number of businesses acquired | business			10
Aggregate consideration | $		$ 55.6	$ 83.3	$ 19.9
All others | Subsequent Event
Subsequent Event [Line Items]
Number of businesses acquired | Trademark	4
Aggregate consideration | $	$ 168